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SUMMARY
A lambda EMBL4 genomic clone was isolated from a trypanosome gene 
library using a 1500bp rat liver glucose transporter cDNA probe. Restriction mapping 
and Southern blot analysis identified an insert of about 2550bp. This was sequenced and 
found to have an open reading frame of 1731 bp and encoding a protein with a predicted 
molecular weight of 63,346 daltons. An enriched plasmid library of trypanosome 
genomic fragments hybridizing to the cDNA, was also constructed and screened with the 
cDNA and with an oligonucleotide probe encompassing the putative glucose binding site 
of the GT superfamily. One of the clones isolated was identical in sequence to the 
lambda clone.
Analysis of the sequence showed that the gene contained a classical 
eukaryotic promoter core structure. The modular arrangement of the gene includes a 
TATA box and a CCAAT box, both of which are consistent with a RNA polll- 
transcribed gene. This is the first report of what appears to be a classical promoter in 
Kinetoplastid genes. The codon usage of this gene is consistent with that of trypanosome 
genes, and with that of a lowly or poorly expressed gene.
Run-off transcripts from the gene in pBluescript were used for in vitro 
translation in a rabbit reticulocyte lysate system. This yielded a protein of about 34-36kD 
on a SDS-PAGE fluorogram.
Northern blot analysis using the gene as probe on RNAs of the 
developmental forms of the parasite (bloodstream and insect/culture forms), indicated that 
it may be differentially expressed in the bloodstream form, a view that may be ascribed
XV
to the location of a putative enhancer core upstream of the start of transcription. This 
motif is associated with developmentally regulated genes, serving as a hot-spot for gene 
conversion or rearrangement. This gene may therefore be "mobile".
At the amino acid, the protein bears little (global) homology to the glucose 
transporter superfamily. However, there is limited/segmental homology to the probes 
used to clone it, some of which correspond to conserved motifs in the superfamily. 
Hydrophobicity analysis indicated that it lacked the classical putative 12 membrane- 
spanning domains typical of the glucose transporters. This is attributed to a 
preponderance of charged groups in the sequence. The presence of potential N-linked 
glycosylation sites analogous to those in the GT family indicate that it may be a 
glycoprotein.
A run of regularly spaced arginine residues within the sequence was noted, 
and the implications for a channel or a coupled carrier are discussed within the context 
of similar observations in ligand- and voltage-gated channels.
On the basis of the diminished hydropathy profile and limited homology 
to the GTs, the cloned gene may not encode a glucose transporter. IF it does, it is 
substantially different from the rest of the family.
A comparison of the C-terminus of the protein with those of 
microbody/peroxisomal proteins identified a topogenic signal that is highly homologous, 
and may suggest that the protein is probably targeted to the glycosome. This may be 
credible on the basis of the similarities shared between this protein and other glycosomal 
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1.1 Overview of the trypanosomiases: aetiology and epidemiology
The two genera of the Trypanosomatidae which are of medical/economic 
importance to man are the Trypanosoma and the Leishmania. Within the Trypanosoma 
are the Stercoraria, which are transmitted through the excrement of reduviid bugs, and 
the Salivaria, which constitute the largest collection of trypanosomes and are transmitted 
prandially. T. cruzi. the most medically important Stercorarian, is the etiological agent 
of Chagas disease. Human infection is endemic throughout major regions of South and 
Central America between latitudes 40°N and 40°S (1). The chief vectors are the 
hemipterans Triatoma infestans. T. braziliensis and Rhodnius prolixus. The early stages 
of metacyclic T. cruzi infection are typified by conjunctivitis or a "chagoma" depending 
on their destination. This phase may be fatal due to the development of febrile 
paroxysms, lymphadenopathy and malaise. The subsequent phase is asymptomatic, 
irregular and protracted, while the chronic phase follows with cardiac and visceral 
involvement which invariably are enlarged. In the meantime, the host is 
immunocompromised as the parasite develops a predilection for macrophages.
Trypanosoma brucei. the agent of African trypanosomiasis or sleeping 
sickness, is a complex of various strains differing more in their virulence than in their 
life styles or morphology. The most significant difference between both forms of 
trypanosomiasis is the degree of severity. Whereas African trypanosomiasis is inevitably 
terminal in its prognosis, Chagas disease may remain chronic for a lifetime with no overt
2symptoms despite occasional recrudescence of parasitaemia.
African trypanosomiasis is spread by the tsetse fly Glossina spp. Of this 
there are various strains that differ in the strain of trypanosome they transmit. The main 
vectors for T.b. rhodesiense. which causes the rhodesian or East African form of the 
disease, are G. morsitans. G. swvnertonni and G. pallidipes. These inhabit the woodlands 
and savanna regions of East Africa. The gambian or West African form of the disease is 
caused by T.b. gambiense which is transmitted by G. fascines. G. palpal is and G. 
tachinoides. These inhabit riverine vegetation. The distribution of these vectors is 
inextricably linked to that of the two forms of the disease as depicted in the map below.
Needless to say, both diseases ravage large populations of the Third world 
and to date, are refractory to chemotherapy. They are two of the six major tropical 
diseases targeted by the WHO Special Programme for Research and Training in Tropical 
Diseases (TDR).
3Fig. 1 Distribution of the African trypanosome and trypanosomiasis. The 
distribution of the Gambian (G) and Rhodesian (R) forms of the parasite 
and disease are as indicated.
1.2 Medical and economic importance
African sleeping sickness is rife in regions of great deprivation. The 
sociobiology of the tsetse fly is intimately linked to population movements in sub-Saharan 
Africa, and the economic geography of several countries has been affected by the disease. 
Its fatal nature means that not only human populations are at risk of elimination, but also 
large herds of cattle are lost through the animal form of the disease- nagana. Thousands 
of people and cattle are infected or at risk of infection each year. The loss of large 
reserves of fertile arable land as a result of population drift from tsetse fly infested zones, 
coupled with the debilitation of people and cattle, produces unmitigated misery in national 
economies. Malnutrition or under-nutrition as a result of the loss of cattle, a vital source 
of meat and milk, is an intractable sequel to trypanosome afflictions. The refractory nature 
of the disease, and the inability of national economies to deal with it due to the lack of 
proper surveillance, equipment or trained man-power, makes the plight of many real 
indeed. Even though large areas have been rendered tsetse-free, there remain residual foci 
of smoldering endemicity from which new cases may evolve sporadically.
The importance of this disease to mankind is reflected in concerted efforts 
worldwide to eliminate it at the level of the vector or through drug-targeting strategies in 
the parasite.
1.3 Basic biology of the African trypanosome
1.3.1 Identification and classification
The trypanosomes are dixenic parasites, infecting both vertebrates and 
invertebrates, and are characterized by flagella and kinetoplasts. In the bloodstream, the 
flagellum is the organ for motility but is modified for attachment in the insect vector. The 
characteristic morphological forms are the fusiform trypomastigotes, typically found in 
blood and tissues of their vertebrate hosts, and the epimastigotes in the invertebrate 
vector. They vary in shape and size from 15-100um in diameter. They have a typical unit 
plasma membrane approximately 2-4nm in width, which consists of dense osmiophilic 
layers on the periphery and separated by a clear layer (1). The flagellar pocket at the base 
of the flagellum is lined by the plasma membrane, and modified for food intake by 
pinocytosis.
Trypanosome classification has been based on a combination of phenotypic 
and genotypic features of the various strains. Similar structural features e.g the flagellum 
or the position of the kinetoplast may enable the identification of one strain with another 
by the cladistic or holistic approach. However, the subjective nature of this approach may 
be circumvented by applying molecular techniques that can delineate finer differences (2). 
It is therefore possible to separate trypanosomes into demes based on identical isoenzyme 
patterns or zymodemes (3), and similar restriction patterns of their kinetoplast DNA or 
schizodemes (4). Being the trypanosome equivalent of mitochondrial DNA in higher 
eukaryotes, the kinetoplast (mini-circle) DNA is suitable as a genotypic marker in 
determining closely related strains/demes, and for finger-printing individual strains.
Restriction profiles of the total genomic DNA may also identify polymorphs within a 
strain. This strategy may be made more sensitive if combined with DNA probes derived 
from a known strain. The polymerase chain reaction (PCR) is currently in vogue as a 
powerful tool to differentiate between single cells. It is also possible to use antibodies 
raised to key housekeeping proteins to classify trypanosomes. All these methods have 
their inherent shortfalls and may therefore be used to complement each other.
It is also conceptually possible to delineate inter-specific differences based 
on the sequences of small ribosomal RNA (rRNA) since they constitute the basic 
machinery for protein synthesis both in prokaryotes and eukaryotes. The primary and 
secondary structure, and the relative positions of the genes within the ribosomal cistron 
reflect phylogenetic distances between organisms (5,6). Comparative analysis based on 
the sequences of rRNAs indicated that protozoans in general diverged very early in 
evolution from a primordial ancestor (7).
Ml M2 M3 M4 M5 M6
T.cruzi vs T.brucei 91.2 90.5 86.6 81.7 - 67.1
T.cruzi vs Crithidia fasciculata 94.0 91.9 89.5 89.0 89.3 70.9
T.brucei vs C. fasciculata 91.2 92.1 89.0 85.4 - 70.9
Fig. 2 Percentage homology between trypanosomal small ribosomal RNA
subunits. Adapted from (8).
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Megatrypanum Herpetosoma Schizotrypanum Duttonella Nannomonas Trypanozoon
Representative T.(M.) theileri T.(H.) lewiti T.(S.) cruzi
species T.(H.) musculi
T. (H.) rangeli
T. (D.) uniforme T. (N.) congolense T. (T.) brucei
T. (D.) vivax T. (N.) simiae T. (T.) b. brucei
T.(T.) b. rbodesiense 
T.(T.) b. gambiense 





Trypanosome development in the mammalian host begins shortly after a 
blood meal by the tsetse fly. In the immediate vicinity of the bite, the trypomastigotes 
proliferate causing an induration or trypanosomal chancre. From here, they are 
disseminated throughout the body via the lymphatic system. The first level of 
multiplication in the bloodstream causes a wave of parasitaemia that results in febrile 
paroxysms. Host antibody pressure results in a temporary remission of parasitaemia with 
short stumpy forms predominating (1,10). The surviving forms or heterotypes are long 
and slender and these reacquire a surface coat that confers immune protection for a 
further cycle of differentiation to intermediate and stumpy forms. These are the pre- 
adaptive forms (procyclics) for survival in the insect midgut after the next feed. These 
transform rapidly into epimastigotes and migrate to the salivary glands, attaching 
themselves to the microvilli of the gland. At 15-35 days after infection, they are 
transformed into the metacyclics and the fly is infective once again to the vertebrate host. 
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Fig. 5 Ultrastructure of the bloodstream form of the African trypanosome.
Organelles are as labeled. The arrows indicate the direction of undulation 
or propulsion. Adapted from (1). Insert is a trypanosome among red blood 
cells.
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Fig. 6 Life cycle of the African trypanosome. Adapted from (10).
Premetacyclic Nascent Metacyclic
u-
hor.: rw .rovn nNtoci«ond«<on deuicnmen:





IN JE CT tON 
IN T O  MAMMAL
MIGRATION TO 




















c ea se s
tubular





















Fig. 7 Schematic of the trypanosome life-cycle. Adapted from (11).
1 3 3  Biochemical and molecular correlates of trypanosome biology
1.33.1 Energy metabolism
The digenetic life cycle of the African trypanosome engenders a switching 
mechanism for amino acid and glucose dependence for its energy requirements, generating 
2ATP and 2 pyruvate molecules per glucose molecule under aerobic conditions (12-16). 
The relatively inefficient energy production is compensated for by a high rate of 
glycolysis consequent upon a high rate of glucose transport (17), in order to support 
among other things, the rapid cell division which occurs in every 6-8 hours. The procyclic 
forms depend on proline for most of their energy requirements in the insect vector, which
13
has about 150mM amounts of this substrate in its haemolymph. These forms have a fully 
functional mitochondrion and a tricarboxylic acid (TCA) cycle, as shown by high levels 
of activity of proline, succinate, and a-ketoglutarate oxidases (10,18). Evidence from this 
accrues from the observation of an electromotive force (EMF) across the inner 
mitochondrial membrane of the transitional forms and the accumulation of rhodamine 123 
(19). This EMF, which emanates from the NADH dehydrogenase site of oxidative 
phosphorylation, was inhibited by the classical inhibitors of the cytochrome mediated 
pathway of energy metabolism viz 2,4-dinitrophenol, rotenone, and salicylhydroxamic 
acid (SHAM) but not by antimycin A, cyanides or oligomycin. On this basis the 
existence of a functional FjFq ATPase was possible. This was corroborated by the work 
of Williams et al (20), which illustrated a developmentally regulated expression of the 
ATPase. Western blot analysis using F0 and Fj antibodies showed elevated expression in 
the procyclics relative to the bloodstream forms. Additional evidence comes from the 
observation that there was a 30-fold lower steady state levels of the 9S and 12S 
mitochondrial ribosomal RNAs in the long-slender forms relative to the culture forms
(21). Transcripts of cytochrome b and cytochrome oxidase subunits I and II were 
elevated 100-fold in stumpy forms compared to slender forms, heralding the onset of the 
development of the oxidative pathway of substrate phosphorylation (21). Further 
molecular evidence for the developmental regulation of energy metabolism comes from 
the observation that aldolase activity was decreased about 30-fold in the procyclics (22) 
and pyruvate kinase mRNA was 10X more abundant in the bloodstream forms (23). In 
the latter, the glycosomal form of phosphoglycerate kinase was 9X more abundant than
14
the cytoplasmic form whereas the converse was true in the procyclics (24) with an overall 
decrease in activity of about 2.5-fold (25).
The bloodstream forms, on the other hand, have a vestigial mitochondrion 
and a cyanide insensitive cytochrome system. They are therefore entirely dependent on 
substrate level phosphorylation/glycolysis for their energy supply. The metabolic 
processes involved in this are confined to the glycosomes, which are micro-organelles 
typical of the Kinetoplastids (13). They measure about 0.3um in diameter, and exist in 
groups of 200-300 per cell, thus constituting about 4% of cell volume and of protein 
content. A myriad of other functions have been ascribed to the glycosomes as indicated 
below. The first seven enzymes of the glycolytic pathway are contained within these 
organelles, in addition to the two involved in glycerol metabolism and the re-oxidation 
of NADH. These (seven) enzymes are tightly packed together, ensuring minimal transit 
time between metabolite intermediary states and the next and optimal local concentration 
of both enzymes and substrates, thus accounting for the high rates of energy metabolism 
or glycolytic flux in these organisms. This, by implication, means that none of these 
steps could possibly be the rate limiting step in glycolysis, as has been confirmed by 
















Tb Tc L Cl/Cf 
Hexokinase + + + +/
Phosphoglucose isomerase + + +/
Phosphofructokinase + + +/
Aldolase + + +/
Triosephosphate isomerase + + +/
Glyceraldehyde phosphate
dehydrogenase + + +/
Phosphoglycerate kinase + + +/
Glycerol 3-P dehydrogenase + + +/
Glycerol kinase + +




transferase + + + /+
Orotidylate 5'-phosphate
decarboxylase + + + /+
Hypoxanthine guanine
phosphoribosyl transferase + + +
DHAP acyltransferase + +
Acyl/alkyl/DHAP reductase +
Acyl CoA reductase +









Integration and control of trypanosome metabolism: role of the
glycosome. Tb CL brucei): Tc CL cruzi): Cl (Crithidia luciliae); L
(Leishmania spp) and Cf (C.fascisculata). Adapted from (27).
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A lanine A sp a rta te
Catabolism of proline in the culture forms of T. brucei. End products are 
boxed. Enzymes: 1, L-proline oxidase; 2, glutamate semi-aldehye 
dehydrogenase; 3, alanine aminotransferase; 4, aspartate aminotransferase; 












Fig. 10 Catabolism of glucose in the culture forms of T. brucei. End products are 
boxed. Enzymes: 1, alanine aminotransferase; 2, carnitine acyltransferase; 




































Fig. 11 Compartmentalization of glycolysis and glycolytic intermediates in the
bloodstream form. Abbreviations: G-6-P, glucose-6-phosphate; FDP, 
fructose-1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; G-3-P, 
glycerol-3-phosphate; 1,3-DPGA, 1,3-diphosphoglycerate; 3-PGA, 3- 
phosphoglycerate; Pi, inorganic phosphate. Reproduced from (16).
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1.33.2 Genomic organization and housekeeping genes
Like most eukaryotic genomes, that of T. brucei comprises a significant 
percentage (32%) of repetitive sequences. The remaining 68% is made up of single copy 
gene sequences (29). It has been found that the trypanosome is diploid for all its house­
keeping genes, i.e there are two copies for every house-keeping gene (30). Some of these 
genes are in tandem linkage or are found in multiple copies e.g the genes for aldolase
(22) and glyceraldehyde phosphate dehydrogenase (31) are duplicated, whereas those of 
phosphoglycerate kinase (32) and calmodulin exist as three copies (33). Others such as 
the VSG genes which exist in about 1000 copies, are highly clustered in the genome (34) 
much like the a- and b-tubulin genes which are in tight tandem linkage of 15 alternating 
alleles for these forms (35). The occurrence of several copies of the same gene may be 
linked to the gene regulation machinery of the trypanosome in consonance with its life 
cycle. By appropriately shifting copies of a gene to an expression locus, the synthesis of 
gene products may be modulated at the transcriptional level.
20
Number of Number of Indications for
Gene
genes per clusters polycistronic
cluster per cell transcription
RNA pol I 1 2
RNA pol II 1 4
RNA pol III 1 2
ODC I 2
gPG I 1 2
gTIM 1 2
cG A PD H 1 2
gG A PD H 2 2 +
gA L D 2 2 +
cPY K 2 2
g + c PGK 3X1 2 +
PARP 2 4 +
Actin 2 -4 2 +
Calmodulin 3 2 +
hsp 70 5 2 +
&}($ tubulin 15 2 +
Cysteine proteinase - 2 0 2
Fig. 12 Organization of genes in T. brucei. Adapted from (40).
1.33.3 Ploidy
The use of schizodeme and zymodeme analyses and RFLPs have not only 
been invaluable in strain identification and classification, but also provided information 
regarding the possible mechanisms of gene exchange in the African trypanosome. These 
methods have established mating in the metacyclic forms, which follows classical diploid 
Mendelian inheritance (36,37).
The karyotype of T. brucei as analyzed by pulse field gel electrophoresis 
has shown a spectrum of chromosomes ranging in size from 30-150kb for the
21
minichromosomes to over 2000kb making up a total of 20 bands encompassing the whole 
genome of the parasite (38). There are about a hundred minichromosomes in band one 
and these may be involved in conferring antigenic expression plasticity; 5-7 moderately 
sized chromosomes (200-700kb) and five others of about 2000kb (39). There are 
significant numerical and morphological differences of chromosomes from one deme to 
another within the Trypanosomatids due primarily to chromosomal rearrangements and 
suggestive of an underlying mechanism for gene exchange or expression.
133.4  Gene structure
1.33.4.1 Codon usage
The degeneracy of the universal genetic code coupled with the number of 
transfer RNA (tRNA) molecules available per codon places restrictions on codon choice 
and usage. Whilst it may be said that there is a canalised pattern of codon usage for some 
genes, there can still be found a broad spectrum of codon preferences in the trypanosome. 
It has been observed that most or all housekeeping genes have no preferences in terms 
of the overall nucleotide composition, although they have a predilection for C as the third 
base of their codons and a strong bias against A in this position (40). However, there is 
no clear bias in the codon usage of VSG genes and expression site-associated genes or 
ESAGs. Highly expressed genes are the most biased in their use of codons and are 
predominantly GC-rich. Lowly expressed ones use a greater fraction of the rare codons 
but still use the common ones as well (41).
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Fig. 13 The frequency of the third base of the codons used in eight housekeeping 
genes and three VSG genes of T. brucei, and the overall nucleotide 
composition of those genes. Reproduced from (40).
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1.33.4.2 Nature of flanking sequences/regulatory elements
Classical canonical gene regulatory sequences viz CCAAT and TATA 
boxes which are associated with promoter activity in most eukarytoic genes (11,42), are 
absent from all trypanosome genes analyzed so far, and neither do they have any 
consensus polyadenylation signals (AAUAAA) (43). However, deletion mapping of a 
VSG gene with the aid of chloramphenicol acetyltransferase (CAT) reporter activity, 
identified a putative promoter within 90bp upstream from the transcription site (44). This 
promoter is markedly different from the promoters of T. brucei ribosomal RNA (45) and 
procyclin genes (46), which are transcribed in a similar fashion by an a-amanitin resistant 
RNA polymerase 1. Sequences 3’ to this promoter appeared essential for expression in 
a stage-specific manner as shown by expression using chimaeric constructs of VSG and 
procyclin genes. The result indicated a decrease in activity in procyclics compared to 
bloodstream forms. The PARP promoter is presumed to be located between 200bp 
upstream, and the presumptive 3’-splice acceptor site (46).
. For a majority of eukaryotic genes, the most important determinant(s) of 
translation are the cap sites, and the sequences immediately upstream and downstream of 
the start codon AUG (47,48). A consensus sequence was compiled from about 211 
eukaryotic genes (49) as CC(A,G)CCATGG, positions -3 and +4 being the most 
conserved bases. This compares favorably with the consensus derived from some 
protozoan genes below. The G position at +4 was suggested to base pair with the fourth 
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Fig. 15 Flanking nucleotide sequences in some protozoan genes. The first base 6 
the coding region is indicated by +1.
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1.3.4 Variant surface glycoproteins (VSGs)
1.3.4.1 Nature and structure of VSGs
The differential expression of VSGs or antigenic variation is the basis for 
the survival of the African trypanosome within the mammalian host (59,60). Each VSG 
is made up of 450-500 amino acids [50-60 kd] with a 7-17% carbohydrate content. This 
forms a monolayer of homodimers on the surface of the parasite of about 12-15 nm 
thickness and 10 million molecules per cell (61-63). There are two domains: the N- 
terminal domain of about 400 amino acids which constitutes the variable region and 
which is distinct for each variant antigenic type (VAT). This is the region also presented 
to host antibodies. The C-terminus is relatively more conserved with about 110 amino 
acid residues. The entire VSG layer is sequestered to the membrane via a hydrophobic 
glycophosphatidylinositol (GPI) anchor at the C-terminus. The fatty acid moiety of the 
phospholipid is myristic acid [C14:0] (64). The nascent VSG has a 20-40 amino acid 
signal sequence which aids in sorting and insertion into the membrane, the latter function 
being more the prerogative of the 17-23 residue extension at the C-terminus. Both the N- 
and C- terminal extensions are cleaved off post-translationally and after the incorporation 
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Fig. 16 Structure of a VSG in T. brucei. (a) Schematic representation of the
trypanosome membrane. The shaded sections represent the protein portion 
of the molecule to which is attached a glycan containing a Cross Reactive 
Determinant, and a diacylglycerol anchor by which the whole molecule is 
sequestered to the plasma membrane, (b) Sketch of the subunit structure 
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Fig. 17 VSG gene organization showing the mini-exon and structure of the protein-
coding domain. Reproduced from (11).
1.3.4.2 Antigenic variation
In a typical clonal infection with trypanosomes, the course of the disease 
is presented in a series of remissions and recrudescences, which are reflected in the levels 
of parasitaemia. The initial rise in parasitaemia following an infection is followed by a 
remission, consequent upon the release of antibody by the host and specific to each VAT
(66). However, because the parasite has the ability to alter its surface coat, it is able to 
evade host immune attack by expressing a serologically distinct antigenic coat (10,60,67). 
In this way, different immunologically distinct trypanosome populations appear at every
29
7-10 day interval. Peak parasitaemia may reach antilog 8-9 cells/ml of blood, and at a 
switch rate of lO^-lO'7, spontaneous recovery almost never occurs (63,68-70). As a result 
of such a sinusoidal relationship between parasite load and host response, infections are 
protracted. This is a teleological adaptation of the parasite to ensure its survival without 
having to eliminate its host prematurely. This relationship can only continue for as long 
as the host can respond immunologically to the antigenic repertoire of the parasite. 
However, because of the plastic nature of this repertoire involving about 100 VSGs (71), 
the host humoral pressure cannot sustain it and as such the host becomes 
immunocompromised before the trypanosome runs out of antigenic repertoire.
This phenomenon of antigenic variation is common to the Salivaria, and 
is mediated by the sequential expression of the extensive series of VSGs. It has not been 
observed in other tiypanosomatids like T. cruzi. which expresses a VSG-like glycoprotein 
in the trypomastigotes (72), or the Leishmania which have evolved alternative defence 
mechanisms against host immune pressure by dwelling within the macrophages (1). In 
Babesia and malaria infections, the antigenic variation which has been reported is 
attributed to antigens located on the surface of the erythrocyte membrane (73). This has 
only recently been shown to occur in P. falciparum (74). Other protozoa such as 
Paramecium caudatum and Tetrahymena also exhibit antigenic variation, though the 
functional significance of this has not been established. Antigenic variation in the latter 
has been thought to occur through a series of repressor and derepressor genes (75).
Inspite of the versatility of the trypanosome to change its surface coat, the 
pattern of antigenic variation is not completely random, given the size of the repertoire.
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All VATs have an intrinsic tendency to produce variable antigens in a sequential yet 
unpredictable pattern, and to revert after each cyclical transmission to one and the same 
VAT i.e the parent antigenic type of the strain, thus resetting the repertoire (76,77). This 
suggests that re-expression of early VATs occurs continuously in a chronic infection, 
these being almost inevitably eliminated by host antibody. The reversion to a common 
basic antigenic type, regardless of the nature of their surface antigens at the time of 
infection, held hopes of a vaccine from inactivated trypanosomes carrying the basic 
antigens. However, it has been shown that there is a great deal of heterogeneity among 
metacylic trypanosomes- the infective forms (78,79).
The kinetics of appearance of new VATs suggests that population survival 
is at the expense of 99.9% trypanosome destruction (69,80). The maximum number of 
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Fig. 18 Schematic representation of antigenic variation. The sequence of 
appearance of the VATs is represented by the VSGs expressed in a time 
series, VSG A-D. The peaks may represent parasitaemias of antilog 9. A 
simplified model of the trypanosome is inserted. Reproduced from (11).
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1.3.4.3 Modulation of VSG expression
As earlier indicated, the ability of the African trypanosome to switch coats 
is the function of the repertoire of about 1000 VSG-encoding nuclear genes (34,82). The 
temporal expression of these genes is mutually exclusive both at the levels of 
transcription and antigenic presentation. Their products (VSGs) are immunologically 
distinct and unique even though mosaic coats have been observed (83). Switching may 
be facilitated by cleavage by phospholipase C thereby promoting VSG turnover during 
antigenic switch. Although the rate or frequency of switching is very low, it is enough 
to maintain a chronic infection indefinitely, during which there is a preferential 
predetermined expression of early and late VATS.
Expression of these antigenic variants is developmentally integrated and 
regulated. The insect mid-gut forms or procyclics assume a unique coat protein, 
procyclin, upon differentiation. The expression of this coat is regulated by TCA cycle 
intermediates and a temperature shift to 27°C (84,85). Procyclin genes comprise a 
polymorphic gene family found in two genetic loci A and B and in two tandem copies 
per locus, alpha and beta (53). As indicated in Fig. 12, there are eight PARP genes 
encoded at two A loci, one B1 locus and one B2 locus distributed among four different 
chromosomes. The encoded protein [PARP], is not expressed in the bloodstream form 
but is rapidly induced upon differentiation to procyclics (86). Like the VSGs, 
transcription of PARP genes is insensitive to a-amanitin, an inhibitor of RNA polll (87). 
RFLPs analysis indicate that there are structural differences between PARP genes in both 
bloodstream and procylic forms of T. brucei variant 118, ruling out genomic
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rearrangement as a mechanism to control expression as observed in VSGs (11). The 
metacyclic (salivary gland) forms possess a coat analogous to the VSG, whose expression 
is determined by a repertoire of 10-20 strain-specific VSG genes or the mVATs (88). 
The size of this repertoire varies from one isolate to another (89). These genes are 
expressed at the last developmental stage in the vector prior to infection. They are then 
employed in the very initial stages of establishment within the host to expedite switching 
at a very high rate of 1 per every cell division (90-92). The VSGs of mVATs are 
telomeric and may be expressed in situ. Each bloodstream form VSG gene is flanked by 
70bp repeat units with a strong Z-DNA potential. This may be a chiral determinant of 
recombination or segmental gene conversions between basic copy (BC) and expression 
linked copies (ELC). The absence of these repeats in mVAT genes means that the 
metacyclic VSG repertoire is relatively more stable and therefore accounts for the 
absence of rearrangements in these genes (90,93).
RECOMBINATIONAL EVENTS IN AN ACTIVE EXPRESSION SITE
OUPUCATIVE
TRANSPOSITION
ac n n n





J Q . . .
EXPRESSION SITE SWITCHES
UNKNOWN MECHANISM
________________ □ __ I E S I
I . E S 2
-£ L _ I  E S i
J . . . I  e s 2
Fig. 19 Mechanisms of VSG expression. Open boxes represent basic copy (BC) 
genes, and solid boxes represent expression linked copies located within 
an expression site. The direction of transcription is indicated by a 




In general, splicing reactions occur at consensus splice sites or signals 
[AG/GT and C(T)AG/GT], and are catalyzed by small nuclear ribonucleoprotein particles 
[snRNPs] (94). The result is a removal of introns or intervening sequences (IVS), which 
are non-coding, and a splicing together of coding, translatable mRNA sequences.
In the African trypanosome, two types of splicing mechanisms may be 
involved, although there is no evidence for cis-splicing in these organisms. This may be 
due to the absence of introns in the genes that have been characterized so far.
However, all trypanosome pre-mRNAs so far identified are derived from 
polycistronic templates and mature by trans-splicing onto a splice leader sequence known 
as the mini-exon (96-100), and by polyadenylation following cleavage, to generate 
multiple mRNA templates. This mini-exon comprises 39 nucleotides 5 ’ to the coding 
region and is encoded in arrays of 1.35kb repeats of about 200 copies that are clustered 
in the genome, and is transcribed as a 140-nt RNA species termed medRNA (mini-exon
derived RNA) (95). It has the same cap structure (trimethylguanosine cap) as the mature
RNA species. However, the 5’ most nucleotide of the cap is 7-methylguanosine. Nuclear 
run-on transcription assays showed a 700-fold higher rate of transcription compared to 
other RNA species indicating that the medRNA is transcribed independently of the rest 
of the mini-exon repeat sequence (99). In addition, it has been found that there is no 
mini-exon in the intergenic region of the ab tubulin gene cluster before transcription: it 
is spliced in trans after transcription of the gene (98). The sensitivity of the medRNA
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transcription to a-amanitin, in sharp contrast to the insensitivity of VSG gene 
transcription (1 mg/ml), further lends credence, albeit tenuously, to the supposition that 
the two RNA species are not of the same precursor and that transcription is indeed 
discontinuous in the trypanosome.
This form of splicing is by no means peculiar to T. brucei. It has been found as 
a regular feature in mRNA processing in other kinetoplastids (99), and in Caenorhabditis 
elegans which has a 22nt splice leader (100).
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Organism Mini-exon sequence
T. brucei AAC GCTATTA TTAGAACAGT TTCTGTACTA TA [TTG/GTATG 
T. vivax AAA GCTTTTA TTAGAACAGT TTCTGTACTA TA [TTG/GTATG
T. cruzi AAC GCTATTA TTGATACAGT TTCTGTACTA TA [TTG/GTACG
CONSENSUS AA GCT TTA TT ACAGT TTCTGTACTA TA [TTG/GTA G
Fig. 20 Comparison of kinetoplastid mini-exons. Splice junctions are indicated 
with a slash. Reproduced from (99).
Immediately downstream of the mini-exon is a putative splice donor site 
[5’TTG/GTAPyG 3’] which resembles the consensus (101) for splice donor site 
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Fig. 21 Trans-splicing as elucidated in the Kinetoplastidae compared to the 
conventional cis-splicing mechanisms of intron removal from primary 
RNA transcripts. Transesterification reactions (TE) lead to the 
formation of a 2 ’-5’ phosphodiester bond which constitutes the branch 
point for both the lariat and the Y-structure. Reproduced from (9).
1.3.5.2 RNA editing
As indicated above, the kinetoplast or mitochondrial DNA (mtDNA) in 
the trypanosome is varied, comprising the mini and maxi circles. The mini circles encode 
the guide RNAs that are involved in editing (278) whilst the maxi circles are the 
trypanosome equivalent of higher eukaryotic mtDNA with regards to energy metabolism. 
Among others, it is here that the cytochrome genes are transcribed and processed, 
notably the subunits I, II, and III of cytochrome c oxidase. Paradoxically however, 
mitochondrial RNA metabolism seems to defy the central dogma in molecular biology 
viz: DNA makes RNA makes protein. By and large, transcripts do not totally correspond 
to their encoding genes in nucleotide sequence. This is due to a deletion/insertion strategy 
involving uridine residues (102). As a result, while some transcripts are only moderately 
edited e.g apocytochrome b (103), others such as coin are edited by up to 55%, with the 
gene significantly different from its message in nucleotide composition (104,105). The 
significance of this is that editing may be used to regulate the expression of mitochondrial 
genes in the trypanosome. Frame shifts or the creation of start codons might make this 
possible (106).
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Tb protein * - -CysCys CysCysPheValLeuTrpteuSerLeuLeuPhe GlyPhe - - - - LeuCysValHetTyrleuCysVal***
Tb DNA - - • G GTTTTG G G A A G A G A G  G G  GTTTTG.......... A G G A G A  G G G G A A
Tb mRNA - * -uGuuG UUGuuGuuuuGuAuuAuGAuuGAGuuuGuuGuuuG Guuuu- - - - -uuAuGuGuuAuGuAuuuGuGuGuGuAA
Cf ONA • - -TTATG TGTATTATTTGTGCTTTGATCCGCTATATTTATTG GTTTT....... TTATGCGTAG7GTATTTATGTGCATAA
Lt DNA - - -TTATG TGTTTTATTTATGTTATGAGTAGGAATATTATTTG GTTTT....... TTAAGTGTAGTATACTTATATGCATAA
Fig. 22 RNA editing in cytochrome c oxidase III (COIII) in T. brucei. Insertions 
and deletions of uridines (u) are indicated in the mRNA. A termination 
codon, TAA has been created by editing. A comparison is made with 
corresponding genes of the gene in Crithidia fasciculata (Cf) and 
Leishmania tarentolae (Lt) where RNA editing does not occur. Reproduced 
with permission from (9).
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A SEQUENCE OF EVENTS fi GUIDE RNA MODEL
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Fig. 23 Models of RNA editing. (A) Sequence of events and enzymatic reactions
leading to the insertion or deletion of uridines. (B) The guide RNA model. 
Two hypothetical, different guide RNAs are shown that would promote 
insertion (#1) or deletion (#2) of U residues at the same editing site. 
Asterisks represent a G.U base pair. Vertical lines indicate conventional 
base pairing. Adapted from (106).
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1.4 Control of African trypanosomiasis
1.4.1 Vector control
Targeting the tsetse fly earlier presented an opportunity for the elimination 
of the disease by the use of non-residual insecticides such as DDT, Aldrex T etc. 
Unfortunately, the tsetse fly developed resistance to these. Other tsetse control measures
have included baited traps, sterile male techniques, clearing vegetation, and biological
control using insectivorous predators.
1.4.2 Chemotherapy
The path of the chemotherapy of African sleeping sickness has been marred 
not so much by the refractory nature of the disease to the available drugs, as by the lack 
of sufficient information about the basic biology of the parasite- information that may 
provide leads for the rational development of safe drugs.
1.4.2.1 . Current treatment regimens: drugs and their limitations
Although chemotherapy is as old as the trypanosome (in terms of 
discovery), there is little advance in the treatment of African sleeping sickness compared 
to the rapid treatment regimens available for other diseases. Current treatment regimens 
rely on suramin, melarsoprol and pentamidine wliich have largely been derived 
empirically (107). Their inefficacies stem from poor pharmacokinetics to death in the 
subjects. They are not only unduly toxic - principally because they have not been 
designed for any specific target molecule in the parasite-, but also have a very limited
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effect on parasite elimination. As a result, there may be periods of recrudescence of 
parasitaemia with a vengeance, due to survivors that may be increasingly developing 
resistance to the drug in use. At the same time, their level of toxicity means that they 
should be administered under clinical supervision, which in itself is limited in the African 
setting as some areas are inaccessible.
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Fig. 24 Structures of drugs in current use for African trypanosomiasis. 
Reproduced from (28).
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1.4.2.2 Current rational strategies
Attempts are being made to optimize the exploitation of trypanosome 
biochemistry based on differences at the host-trypanosome interface (108). One of these 
relied on the presence of a unique glycerol phosphate oxidase (GPO comprises a glycerol 
phosphate dehydrogenase, ubiquinone and a terminal oxidase) which is absent from 
mammals (109,110). Using chelators like benzhydroxamic acid, diphenyl 
dithiocarbazone, salicylhydroxamic acid (SHAM), it was possible to inhibit GPO non- 
competitively, blocking electron transport between ubiquinone and the terminal oxidase 
and killing them by 02/ATP starvation. However, the parasites employed an alternative 
pathway involving glycerol kinase:
G-3-P + ADP > glycerol + ATP,
in order to survive. Conceptually, increasing the [glycerol] should block the forward 
reaction by a mass action effect. This was observed to be the case as SHAM and glycerol 
synergistically killed the parasites. Infusion of this cocktail produced a temporary 
remission of parasitaemia only to recrudesce a week later. Aside from this limitation, 
excessively large amounts of it (which was unduly toxic) were required and these factors 
made it an impractical regimen to employ.
Another therapeutic strategy relied on the fact that trypanosomes do not 
synthesise purines de novo, and have to salvage them somehow (111). Therefore using 
purine analogues like cordycepin (3* deoxyadenosine), nucleocidin and puromycin proved 
trypanocidal albeit toxic to the host. Allopurinol, a hitherto favourite drug for the
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treatment of gout, has been found to be particularly effective and at the same time of 
tolerable toxicity (112). The apparent selective toxicity of this drug resides in the fact 
that the step from allopurinol catabolism catalyzed by xanthine-guanine phosphoribosyl 
transferase, is of little significance in mammals. Furthermore the nucleotide produced is 
aminated to an analogue of AMP, aminopyrazaopyrimidine ribonucleoside 
monophosphate, a reaction which mammalian enzymes are incapable of catalyzing. The 
incorporation of this analogue into RNA interferes with translation and protein synthesis.
The observation that trypomastigotes do not synthesise spermine offered 
a fresh target. They synthesise putrescine and spermidine de novo from ornithine and 
methionine. The rate-limiting step in polyamine synthesis is thought to be catalyzed by 
ornithine decarboxylase, (ODC) which has a high turn-over rate in mammals, and is 
susceptible to external inducers (113). Using an analogue of ornithine, a- 
difluoromethylomithine (DFMO) it was observed that polyamine synthesis was blocked 
at the ODC step. This mammalian enzyme is 60X less sensitive, therefore providing a 
suitable target for selection (114,115). One reason for this selective toxicity was that the 
trypanosome enzyme has a relatively lower turnover rate compared to the host enzyme 
(116), thereby allowing for inactivation of the former over a long period. However, the 
drug is incapable of curing advanced infections due to its inability to cross the blood- 
brain barrier.
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The African trypanosome is also incapable of synthesising haem and 
therefore lacks catalase, thus providing a channel for treatment by inducing a free radical- 
mediated lipid peroxidation. The accumulation of H20 2 (up to 100X more than in 
mammalian cells) generates HO and HOO radicals in the presence of metalloporphyrins 
e.g hematoporphyrin D. This may be exacerbated by sequestering free radical scavengers 
like riboflavin and glutathione with the naphthoquinones.
Other promising strategies involve exploiting and targeting differences 
between glycosomal enzymes in trypanosomes and mammals (117). Lately, it has been 
observed that trypanosomal glutathione reductases (trypanothione reductases) differ from 
their mammalian counterparts in their absolute requirement for a thiol-containing cofactor, 
trypanothione (118). This cofactor contains a spermidine moiety covalently attached to 
glutathione (119). Inhibition of polyamine synthesis by DFMO is thought to be linked to 
this site, precluding the provision of trypanothione for glutathione reduction which would 
protect it from free radical damage.
It has also been shown that the GPI-anchor of the VSG in bloodstream 
trypanosomes is unique in having myristic acid. In contrast, anchors in mammalian cells 
lack the myristoyl moiety. By introducing analogues of myristic acid in an in vitro system 
designed to monitor VSG biogenesis, it was found that incorporation and synthesis of the 
anchor was impeded, resulting in cell death (120). In contrast procyclics, which lack a 
VSG coat (have a PARP coat), and Saccharomyces cerevisiae with no myristate, survived. 
Other compounds which affected trypanosome morphogenesis such as vinblastine, 
disrupted microtubule formation and trypanosome replication.
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No doubt, the litany of strategies could continue, but suffice to say that in 
a search for selectively toxic drugs, it is not enough to identify a unique pathway as a 
target. Rather, it is imperative to identify strong functional differences between that 
pathway in both parasite and host, and to demonstrate an absolute dependence of the 
trypanosome on the identified pathway. This is where glucose transport comes in.
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1.5 Hexose transport: an overview
Membranes in transport and metabolic regulation
Intermediary metabolism in all living cells is largely dependent on the 
availability- chemical or physical- not only of enzymes, but also of substrates. Physical 
compartmentation of the latter seems to be the main determinant of the rate of 
metabolism. Biological membranes present significant cellular barriers to the utilization 
of substrates. Apart from acting as barriers to substrate flow, they also elicit a selective 
property with regards to the nature of the transported molecule.
1.5.1 Mechanisms of substrate transport
There are four basic mechanisms by which cells may transport substrate 
across their membranes.
i. Simple diffusion
This is a typical scalar phenomenon characterized by first-order kinetics. 
It is essentially stochastic and involves non-specific permeation of solutes, which as it 
were "roll" down their concentration gradients, in consonance with Fick’s law at rates 
directly proportional to the concentration differentials between the two compartments. 
There is no specific interaction between the permeant molecule and the membrane.
ii. Facilitated diffusion
This is a saturable uptake process which relies on a carrier molecule to
traffic solute from one compartment to another. Unlike simple diffusion, there is specific 
interaction between the permeant and the carrier, much in keeping with stereochemical
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requirements. Because there is a finite number of binding sites, which therefore sets a 
limit to the number of solute molecules that can be transported, there is competition 
between substrate analogues and a predilection for saturation of these binding sites. The 
process is also sensitive to the effect of inhibitors, and shows uphill counter-transport 
characteristics.
iii. Active transport.
This requires metabolic energy for the translocation of substrate. It is 
basically a unidirectional flux of solute from a lower to a higher concentration. Because 
this requires energy, the process is susceptible to metabolic inhibitors. Whilst the simplest 
form of this mechanism involves only a single molecular species, more complex transfers 
may occur which involve the coupled transport of solutes simultaneously across the 
membrane in the same direction or symport (121). In this case, there is an obligatory 
sequential attachment of the solutes to the transport site before either can be translocated. 
The energy for transport may also be provided in an electrochemical potential gradient, 
as in the mitochondrial ATPase (122), or the coupled system may involve an exchange 
process as in antiport systems. Like facilitated diffusion, the process shows saturation or 
Michaelis-Menten kinetics and is specific.
iv. Group transfer
This form of substrate transport is accompanied by a covalent modification 
of the transported substrate, relative to its initial state. This is aptly represented in the 
phosphoenoltransferase (PTS) system in bacteria (123).
Glucose transport has been observed to occur largely by facilitated
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diffusion in most cells including the T. brucei transporter and is thought to be the rate 
limiting step in glucose metabolism in the trypanosome (17,124,125).
1.5.2 Phenomenology of the facilitated glucose transporter
The main features of the facilitated transporter enunciated in (ii) above, 
engender a quasi-cyclical process of binding and translocating substrate. This may 
embrace four sequential cyclic steps that describe the carrier as a mobile entity. These 
steps are depicted in:
1. Recognition and binding of substrate on the cis side,
2. Translocation of substrate across the membrane
3. Release of substrate on the trans side
4. Restitution of the carrier to its initial state.
Within this schema, only steps (2) and possibly (4) are vectorial, whereas (1) and (3) may 
be scalar. This model is consistent with enzyme-type catalysis; it is strongly compatible 
with both substrate structural specificities and sensitivities to inhibitors, and intuitively 
involves cyclical changes in affinity of the transporter for substrate on either side of the 
cell membrane. As such, typical Michaelis-Menten kinetics may be assigned in the 
equation:
y _ Vmax S 
Km + S
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Implicit in this equation are all the determinants of the phenomenon of substrate transport, 
with Vmax and Km being, operationally, mutually dependent variables at a given 
concentration of substrate [S]. The rate of transport would be a function of the number 
of binding sites, of a total carrying capacity Vmax. Conformational transitions may occur 
between the two states of free transporter and transporter-substrate complex (upon binding 
substrate), which may result in the lowering of transition/activation energy enabling 
internalization of the complex. The net rate of internalization of substrate will therefore 
be dictated by the proportion of high affinity sites available cis-trans or for steps 2 and
4.
Evidence for conformational change as a prelude to facilitated transport 
accrues from the analysis of circular dichroic spectra of the human erythrocyte glucose 
transporter. This indicated that the a-helices which constitute 50-80% of the protein, have 
a preferential orientation perpendicular to the plane of the membrane, with an effective 
tilt angle below 38° (126). This preferential orientation was slightly improved in the 
presence of D-glucose, suggesting that the binding of substrate may be associated with 
changes in conformation of the transporter. In addition, a comparison of the infra-red 
spectra recorded under conditions of the inward or introverted form of the protein with 
those measured under the outward facing form, revealed small shifts in the bands assigned 
to a-helices and b-strands (127) supporting alternating conformation as the mechanism of 
glucose transport
Cytochalasin B (cytB), a fungal metabolite and a known inhibitor of
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glucose transport, is thought to bind to the inward facing conformation of the transporter
as it is a competitive inhibitor of glucose efflux but a non-competitive inhibitor of influx.
The binding of cytB precludes the binding of ASA-BMPA [azidosalicoyl bis(D-mannos-4-
yloxy)-2-propyamine] which is an impermeant competitive inhibitor of glucose uptake
(128). Consequently, ASA-BMPA is thought to bind to the outward-facing conformation.
Binding of these ligands was seen to quench the intrinsic fluorescence of the transporter,
indicating a conformational change. These observations were confirmed from limited
«
cleavage with thermolysin (128). Based on altered sensitivity at defined cleavage sites 
determined by limited proteolysis in the presence of various substrates or inhibitors of 
transport, Gibbs et al. (129) were able to detect conformational changes associated with 
the function of the erythrocyte transporter. A similar observation has been made with the 
Na+-linked renal glucose transporter (130), where a ligand/glucose-induced 
conformational change affected the binding of eight different monoclonal antibodies. 
Other observations were made using 1-fluoro 2,4-dinitrobenzene FDNB (131), 
ethylmaleimide and chloronitrobenzoxadiazole (132) and ethylidene glucose (133) which 
induced a fluorescent transient and hence a conformational change in the transporter. 
This transient has been attributed to a reorientation of the transporter as a result of 
ethylidene binding to the exofacial site thus inducing a "flip” from the inward- to the 
outward-facing conformation.
With this information however, it is subjective to link all segments of the 
transporter in the conformational change. The reality was that these changes were rather 
localised. Labelling with the above ligands therefore implicated transmembrane region
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(TM9) as the mobile region conferring conformational change, as it is presumed to form 
a hydrophobic cleft in the substrate-binding site. Pawagi and Deber (134) suggest 
however that TM10 may be the dynamic segment of the glucose transporter.
1.5.3 Structure and function correlations in glucose transport.
j
The pyranose chair configuration of glucose appears to be the preferred 
substrate for the erythrocyte-type transporter. Kahlenberg and Dolansky (135) provided 
earlier indications of the structural requirements of the transporter for its substrate. They 
established that substrate docking requires hydrogen-bonding at the anomeric carbon (C- 
1) hydroxyl of the pyranose chair configuration. This (anomeric hydroxyl) was found to 
be the most critical, although all of them had the propensity to H-bond to varying 
degrees (136). Using glucose analogues, it was observed that the C-l, C-3, and C-6 
hydroxyls of glucose were the most important moieties in binding to the erythrocyte 
glucose transporter (137). Substitution of OH groups with bulky hydrophobic groups at 
C-l, C-4 and C-6 positions suggested the existence of a hydrophobic cleft adjacent to the 
C-4 and C-6 positions of bound glucose, and that it was the C-l and C-6 hydroxyls of 
the sugar that initially interact with the inward and outward facing conformations of the 
transporter respectively. The general picture that emerges from these studies is the 
polarised binding of glucose i.e that the glucose molecule enters with the C-l end, which 
is free from steric hindrance, and tails in with the C-6 where there is a larger spatial 
constraint. This view is consistent with the "reactive site-directed" proposal of Berlin 
(138), that since phosphorylation of the glucose molecule by hexokinase occurs at the C-6
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position, this position would be protected from direct interaction with the transporter 
during translocation of the glucose/transporter complex. This specificity requirement is 
lacking in situations where hexokinase is absent, e.g gluconeogenesis, further confirming 
the positional importance of C-l with respect to the binding site and a lack of protection 
of C-6 on glucose.
These observations were translated to specificity studies of the glucose 
transporter in T\ brucei (17). It was established that H-bond interactions occurred at C -l, 
C-3, C-4 and C-5 between the transporter and glucose, C-2 and C-6 appearing to have 
hydrophobic interactions with the transporter. By systematically substituting various 
groups at the various carbon positions of the pyranose ring, it has been possible to map 
out the chemical and steric determinants of the glucose-transporter interactions. Spatial 
constraints were ascribed to the C-4 position in contrast to the mammalian forms where 
this constraint resides at the C-6 position.
The use of infra-red spectroscopy enabled the analysis of the kinetics of 
hydrogen-deuterium exchange in the erythrocyte GT (139). These experiments suggested 
that a large proportion of amide hydrogens in the membrane-spanning segments of the 
protein were easily accessible to water and hence support for the possible existence of 
an aqueous channel (139). The exchange kinetics of these channel-associated hydrogens 
were drastically altered in the presence of glucose and cytB. It may be surmised here that 
the glucose molecule is heavily solvated in transit through the lipid bilayer, from the 
exterior to the inside of the cell.
The structural model predicted (see below) for the GT is largely based on
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multiple alignments of cloned sequences. These alignments highlight residues conserved 
within the superfamily and may subserve the common function, directly or indirectly, of 
glucose transport. These residues include the serine and glutamic acid residues in TM7 
which may provide OH and amino groups in building an aqueous channel or H-bonding 
to glucose. The largely amphipathic nature of TM5 and TM8 makes them candidates for 
building this channel. The H-bonding interactions between glucose and the binding site 
may be occurring between helices TM7, TM8 and TM11, while the hydrophobic cleft 
may occur between helices TM9 and TM10 (140). Evidence of this comes from the 
observation of hydrogen exchange experiments that the aqueous channel collapses on 
binding glucose (127). This was corroborated by tagging the transporter with ASA- 
BMPA and cytB, followed by proteolysis. Hence, it is clear that some residues at the 
glucose binding site provide the relevant bonding interactions to facilitate binding and 
translocation. The relevance or role of more distal residues may involve conferring 
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Spatial disposition of GT and glucose in binding and translocation across 
the erythrocyte membrane. The carbons are numbered 1-6. Reproduced 
from (140).
TRY
Fig. 26 Structural dissection of the erythrocyte GT. The sites for ASA-BMPA, 
cytochalasin B (cytB) binding and tryptic cleavage are indicated. The 
potential glycosylation site is indicated by CHO. Transmembrane domains 
are numbered from M1-M12. Reproduced from (140).
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1.6 Molecular biology of glucose transport
1.6.1 Prokaryotes
As may be inferred from the phenomenology of sugar transport, transport 
proteins are as multiple as they are ubiquitous. Among the prokaryotes, there are the PEP 
transferase system, the cotransporters, and the sugar binding proteins. The PEP system has 
been referred to above and will not be mentioned any further.
The sugar binding proteins are a class of perisplasmic proteins which serve 
as the initial components of high-affinity active transport systems. They may act as initial 
receptors for chemotaxis, and aside from sugars, they may also carry amino acids and 
ions in Gram-negative bacteria (141). These proteins include the arabinose-binding protein 
as well as those specific for galactose and maltose.
The cotransporters are essentially active transporters involved in the 
sequential binding of ion and sugar and their simultaneous translocation. Invariably, the 
ion of choice is H+, the electrochemical gradient of which provides the energy for 
transport. The essential pre-requisite for coupled transport is a binding site for both ion 
and sugar, and the binding of one should not induce a conformational change that 
precludes the binding of the other.
A number of coupled transporters have been cloned and sequenced 
especially for H7xylose (142), HVarabinose (143) and lac permease (144) of Escherichia 




Glucose transporters in eukaryotes are essentially of two kinds: 
cotransporters/symporters and facilitated transporters.
Since the studies using the red blood cell as a model system, there has 
been a burgeoning collection of information regarding not only the ubiquity and similarity 
of function of these molecules, but also basic identities in structure.
The cotransporters, as alluded to above, involve H+ or Na+. The yeast 
GAL2 transporter (148) is an example of this group. Among the lower eukaryotes, it has 
been observed that Leishmania transports sugar coupled to a H+ gradient (149,150). A 
similar observation has been made in P. voelii (151). Even though the bloodstream form 
of T. brucei has been shown to transport sugar via a facilitated transporter (17,124,125), 
other work indicates that the procyclics may employ a H+ gradient while the bloodstream 
forms couple transport to a Na+ gradient (152,153). Whichever way this may be 
considered, there is evidence both for a facilitated and a coupled carrier system in the 
trypanosome. This links the lower eukaryotes in an evolutionary relationship to the 
prokaryotes in terms of function.
In the higher eukaryotes, the Na+/glucose transporter in the renal and 
intestinal brush-border membrane has been the most studied (154), and even though it 
may be functionally identical to the facilitated and cotransporters, the two types of 
transporter are significantly structurally different. In either coupled transport systems ( 
prokaryotes and eukaryotes), binding sites are accessible to both ion and sugar, and the 
stoichiometry approaches 1:1.
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In contrast to symporters, the facilitated carriers are uniport systems that 
equilibrate across the membrane in response to sugar. It is becoming increasingly clear 
that these carriers exist in isoforms in mammals, differing more in their stage and/or 
tissue specificity and to some extent their kinetics, than in their structure. No isoforms 
have been identified in the prokaryotes or the lower eukaryotes, possibly due to their 
comparatively simpler energy pathways/requirements or smaller genome sizes. By and 









































GT isoform 1 from Human (HUM), rat, mouse 
(MUS), pig and cow (BOS)
GT isoform 2 from human, rat and mouse
Human GT isoform 3
GT isoform 4 from definitions above.
Human GT isoform 5
GT from the plant A. thaliana
E. coli xylose/H+ symporter
E. coli arabinose/H + symporter
Yeast galactose transporter
Yeast high affinity glucose transporter
Lactose permease of Kluvveromyces lactis
GT of Zvrnomonas mobilis
Putative GT for Leishmania enriettii
TRYPAN_THT1 Trypanosome putative hexose transporter
N_CRASSQTR Quinate transporter of Neurospora crassa
A_NIGQPERM Quinate permease of A. nigeriensis
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COLOUR CODES FOR AMINO ACIDS IN SEQUENCE ALIGNMENT
Colour Code
Yellow cysteins
Black prolines and glycines
Magenta hydrophobic side chains
Green aliphatic side chains
Cyan aliphatic hydrocarbon side chains
Red negatively charged/acidic side chains
Blue positively charged/basic side chains
Sequence aligment was performed according to Barton and Sternberg (208) and of 
Stockwell (209). Conserved amino acid residues/motifs are overlined.C »r>
d L rw ? c v w » S  ^  \ — * 2 .  )  w i  -
i( 1 - 95)
IHUMGLUT1 ( 1- 11): MEPSSKKLTGR
IRATGLUT1 ( 1- 11): MEPSSKKVTGR
IMUSGLUT1 ( 1- 11): MDPSSKKVTGR
RABGLUT1 ( 1- 11): MEPSSKKVTGR
PIGGLUT1 ( - ):
B0SGLUT1 ( 1- 11): MEPTSKKLTGR
HUMGLUT2 ( 1- 9): MTEDKVTGT
RATGLUT2 ( 1- 9): MSEDKITGT
MUSGLUT2 ( 1- 9): MSEDKITGT
HUMGLUT3 ( 1- 9): MGTQKVTPA
HUMGLUT4 ( 1- 23): MPSGFQQIGSEDGEPPQQRVTGT
RATGLUT4 ( 1- 23): MPSGFQQIGSEDGEPPQQRVTGT
MUSGLUT4 ( 1- 25): MPSGFQQIGSDVKDGEPPRQRVTGT
HUMGLUT5 ( 1- 16): MEQQDQSMKEGRLTLV
A_THALIANA ( 1- IB): MP AGG FW GDG QKA YP GK
SYNECHOCYS ( 1- 15): MNPSSSPSQSTANVK
ECOARAB/H+ ( 1- 20): MVTINTESALTPRSLRDTRR
ECOXYLO/H+ ( 1- 8): MNTQYNSS
SCERE_GAL2 ( 1- 66): MAVEEMNVPWSQQPQAGEDVISSLSKDSHLSAQSQKYSNDELKAGESGPEGSQSVPIEIPKKPMS
SCERE_SNF3 ( 1- 95): MDPMSNSSSETLRQEKiQGFLDKALQRVKGIALRRi'iNSNKDHTTDDTTGSIRTPTSLQRQNSDRQSNMTSVFTDDISTIDDMSILFSEPPQKQSMM
KLACT_LACP ( 1- 67): MADHSSSSSSLQKKPINTIEHKDTLGMDRDHKEALNSDNDNTSGLKINGVPIEDAREEVLLPGYLSK
Z_MOB_GLUT ( 1- 9): MSSESSQGL
KLACT_RAG1 ( 1- 58): MSNQMTDSTSAGSGTEHSVDTNTALKAGSPNDLKVSHEEDLNDLEKTAEETLQQKPAK
CKESS_GLUT ( 1- 22): M A G G G W W S G R G L S T G D Y R G G
LENRI_GLUT ( 1- 39): MSDRVEVNERRSDSVSEKEPARDDARKDVTDDQEDAPPF
TRYPAN_THT1( 1- 31): MTERR DNVS HAPDAIEGPNDGAHAEDTSPGF
N_CRASSQTR ( 1- 16): MTLLALKEDRPTPKAV
A_NIGQPERM ( 1- 16): MSILALVEDRPTPREV
( 96 - 190) 96-- 1 • • •  •  • • *
HUMGLUT1 12- 52) L MLAVGGAVLGS LQFGYNTGVINAPQKV IEEFYNQTW VHRY
RATGLUT1 12- 52) L MLAVGGAVLGS LQFGYNTGVINAPQKV IEEFYNQTW NHRY
MUSGLUT1 12- 52) L MLAVGGAVLGS LQFGYNTGVINAPQKV IEEFYNQTV NHRY
RABGLUT1 12- 52) L MLAVGGAVLGS LQFGYNTGVINAPQKV IEEFYNQTW IHRY
PIGGLUT1 1- 11) EFYNQTW LHRY
B0SGLUT1 12- 52) L MLAVGGAVLGS LQFGYNTGVINAPQKV IEEFYNQTW VQRY
HUMGLUT2 10- 81) L VFTVITAVLGS FQFGYDIGVINAPQQV IISHYRHVLGVPLDDRKAINNYVINSTDELPTISYSMNPKPTPW
RATGLUT2 10- 80) L AFTVFTAVLGS FQFGYDIGVINAPQEV IISHYRHVLGVPLDDRRATINYDINGTDTPLIVTPAHTTPDAW
MUSGLUT2 10- 80) L AFTVFTAVLSS FQFGYDIGVINAPQEV IISHYRHVLGVPLDDRKAAINYDVNGTDTPLTVTPAYTTPAPW
HUMGLUT3 10- 49) L IFAITVATIGS FQFGYNTGVINAPEKI IKEFINKTL TDK
HUMGLUT4 24- 66) L VLAVFSAVLGS LQFGYNIGVINAPQKV IEQSYNETW LGRQGP
RATGLUT4 24- 66) L VLAVFSAVLGS LQFGYNIGVINAPQKV IEQSYNATW LGRQGP
MUSGLUT4 26- 68) L VLAVFSAVLGS LQFGYNIGVINAPQKV IEQSYNATW LGRQGP
HUMGLUT5 17- 57) L ALATLIAAFGSSFQYGYNVAAVNSPALL MQQFYNETV YGR
A_THALIANA 19- 68) LTPFVLFT WA AMGGLIFGYDIGISGGVTSMPSFLKRFFPSVY RKQQEG
SYNECHOCYS 16- 50) F VLLISGVAALGGFLFGFDTAVINGAVAA LQKHFQ
ECOARAB/H+ 21- 54) M NMFVSVAAAVAGL L F GL D IGVIAGAL P F ITDHF
ECOXYLO/H+ 9- 43) Y IFSITLVATLGGLLFGYDTAVISGTVES LNTVFV
SCERE_GAL2 67-106) EYVTVSLL L VRFGGFMFGWDTSTISGFV LQTDFLRRFG
SCERE_SNF3 96-129) M SI VGVFVAVGGFLFGYDTGLINSITSM NYVKS
KLACT_LACP 68-106) QYYKLYGL FITYL ATMQGYDGALMGSIYT EDAYLKYY
Z_MOB_GLUT 10- 43) VTRLALIAAIGGLLFGYDSAVIAAIGTP VDIHFI
KLACT_RAG1 59- 98) EYIFVSL VMVAF GGFVF GWDT GTISGFVN QTDFLRRFG
CKESS_GLUT 23- 70) L T V Y W M V A F M A A  G G LLL GY DNG VTG GW SLE A FEKFFPOVWAKKQE
LENRI_GLUT 40-134) MTANMARVMLVQAIGGSLNGYSIGFVGVYSTLFGYSTN ASFLQENS TTVPNAD KWFVSPTGSSY GWPEVT RKEYAVSSPAEMPGa , AR E
TRYPAN_THT1 32-105) FSFENLGVAQVQWGGTLNGYVIGYVAVYLLLYLTATE K FTTEGA GGAKIYG KW SGTT KF ENPK SEGSD
N_CRASSQTR 17- 55) YNWRVYT AAIASFAS MIGYDSAFIGTTLAL PSFTKEF
A_NIGQPERM 17- 55) YNWRVYLLAAVASFTS MIGYDSAFIGTTLSL QS*QNEF
(191 - 285) 














A_THALI ANA ( 69- 
SYNECHOCYS ( 51- 
ECOARAB/H+ ( 55- 
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119): GESILPTTLTT LWSLSVAI S V G ®  GS SVGL VNR
119): GESIPSTTLTT LWSLSVAI1 SVGGMIGS SVGL VNR
119): GEPIPSTTLTT LWSLSVAI SVGGMIGS SVGL VNR
119): GERILPTTLTT LWSLSVAI SVGGMIGS SVGL VNR
78): GESISPATLTT L S L S V A I  SVGGMIGS SVGL VNR
119): GEPIPPATLTT LWSLSVAI SVGGMIGS SVGL VNR
151): AEEETVAAAQLITML’-SLSVSS AVGGMTAS GG 1 GOTL
149): EEETEGSAHIVTMLWSLSVSS AVGGMVAS GG GDKL
150): DEEETEGSAHIVTMLWSLSVSS AVDGMVAS GG GDKL
117): GNAPPSEVLLTSL SLSVAI SVGGMIGS SVGL VNR-
135): EGPSSIPPGTLTTL ALSVAI SVGGMISS LIGIiSQ' L
135): GGPDSIPQGTLTTL 'ALSVAI SVGGMISS LIGIISQWL
137): GGPDSIPQGTLTTL ALSVAI SVGGMISS LIGIISQWL
125): TQE MED PLTLL SVTVSM P GG IGSLLVGPLVNIO
134): ASTNQ Q DSPTL TM TSSL LAALISSLVASTVTRK
110): TDSLLT GLSVSLALLGSALGA G A G P !ADRH
112): VLTSRLQE WS SM M L G A A I G A L  NG S RL
126): APQNl SESAANSLLG VASAL IGF IIGGAl GG SNR
174): MKHKDGTH 1 SNVRTGLIVAI NIG GG'ILSKGGDM
195): HVAPNHDS TAQQMSILVS'LSLGT G TAP SDS
168): HLDINSSSGTGLV SI NVGQ G P □ K
117): APRHLSATAAAS. S G M W V A V L V G  TGS SG iG R
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1- 22): M A G G G WW SGR GLS TG DYR GG
1- 39): MSDRVEVNERRSDSVSEKEPARDDARKOVTDOQEDAPPF
1- 31): MTERR ONVS HAPOAIEGPNDGAHAEOTSPGF
1- 16): MTLLALKEDRPTPKAV














































11SHY RHVLGVPLDDRKAINN Y VINSTDELPTISY SMNPKPTPW 



















NMF VSVAAAVAGL LF GLOIGVIAGAL PF 
IFSITLVATLGGLLFGYDTAVISGTVES 
YVTVSLL L VRFGGFMFGWDTSTISGFV 
M SI VGVFVAVGGFLFGYDTGLINSITSM 
QYYKLYGL FITYL ATMQGYDGALMGSIYT 
V1RLALIAAIGGLLFGYDSAVIAAIGIP 
EYIFVSL VMVAFGGFVF GWQ T GTIS GF VN 
LTVYVVMVAFMAA GGLLLGYDNGVTGGVVSLEA FEKFFPDVWAKKQE
MTANNARVMLVQAIGGSLNGYSIGFVGVYSTLFGYSTN ASFLQENS TTVPNAD KWfVSPTGSSY GwPEVT RKEYAYSSPAEMPGALAR E 
FSFENLGVAQVQVVGGTLNGYVIGYVAVYLLLVLTATE K FTTEGA GGAKIYG KW SG T1 KF ENPK SEGSD
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SYNECHOCYS ( 51 
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119): GESILPTTLTT LWSLSVAlFSVGCftlGSFSVGLFVNRF GRRNSMLMMNLLAFVSAVLMGFSKLGKS
119): GESIPSTTLTT LWSLSVAIFSVGGMIGSFSVGLFVNRF GRRNSMLMMNLLAFVSAVLMGFSKLGKS
119): GEPIPSTTLTT LWSLSVAIFSVGGMIGSFSVGLFVNRF GRRNSMLMMNLLAFVAAVLMGFSKLGKS
119): GERILPTTLTT LWSLSVAIFSVGGMIGSFSVGLFVNRF GRRNSMLMMNLLAFVSAVLMGFSKLAKS
7B): GESISPATLTT LWSLSVAIFSVGGMIGSFSVGLFVNRF GRRNSMLMMNLLAFISAVLMGfSKLGKS
119): GEPIPPATLTT LWSLSVAIFSVGGMIGSFSVGLFVNRF GRRNSMLMMNLLAFVSAVLMGFSKLGKS
151): AEEETVAAAQLITMLWSLSVSSFAVGGMTASFFGGWLGDFL GR1KAMLVANIL SL VGAL L MGF SKL GPS H
149): EEETEGSAHIVTMLWSLSVSSFAVGGMVASFFGGWLGDKL GRIKAMLAANSLSLTGALLMG SKFGPA H
150): DEEETEGSAHIVTMLWSLSVSSFAVDGMVASFFGGWLGDKL GRIKAMLAANSLSLTGALLMG SKFGPA H
117): GNAPPSEVLLTSLWSLSVAIFSVGGMIGSFSVGLFVNRF GRRNSMLIVNLLAVTGG FMGL KVAKS V
135): EGPSS1PPGTLTTLWALSVAIFSVGGMISSFLIGIISQWL GRKRAMLVNMVLAVLGGSLMGLANAAAS Y
135): GGPOSIPQGTLTTLWALSVAIFSVGGMISSFLIG11SQWL GRKRAMLANNVLAVLGGALMGLANAAAS Y
137): GGPOSIPQGTLTTLWALSVAIFSVGGMISSFLIGIISQWL GRKRAMLANNVLAVLGGALMGLANAVAS Y
125): TQEFMEDFPLTLLWSVTVSMFPFGGFIGSLLVGPLVNKF GRKGALLFNN1FSIVPAILMG SRVATS F
134): ASTNQY QYDSPTL TMFTSSLYLAALISSLVASTVTRKF GRRLSMLFGGILF AGALINGFAKHVW
110): TDSLLT GLSVSLALLGSALGAf GAGPIADRH GRIKTMILAAVLFTLSSIGSGLPITIWD F
112): VLTSRLQEWVVSSMMLGAAIGALFNGWLSFRL GRKYSLMAGAILFVLGS1GSAIATSV
126): APQNLSESAANSLLGF VASAL IG 11GGALGGY SNRF GRRDSLKIAAVLFFISGVGSAWPELGFISINPDNTVPVYLAGYV
174): MKHKDGTHYLSNVRTGLIVAIFNIG AFGGIILSKGGDMY GRKKGLSIWSVYIVG111QIAS INKW Y
195): HVAPHHDSFTAQQMSILVSFLSLGTFFGALTAPFISDSY GRKPTIIFSTIFIFSIGNSLQVGAGG I
168): HLDINSSSGTGLVFSIFNVGQI GAFFVPLMD WK GRKPAILIG LGVVIGAIISSLTTTKSA
117): APRHl.SATAAASLSGMVWAVLVG VTGSLLSGWIGIRFFGRRGGLLMSSI FVAAGFGAALTEKLFGTGGSA L
KLACT_RAG1 ( 99-166): 
CKESS_GLUT ( 71-136): 
LENRI_GLUT (135-213): 
TRYPAN_THT1(106-178): 
N_CRASSQTR ( 56-124): 
A.NIGQPERM ( 56-120):
QEKAOGSHVLSNVRTGL1V S 1FNIG AVGGIVLSNIGDRW GRRIGLIIV111VVIG111qIASVDKWY 
VHEDSPY TYONAKLQLFVSSLFLAGLVS LFASWITRNM GRKVTMGIGGAFFVAGGLVNAFAQDM 
ADSR RWSYSQEE QNPSGYSSSESGIFAGSMIAG LIGSVFAGPLASK IGARLSFLLVGLVGWASVMYHAS AA DEF
PSDS KNEVAYT SVYSGIFA AMIVGSMVGSIIAGK ITTF GLKKSFIIVSIT TIA W V Q V A I  EYNNYYAL
DFASYTPGALALLQSNIVSVYQAGAFFG LFAYATSYFL GRRKSLIAFSWFIIGAAIMLAAOGQGRG I
NWESLNTOLISANIVSL YQRGAFFGALFAYPIGHFW GRRwGLMFSAL IFFLGAGMhLGANGDRG L











































203): EMLILGRt-IIGVY GLTTGFVPM YV GEV SP TAF RG ALG TL HQL GI WG 1LI AQ VFG L DSIM 
203): EMLILGRFIIGVY GLTTGFVPMYVGEV SP TAL RG ALG TL HqL GI WG ILI AQ VFG L DSIN 
203): EMLlLGRt IIGVY GLTTGFV PM YV GEV SP TAL RG ALG TL HqL GI WG IL IAqVFGL DSIM 
203): EMLILGRtIIGVY GLTTGFV PM YV GEV SP rAL RG ALG TL HqL GI WG ILI Aq VFG L DSIM 
162): EMLILGRFIIGVY GLTTGFVPM VV GEV SP TAL RG ALG TL HqL GI WG ILI Aq VFG L DSIM 
203): EMLILGRFIIGVY GLTTGFVPM YV GEV SP TEL RG ALG TL HqL GI WG ILI AO VFG L DSIM 
235): ILIIAGRSISGLY GLISGLVPMYIGEIAPTALRGALGTFHOLAlVT GIL ISQ11GL EF1L
233): ALIIAGRSVSGLY GLISGLVPMYIGEIAPTTLRGALGTLHqLALVTGILI SO IAGL SFIL
234): ALIIAGRSVSGLY GLlSGLVPMYIGEIAPTTLRGALGTLHqLALVTGILISqiAGL SFIL
201): EMLILGRlVIGLF GL TGFVPMYIGEISPTALRGAFGTLNOLGIWGILVAqIFGL EFIL 
219): EMLlLGRrLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNqLAlVIGlLlAqVLGL ESLL 
219): EILILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNqLAIVIGlLVAqVLGL ESML 
221): EILlLGRfLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNRLAIVIGILVAqVLGL ESML 
209): EL 11ISRLLVGI AGVSSNWPMYLGELAPKNLRGALGWPqLF ITVGIL VAq IF GL RNLL
218): MLIVGRILLGFGIGFANqAVPLYLSEMAPYKYRGALNlGFqLSITIGILVAEVLNY FFAK
202): IFwRVLGGIGVGAASVlAPAYIAEVSPAHLRGRLGSLqqLAIVSGIFlALLSMWFlALMAGGSAqMPw
194): EMLlAARVVLGlAVGIASYTAPLYLSEMASENVRGKMlSMYOLMVrLGIVLAFLSDTAFSYS GN 
216): PEFVIYRIIGGIGVGLASMLSPMYIAELAPAHIRGKLVSFNOFAlIFGOLLVY VNYFIARS GDAS 
258): OYFI GRIISGL GVGGIAVL PMLISEIAPKHLRGTLVS YqLMITAGIFLGY TNYGTKSVSNSVq 
280): TLLIVGRVISGIGlGAISAWPLYqAEATHKSLRGAIISTYqWAlTWGLLVSSAVSqGlHARNDASS 
253): LIGGRwFVAF FAT IANAAAPTY AEVAPAHLRGKVAGLYNTLWSVGSIVAAFST YGTNKNF PNSSK
207): qiF FFRFLAGLGIGWSTLTPTYIAEIRPPDKRGqMVSGqqMAIVTGALTGYlFTWLLAHFGSIOWV 
250): OYFIGRIISGLGVGGITVLSPMLISETAPKHLRGTLVS YqLMITFGIFLGY TNYGTKNYSNSVQ
219): AMLIVGRVLLGFGVGLGSqWPqYLSEVAPFSHRGMLNIGYqLFVTIGILlAGLVHYAVRDWENG 
308): WVLIVGRFV1GLFLGVI VA PVYTOONAHPKwKRTIGVMFqVFTTLGIFVAALMGLALGqSIRFDHDGDqKVMARMOGL VF STLFSLLTWLG 
268): TGRVL1GLGVG1L SV PMYVNENAHPKL KMDGVLFqVFTTLGIMLAAMLGLILDKTGASKEEANMAGRLHVFSAVPLGLSVAMFLV G
211): OP11A6RVLAGIGVGGASMMVPIYISELAPPAVRGRLVGIVELGWQIGGLVGFwInVGVIJTTMAPIRS QWLIPFAVQLIPAGLLFLG
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290): LPF PESPRFLL INRNEENRAKSV 
290): LPF PESPRFLL INRNEENRAKSV 
290): LPF PESPRFLL INRNEENRAKSV 
290): LPL PESPRFLL INRNEENRAKSV 
249): LPF PESPRFLL INRNEENRAKSV 
290): LPF PESPRFLL INRNEENRAKSV 
322): LH PESPRYLY IKlOEEVKAKOS
320): L L F  P E S P R Y L Y  L N L E E E V R A K K S
321): L L F  PESPRYLY IKLEEEVRAKKS 
288): LPF PESPRFLL INRKEEENAKQI 
306): LPF PESPRYLY IIONLEGPARKS 
306): LPF PESPRYLY IIRNLEGPARKS 
308): LPF PESPRYLY IIRNLEGPARKS 
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374): Ml FLPESPRVYV LKDKLDEAAKSLSFI RGVPVHDSGLLEELVEIKATYOYEASF GSSNFID FISSKSRPKqTLRMI TGIALqAFqqFSGlNFI 
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360): IVT RESRAKFDGGEEGRAELNPSEYGYVEMIPR 
322): MFL RESTATFAqDDDGKAOGGMDPNEYGWGOMLWP 
304): SFWIPESPRWLY ANGKREEAMKVL WIRNLEPTDRYIVqEVSFIDADLERVTRqVGNGFWKPF LSLKORKVqwRFFLGGMLFFWqNGSGlNAI 
301): AILIRESPRWLF LRGNREKGIETLAWIRNLPADHIYMVEEINMIEqSLEqqRVKIGLGFWKPFKAAWINKRILYRLFLGSMLFLWqNGSGINAI
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LENRI_GLUT (135-213): 
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203): EMLILGRFIIGVY GLTTGFVPMYVGEVSPTAFRGALGTLHQLGIWGILIAQVFGL DSIM 
203): EMLILGRFIIGVY GLTTGFVPMYVGEVSPTALRGALGTLHQLGIWGILIAQVFGL DSIM 
203): EMLILGRFIIGVY GLTTGFVPMYVGEVSPTALRGALGTLHQLGIWGILIAQVFGL DSIM 
203): EMLILGRFIIGVY GLTTGFVPMYVGEVSPTALRGALGTLHQLGIWGILIAQVFGL DSIM 
162): EMLILGRFIIGVY GLTTGFVPMYVGEVSPTALRGALGTLHQLGIWGILIAQVFGL DSIM 
203): EMLILGRFIIGVY GLTTGFVPMYVGEVSPTELRGALGTLHQLGIWGILIAQVFGL DSIM 
235): ILIIAGRSISGLY GLISGLVPMYIGEIAPTALRGALGTFHQLAIVTGILISQIIGL EFIL
233): ALIIAGRSVSGLY GLISGLVPMVIGFIAPTTLRGALGTLHQLALVTGILISQIAGL SFIL
234): ALIIAGRSVSGLY GLISGLVPMYIGEIAPTTLRGALGTLHQLALVTGILISQIAGL SFIL
201): EMLILGRLVIGLF GL TGFVPMYIGEISPTALRGAFGTLNQLGIWGILVAQIFGL EFIL 
219): EMLILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNQLAIVIGILIAQVLGL ESLL 
219): EILILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNQLAIVIGILVAQVLGL ESML 
221): EILILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNRLAIVIGILVAQVLGL ESML 



















194): EMLIAARWLGIAVGIASYTAPLYLSEMASENVRGKMISMYQLMVTLGIVLAFLSDTAFSYS GN 
216): PEFVIYRIIGGIGVGLASMLSPMYIAELAPAHIRGKLVSFNQFAIIFGQLLVY VNYFIARS GDAS 
258): QYFI GRIISGLGVGGIAVL PMLISEIAPKHLRGTLVS YQLMITAGIFLGY TNYGTKSYSNSVQ 
280): TLLIVGRVISGIGIGAISAWPLYQAEATHKSLRGAIISTYQWAITWGLLVSSAVSQGTHARNDASS 
253): LIGGRWFVAFFATIANAAAPTY AEVAPAHLRGKVAGLYNTLWSVGSIVAAFSTYGTNKNFPNSSK
207): QIF FFRFLAGLGIGWSTLTPTYIAEIRPPDKRGQMVSGQQMAIVTGALTGYIFTWLLAHFGSIDWV 
250): QYFIGRIISGLGVGGITVLSPMLISETAPKHLRGTLVS YQLMITFGIFLGY TNYGTKNYSNSVQ
-219): AMLIVGRVLLGFGVGLGSQWPQYLSEVAPFSHRGMLNIGYQLFVTIGILIAGLVNYAVRDWENG 
-308): WVLIVGRFVIGLFLGVI VA PVYTDQNAHPKWKRTIGVMFQVFTTLGIFVAALMGLALGQSIRFDHOGDQKVMARMQGL V F S T L F S L L T W L G  
268): TGRVLIGLGVGIL SV PMYVNENAHPKL KMDGVLFQVFTTLGIMLAAMLGLILDKTGASKEEANMAGRLHVFSAVPLGLSVAMFLV G
211): DPIIAGRVLAGIGVGGASMMVPIYISELAPPAVRGRLVGIYELGWQIGGLVGFWINYGVNTTMAPTRS QWLIPFAVQLIPAGLLFLG
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290): LPF PESPRFLL INRNEENRAKSV 
290): LPF PESPRFLL INRNEENRAKSV 
290): LPF PESPRFLL INRNEENRAKSV 
290): LPL PESPRFLL INRNEENRAKSV 
249): LPF PESPRFLL INRNEENRAKSV 
290): LPF PESPRFLL INRNEENRAKSV 
322): LFF PESPRYLY IKLDEEVKAKQS
320): LLF PESPRYLY LNLEEEVRAKKS
321): LLF PESPRYLY IKLEEEVRAKKS 
288): LPF PESPRFLL INRKEEENAKQI 
306): LPF PESPRYLY IIQNLEGPARKS 
306): LPF PESPRYLY IIRNLEGPARKS 
308): LPF PESPRYLY IIRNLEGPARKS 
296): LPFFPESPRYLL IQKKDEAAAKKA 
302): SLVLPDTPNSM IERGQHEEAKTK 
285): AFLIPESPRYL VAQGQGEKAAAI 
277): W F L P N S P R W L  AEKGRHIEAEEV 
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MFYAPVLFMTIGFTT DASLMSAWTGSVNVGATLVSIYG VORWGRRFLFLEGGTQMLI Q A W A A  IGAKFGVOGTPG ELP K W Y A I V W T F  
FYYSSVLWRSVGFTE EKSLLITVITGFIMILTTIVAIAF VDKF GRKPLLLMGSI GMT I T L G I L S W F  G G A T W N G  QP TLT GAAGIIALVT 
MYYAPRIFKMAGFTTTEQQMIATLWGLTFMFATFIAVFT VDKAGRKPALKIGFSVMALGTLVLGY LMQFD NG TAS SGLSWLSVGM 
LYYAPEVFKTLGAST DIALLQTIIVGVINLTFTVLAIMT VDKFGRKPLQIIGALGMAIGMFSLGTAFYTQ APGIVALLS
FYYGTVIFKSVGL DDSFETSIVIGWNFASTFFSLWT VEMLGRRK LLLGAATMMA MVIYASVGVTRLYPHGKSQ PSS KGAGN MIVF 
FYYGVMFFNKTGV SN SYLVSFITYAVNWFNVPGLFF VEFFGRRKVLWGGVIMTIANFIVAIVG SL K TVA AAKVMIAF
SYYLPTMLRNVGHKSVSLNVLMNGVYSIVTWISSI g a f f  i d k i g r r e g f l g s i s g a a l a l t g l s i  t a r y  e k t k k k s a s n g a l v f
LYYAPQMFQNLGFGA DTALLQTISIGWNFIFTMIASRV VDRFGRKPLLIWGALGMAAMMAVLG FWFK VGGVLPLAS
FYYGTTIFQSVGM DDSFETSIVLGIVNFASTFFALYT VDHFGRRN LLYG VGMVA YW YAS VGVTRLWPDGPDHPDISSKGAGN MIVF 
IFYVPVLFSSLGSAN SA ALLNTVWGAVNVGSTLIAVMF SOKFGRRFLLIEGGIQ LA ML T T G W L A I E F  AKYGTDPLPKAVASGILAV 
MNYAPTIMGSLGL APLVGNFWMLWNFVTTLASIPLSYVFTMRHVFLFGSIFTS M LFM GIPVYPG VSKKLEAKNGVAITG
MNYAPKITENLGM DPSLGNFLVMAWNFVTSLVAIPLASRFTMRQMFIT SFVAS M LFL GIPVFPG VAGK EVKNGVATTG
NYYSPTVFRSIGITGTDTGFLTTGIFGWKMVLTIIWLLWLVDLVGRRRILFIGAAGGSL MWFIGAYIKIADPGSNKAE DAKLTSGGIAAIFF 
NYYSPRVFKSIGVSGGNTSLLTTGIFGWTAVITFVWLLYLIDHFGRRNLLLVGAAGGSV LWIVGGYIKIAKPENN PE GTQLDSGGIAAIFF














































































IFLFVSFFEIGPGPIPWFMVAEFFSQGPRPAALAIAAFSNWT NFIVAL FQ 
IFLFVSFFEIGPGPIPWFMVAEFFSQGPRPTALALAAFSNWV NFIIAL FQ 








TMM I A G YA MS AAP WWI L SEIQPLK ROFGIT STTTNWVSNMIIGATFLT 
MLFYVAAFAMSWGPV WVLLSEIFPNAIRGKALAIAVAAQWLANYFVSWTFPMMDKNSWLVAHF 
T FYIF YATTWAPVAWVITAESFPLRVKSK MALASASNWVWGFLIAFFTP FITSA
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492): ETKGRTFDEIASGF R QGGAS
492): ETKGRTFDEIASGF R QGGAS
492): ETKGRTFDEIASGF R QGGAS
492): ETKGRTFDEIASGF R QGGAS
451): ETKGRTFDEIASGF R QGGAS
492): ETKGRTFDEIASGF R QGGAS
524): ETKGKSFEEIAAEF Q KKSGS
522): ETKGKSFDEIAAEF R KKSGS
-523): ETKGKSFEEIAAEF R KKSGS
496): ETRGRTFEDITRAFEGQ AHGAD
509): ETRGRTFDQISAAFH R TPSLL
-509): ETRGRTFDQISATFR R TPSLL
510): ETRGRTFDQISAAFR R TPSLL-
501): ETKAKTFIEINQIF T K NKV
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491): ETKGKTLEELEALW 
•574): ETKGLSLEEIQELVCefSflP KSEG P 
■573): ETKGLTLEEiQE 
587): ETKGRS..EE E E PNPRK
473): ETKSRS DE EE RSK
-567): ETKG T EE NE SEG- P KSSS P SSRRG E D O QHDDKP K
533): ETKG P ER Q RH NR GP E EDEKR S KEEELSK/'K
567): HP DEERDGKK P GKKE SEES GNR E
-527): P D NQDHENDHGGEP EQKT P E SPRN
-537): ■TKS P E DR E KP QN NKN E N DRNPEREESSS DOKDRVTQTENAV
-533): ETKG P ES‘ ET DKKP H HSQ RE RENEE R D G SGKGG TKE 'EE
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1.6.4 Molecular organization of glucose transporters
1.6.4.1 Molecular cloning and characterization of glucose transporters
The advent of recombinant DNA technology enabled the isolation, cloning 
and sequence analysis of the structural genes encoding GTs. This was the first step in an 
attempt at rationalising the kinetics/phenomenology of transport as enunciated above, in 
terms of structure. The first of these was the Hepatoma G2 (HepG2) glucose transporter 
(156). This was cloned by using antiserum raised against the human red blood cell 
glucose transporter, on an expression library in lambda gtl 1. The predicted amino acid 
sequence of the encoded protein was identical to that of the red blood cell glucose 
transporter which was determined by N-terminal sequencing and carboxypeptidase 
digestion at the C-terminal. Structural analysis by fast atom bombardment (FAB), 
proteolysis and N-terminal sequencing of peptides generated thereof, indicated that not 
only was the protein hydrophobic, but it was also glycosylated. Its hydrophobic nature 
was confirmed by a Kyte-Doolittle hydropathy plot (157). Further characterization of the 
transmembrane topology using the Eisenberg algorithm (158) indicated 12 anti-parallel 
putative membrane spanning segments with an average hydrophobicity over 21 residues 
greater than 0.42. B-tums were predicted to loop between the 12 a-helices using the 
Chou-Fasman algorithm (159). Hence, an a-helix content of 70%, a B-strand component 
of 10%, and a B-tum contribution of 15% derived from Raman spectroscopy, have been 
assigned to the lac permease (160). Notably, TM3, TM5, TM7, TM8, and TM11 were 
amphipathic and contained serine, threonine, aspartic acid and asparagine residues which 
may be on the same face of the a-helix. These may provide hydroxyl and amide side-
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chains to build an aqueous channel for glucose transport. This characterization is the 
prototype upon which other glucose transporters were cloned and founded, and provided 
impetus for the search and isolation of related genes (161-166).
Fig. 29 Hydrophobicity profile for the aligned sugar transporters. The plot is 
based on the algorithm of Kyte and Doolittle, using a scanning window of 
19 residues (160). Transmembrane segments are represented by peaks 
(green line) at about 1.58. Potential amphipathic helices (red and yellow 




All the mammalian GT genes that have been cloned contain introns, which 
span several kilo base pairs, but with identical exon-intron organization. This 
arrangement may be important as a mechanism for exon shuffling in the regulation, 
stage- and tissue-specific expression of the mammalian GTs.
Another feature of these transporters is a pseudo-symmetrical arrangement 
of the domains, which may be suggestive of the duplication of a primordial six 
membrane-spanning transporter. This is made all the more credible by the identities 
shared between TM1 and TM7, TM2 and TM8, TM3 and TM9, etc. Other workers have 
earlier tried to compare the N- and C-termini in an attempt at rationalizing the 
duplication concept (167). This, I consider, is inappropriate because the two termini are 
the ends of the protein and should be viewed as such.
Subsequent searches using heterologous gene probes on the gene libraries 
of other organisms ranging from E. coli to plants (142,168,169), identified genes whose 
products were homologous at the amino acid level and were predicted to assume identical 
secondary structures (145). Based on these structural identities with the cloned GTs, a 
presumptive membrane protein cloned from L. enrietti has been assigned to this family 
of membrane proteins although its ligand is at best conjectural (56). From the outset, 
there appears to be a major discrepancy between the sizes of the predicted amino acid 
sequence and that deciphered from affinity labelling with cytB (170), notwithstanding 
reducing SDS-PAGE conditions, proteolysis or biosynthetic modifications such as 
glycosylation.
The function of the products of these genes was variously expressed: in
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E. coli (162), Xenopus laevis oocytes (163), or as complements to sugar transporter 
lesions (168). Others used functional expression as the tack to isolate the related 
transporter, Na+/glucose cotransporter, from intestinal brush border using Xenopus 
oocytes (171). Significantly, the predicted amino acid sequence and secondary structure 
of this transporter was different from the family of facilitated or proton-coupled 
transporters.
Having established a relationship between transport and transporters, a 
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Fig. 30 Molecular organization of the (representative) facilitated GT. Exon-intron 
junctions are shown between light and dark circles (amino acids), a-helices 
are numbered from M1-M12. Reproduced from (170).
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Intron Exon Location 
Number Size
I 226 bps 226
Donor
SerLys





. .  .ttttttccctctgcagAAGGTG
II 96 bps 322
GlnLys
CAGAAGgtaagt. . .  - -13,000 bps -
V a llle
. . .gctcttctccctgcagGTAATT
III 161 bps 483
eGlyAr
TQGCAGgtaagc. . . -  145 bps -
gArgAs
. . .  tgogacccattcccagXDGAA
IV 241 bps 724
AlaGln
QCDCAGgtaagc. .  . -  684 bps -
ValPhe
. . .  c c ta g ttc ttg tc c a g jlG l IC
V 163 bps 887
ysSerV
JYSAGTGgtacgg.. . -  90 bps -
alLeuL
. . .  cxrtccggtcccaccagTQCTGA
VI 188 bps 1075
AsnAla
AATQCTgtgagt. .  . -  278 bps -
ValPhe
. .  .tctccctttctggcagL .iL .rif
VII 105 bps 1180
ValSer
GTGTCGgtaagt. . . -  398 bps -
LeuPhe
. . .  t t tc tc c tt tc c a c a g j iG  1'IC
VIII 102 bps 1282
LeuLeu
CTQCTGgtgagt. . . -  1228 bps -
GluGln
. .  .cattctccctcaacagGAGCAG
IX 204 bps 1486 
1089 bps 2575
ValGlu
GTOGWjgtgagc.. .  
TAGAAA
-  274 bps -
GlnLeu
. . .  tgtgttttttttccagZAACTG
Fig. 31 Exon-intron boundaries of the rat glucose transporter gene. Exon sequences 
are indicated by capital letters, and introns by small letters. Amino acids 
are shown above the corresponding codons. Splice donor and acceptor sites 
are indicated, and Fit the consensus splice junction sequences (101). 
Reproduced from (172).
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1.6.4.2 Structural characterization of glucose transporters
The topology of membrane spanning proteins and for that matter glucose 
transporters, has been determined from a combination of biochemical and molecular 
approaches. The use of limited proteolysis involving tryptic cleavage for instance would 
not only locate accessible or exposed residues, but also those regions of relatively high 
mobility or fluidity (173). This would be expected of surface loop regions between helices 
or similarly exposed segments lacking defined secondary structures. Hence such cleavage 
would be invaluable in delineating structural domains. By this approach, two membrane- 
associated fragments were obtained from the tryptic cleavage of GLUT1, as trypsin 
cleaved on the cytoplasmic face of the transporter. Of these two fragments, one bore the 
N-linked glycosylated residue and the other contained the cytB binding site. In addition, 
labelling this transporter with ASA-BMPA and cytB, followed by proteolytic digestion 
with either chymotrypsin or subtilisin yielded a 6-7kD fragment which was labelled with 
either ligand (128). This enabled the localization of ASA-BMPA and cytB binding sites 
to between M9 and M il, after chemical cleavage at cysteine and tyrosine residues using 
2-nitro-5-thiocyanobenzoic acid and N-bromosuccinimide, respectively in the erythrocyte 
GT (128,174,175).
Monoclonal antibodies have also been extremely helpful in this regard. 
These antibodies would only react with exposed epitopes which are the structural features 
of the protein. The specificity of this interaction makes this approach important in 
evaluating structure-function relationships. A combined strategy of limited proteolysis and 
epitope mapping would identify epitopic structural regions associated with certain
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functions when combined with immunoblot analyses. It was therefore possible to establish 
that the C-terminal of the E. coli lactose and the red cell glucose transporters were 
cytoplasmic (176,177). The antigenicity of a structural feature may therefore be 
correlated with hydrophilicity (178), surface protrusions (179,180), and mobility (181), 
even though the hydrophilic character, propensity to form turns and mobility may be 
predicted from the amino acid sequence a priori.
However, the major drawback to these methods is that with polytopic 
membrane proteins (i.e proteins with multiple spanning segments) such as the GTs, some 
hydrophilic domains, especially small ones may not be accessible to cleavage or 
antibody. Therefore, a molecular genetic approach was adopted (182). Based on the fact 
that alkaline phosphatase (phoA) is enzymatically active only when it is exported to the 
periplasm and inactive in the cytoplasm, it was possible to delineate the orientations of 
specific segments of the gene sequence of the maltose transporter. Fusions to periplasmic 
domains resulted in high phoA activity. These findings were corroborated by protease- 
accessibility studies in relation to structure and function (183). Similar results were 
obtained with B-galactosidase fusions (which show increased activity only when B- 
galactosidase is cytoplasmic) and fusions with B-lactamase which confers ampicillin 
resistance only when it is exported to the periplasm (184). No fusions of this nature have 
been performed with the mammalian or lower eukaryote GTs even though this is 
conceptually possible. Hence, the coordinate use of reporter enzyme/gene fusions, 
proteolysis and immunoblotting, may enhance an accurate deduction of the topology of 
these proteins.
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1.6.4.3 The domain organization of glucose transporters
From the earlier studies of bacteriorhodopsin (185,186), it has been found 
that integral membrane proteins derive their transmembrane topology from the spatial 
arrangement of a-helices and b-tums. This was the basis for the structural model of the 
first glucose transporter to be characterized (156).
All the GTs studied conform to a common domain structure based on the 
degree of homology that exists between them, homology of residues that may subserve 
similar functions and may therefore assume identical spatial dispositions within the 
protein.
Three major domains can be deciphered, but a fourth domain of leucine 
zippers is also gaining recognition.
a. The 12 a-helices which constitute the polypeptide backbone with the N-
and C-terminals bathed in the cytoplasm. These helices are built of hydrophobic residues 
of 18-21 (the equivalent of 30 A), each of which is long enough to span the lipid bilayer. 
These residues are often followed by positively charged residues at the cytoplasmic side. 
[The nature of the factors dictating the orientation and stability of these helices is not 
clear, though it is thought that a dipole-dipole interaction may be at play as a result of 
the hairpin anti-parallel arrangement of the helices, aside from the propensities or 
conformational preferences of the constituent amino acids (187)]. This morphological 
model subsumes a channel between the helices with charged residues oriented inward and 
the non-polar ones outward. There are however, some regions of low hydrophobicity 
especially TM5 and TM8. These regions are coincident with regions of high hydrophobic
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moments and with channel forming functions. This has been the observation in 
bacteriorhodopsin, rhodopsin and the acetylcholine receptor (188).
b. An exofacial loop of about 33 amino acids between TM1 and TM2, with
a site for N-linked glycosylation at Asp 45. This position is not however universal among 
the GTs. It is peculiar to the mammalian GTs. The alternative arrangement is a potential 
glycosylation site in the loop between TM6 and TM7.
c. A hydrophilic loop of about 65 amino acids (on the average) joining TM6 
and TM7 and bathed in the cytoplasm. The length of this region varies from one 
transporter to the other.
d. Leucine-zipper motif within TM2.
This is a recent addition to the domain structure of the GTs. Leucine- 
zippers have earlier been associated with the dimerization of DNA binding proteins (189- 
191). They have recently been found to be associated with or adjacent to membrane 
spanning regions of transport or receptor proteins (192). Their presence in the K+-channels 
is thought to be linked to subunit interactions that may mediate voltage-dependent gating 
of the channel (192). The same motif has been found in TM2 of some of the glucose 
transporters where there is a leucine or isoleucine at every other seventh residue for at 
least eight turns of an a-helix (192). Radiation inactivation studies of intact red cell 
membranes suggest that the native GT may exist as a homotetramer. Indeed, phorbol 
ester-induced in vivo phosphorylation of these cells identified a band that ran at 80Kd 
(193). Cuppoletti and Jung (1980) also found that radiation inactivation of the erythrocyte 
transporter yielded a multimer of 185kD, indicating that this GT probably exists as a
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multimer in the native state and in the absence of substrate (194). Similar conclusions 
were made from inactivation of the lac permease of E. coli. (195). These observations 
may lend credence to the possible role of the leucine-zipper in maintaining the transporter 
in an oligomeric form. The potential of this motif to act as a swivel point in the GT 
monomer-dimer equilibrium in response to cellular signals, is an attractive one in terms 
of transport regulation. It has been reported that galactose and maltose induce a 
monomerization of their cognate binding proteins transporters; these are otherwise purified 
as dimers in their native form (196). Furthermore, the affinity of the ligand was found to 
vary directly with the degree of monomerization, showing a preferential affinity for the 
monomer rather than the dimer. Although this feature is not universal among the GTs, the 











Fig. 32 Comparison of leucine-zippers from various glucose transporters: CEF, 
chicken embryo fibroblasts; Ratb, rat brain glucose transporter (GLUT1); 
IRGT, insulin-regulatable glucose transporter; HepG2, human hepatoma 
transporter (GLUT1); Arab/H+, E. coli arabinose/H+ symporter; GAL2, 
galactose transporter from Saccharomvces cerevisiae; Klact, lactose 
transporter from Kluweromvces lactis. Leucine and Isoleucine identities 
are in capital letters as shown.
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Fig. 33 Domain organization/model of the glucose transporter, a-helices are 
represented by ribbons. The entire transporter is viewed as two halves 
of six helices each, and encaving the glucose pocket. The glucose 
molecule is seen docking and leaving the GT in the cytosol. The yellow 
ribbon represents the long intracellular loop connecting TM6 and TM7. 
Kindly provided by Dr. P. Hodgson, Molecular Graphics Unit, Bath University.
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1.7 AIMS OF THIS STUDY
Baseline studies on glucose transport in T. brucei indicate that there is a 
stereospecific, saturable transporter. Its substrate specificity is akin to those of the 
mammalian hosts. However, their kinetics of transport differ significantly. These 
differences are thought to reside in the structures of their cognate transporters. Hence the 
primary aim of this study is to clone the gene encoding the trypanosome glucose 
transporter as a prelude to understanding the molecular or structural basis for the observed 
differences in specificity and kinetics between that transporter and that of the mammalian 
host. Since the trypanosome is absolutely dependent on the glucose transporter for its 
survival within the mammalian bloodstream, it is hoped that the differences in their 
structures might be exploited to synthesise selective trypanocidal drugs in the long term.
CHAPTER 2
2.0 Functional identification of the trypanosome glucose 
transporter
Materials and Methods
2.1 Infection of rats
Previously cryopreserved stabilates of T.b.brucei clone MiTat 1.1, were 
resuspended in 1% glucose/3% sucrose in Krebs Ringer Phosphate Buffer (KRPB) pH8.0 
to give about 10s viable cells/ml in a Neubauer counting chamber. The cells were then 
injected intraperitoneally at doses of l-2xl07 cells per 300g male Wistar ra t Parasitaemia 
was allowed to develop over 72hrs. Infection was verified by carrying out a tail count 
prior to exsanguination, which would give an approximate level of parasite load per rat.
2.1.1 Tail count
The tip of the rat tail was snipped off with a pair of scissors to provide
about 5-50ul of blood. This was then appropriately diluted into KRPB/glucose/sucrose, 
and counted in a Neubauer chamber.
2.1.2 Harvest and purification of trypanosomes
Rats were exsanguinated under diethyl ether anaesthesia, into 1ml heparin 
(200u/ml) in 10-20ml syringes. Bleeding was done from the iliac artery at the point of 
bifurcation. They were laid dorsally, the abdomen cut open, and the viscera drawn aside 
to reveal the bifurcation. Care was taken to avoid coagulation by mixing with heparin
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gently. All tubes and blood were kept on ice until they were centrifuged at 2800rpm and 
4°C in conical propylene tubes using a bench top refrigerated centrifuge (IEC-Centra 3R) 
for lOmins. The upper layer (plasma) was aspirated and the trypanosomes, which 
appeared as a white band between plasma and red blood cells, were resuspended in 
KRPB/glucose/sucrose. They were recentrifuged as was necessary to remove 
contaminating blood.
Purification followed the method of Lanham (199). Briefly, trypanosomes 
were run down a DEAE-cellulose column (Sx 1.5cm) equilibrated in KRPB supplemented 
with lOmM glucose and eluted with the same. Elution was monitored by observing a 
decrease in opalescence of the effluent The cells were then counted as previously and 
total cell harvest calculated from effluent volume, cell dilution factor and volume of the 
counting chamber.
2.13 Preparation of stabilates
Some of the harvested blood was resuspended in 15% glycerol (w/v) with 
gentle agitation to ensure aeration, and taken up by capillary action into haematocrit 
tubes. Both ends of the tubes were carefully sealed off first with wax and then on a 
Bunsen flame; all tubes were placed in a flask of liquid nitrogen to equilibrate for 2-3hrs 
before being transferred for long-term storage in a jar of the same.
81
2.1.4 Metabolic study: rate of glycolysis
The rate of energy metabolism was measured using the Clark (Oxygen) 
electrode as previously described (200).
The effect of cytB (up to 50uM concentration) was similarly investigated. 
Chart recorder speeds were adjusted appropriately and points of substrate or inhibitor 
addition carefully noted for each batch of cells.
2.1.5 Reconstitution of the trypanosome glucose transporter
2.1.5.1 Purification of plasma membranes
The procedure for the isolation and purification of plasma membranes
followed that of Voorheis (201), based on mechanical shearing of cells under osmotic
swelling conditions.
2.13.2 Protein determinations
These were done by the BioRad method. Membranes and bovine serum 
albumin standard were solubilized in 0.5% (final concentration) MEGA-10. Absorbances 




The method of reconstitution by detergent dilution followed that of Kasahara and 
Hinkle (202) with some modifications.
Trypanosome plasma membranes were solubilized in 5 % MEGA-10 to give a final 
concentration of 1% detergent and 1 mg/ml of membrane protein. 30mg of E. coli L-a- 
phosphatidylethanolamine was dissolved in 1ml of lOOmM sodium phosphate buffer pH7.4, 
containing 1% MEGA-10, and sonicated under an atmosphere of nitrogen for l-3hrs (or until 
dissolution was total) in a bath-type Decon FS100 sonicator. The sample was centrifuged at 
20000rpm for 30mins and 4°C. The solubilized membrane was similarly treated. 450ul of 
membrane solubilate was mixed with the phospholipid solution in a 4ml polyethylene tube and 
allowed to stand on ice for 30-60mins to allow vesicles to form. The mixture was then diluted 
to 4ml with assay (phosphate) buffer, and the vesicles used immediately or stored at -70°C until 
required.
2.1.5.4 Infinite-trans/counterflow vesicular transport
Frozen proteoliposomes were thawed slowly at ambient temperature and 
subsequently centrifuged at 20000rpm for 30mins at 4°C. Detergent was removed by cyclical 
spinning with 2.5ml volumes of assay buffer. Vesicles were resuspended in 500ul of 200mM D- 
glucose. After another centrifugation, the pellet was taken up in 50ul of lOOmM D-glucose.
Transport assay was initiated by adding 5ul of preloaded vesicles to 500ul 
of assay buffer containing 4uCi 14C-D-glucose, and mixed rapidly, carefully but thoroughly. This 
produced an internal concentration of lOOmM inside the vesicles and ImM outside. Uptake of
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tracer/label was monitored over a time-course of lmin. All time-points were run in duplicate. 
Each uptake was terminated with 1ml lOuM (0.1 %) phloridzin in assay buffer. After quenching, 
the reaction mixture was immediately filtered (under 5secs) through 0.22um Millipore filters 
previously soaked in stopper, and mounted on a filtration turret linked to a suction pressure tap. 
Filters were washed 2X with 10ml of stopper, and allowed to dry briefly before being 
transferred to scintillation vials. Background or zero-time point values were obtained by adding 
vesicles to the stopper before adding the label.
Scintillation cocktail (5ml) was added to each filter and left to dissolve overnight. 
They were then counted and uptake values obtained by deducting ackground values from those 
at the respective time-points.
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2.2 Molecular cloning of the trypanosome glucose transporter
2.2.1 Materials and Methods
Two trypanosome gene libraries- a complementary DNA (cDNA) library in the 
bacteriophage vector lambda gtl 1, and a genomic library in lambda EMBL4 were gifts from Dr. 
J.D. Barry, University of Glasgow. A glucose transporter cDNA from rat liver was obtained 
from Dr. Harvey F. Lodish (MIT/Whitehead Institute, Cambridge, Mass. USA). COS-7 and 
pSVL were kind gifts from Dr. Adrian Wolstenholme, Department of Biochemistry, Bath 
University.
Restriction endonucleases, DNA modifying enzymes, IPTG, X-gal, DNA markers 
(Pst and Hindlll digested lambda DNA) were purchased from Northumbria Biologicals Limited 
(NBL), Cramlington, UK. Cloning vectors- M13 and pUC, ribonucleotides (rNTPs), deoxy 
NTPs and dideoxy NTPs, T7 polymerase DNA sequencing kit, Escherichia coli poly(A) 
polymerase, Sepharose CL6B, PD-10 columns, were obtained from Pharmacia LKB, Uppsala, 
Sweden; pBluescript SK(+/-), T3 and T7 polymerases, helper phages VCSM13 and R408 were 
from Stratagene; pGEM7 was from Promega, Madison, USA; all bacterial culture media (bacto- 
agar, bactotryptone, yeast extract) were from Difco, Michigan, USA; mammalian cell culture 
media, foetal calf serum, trypsin/EDTA and lipofectin were obtained from GIBCO BRL, 
Gaithersburg, USA; cell culture dishes, bottles, tubes, pipettes were from Sterilin, Nunc, and 
Costar; PBS tablets were purchased from Oxoid, Basingstoke, U.K; ampicillin, agarose (normal 
and low melting) were from Sigma, Poole, UK; radioactive isotopes 35-S ATP (1000 Ci/mmol), 
35-S methionine, a- and g-32P (5000 Ci/mmol), NEN GeneScreen Plus hybridization
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membranes, NENsorb columns and En3Hance were obtained from NEN (Du Pont), Stevenage, 
UK; Hybond N and N + , random primer labelling kit from Amersham International, Bucks., 
UK; acrylamide Sequagel kits were from National Diagnostics, New Jersey, USA; Polyallomer 
Quick-seal ultracentrifuge tubes were obtained from Beckman Instruments Inc., Palo Alto, USA; 
Sequenase kits were purchased from United States Biochemical Corporation, Cleveland, Ohio, 
USA; Polaroid films were from Polaroid Corporation, Cambridge, USA; Millex-GS 0.22um 
filters were from Millipore S. A, France; DE-81 and chromatography paper (46x57cm), pH strips 
were from Whatmann Ltd, Maidstone, UK; redistilled phenol was from Rathbum Chemicals 
Ltd., Walkerbum, UK; all other chemicals of analytical grade (Electran grade ammonium 
persulphate, acrylamide, and N,N,N’N’-tetramethylene diamine, TEMED) were obtained from 
BDH Chemicals Ltd, Poole, UK, Fisons, Loughborough, UK and Sigma, UK.
2.2.2 Isolation and purification of trypanosome genomic DNA
High molecular weight genomic DNA was prepared from bloodstream form 
trypanosomes purified as above. The cells were centrifuged at lOOOg for 5mins and the KRPB 
decanted. The cells were resuspended in Proteinase K buffer (PK 1 mg/ml, TE pH 7.4, 150mM 
NaCl and 0.4% SDS) at 106-108 cells/ml and incubated at 37°C overnight in a 50ml Falcon tube. 
The DNA solution was extracted with lvol Tris-saturated phenol by a series of gentle inversions. 
The phases were separated by spinning the solution at room temperature in a bench centrifuge. 
The upper phase was transferred to a fresh tube using a 1ml tip with the bottom half cut off to 
provide a wide bore. If the solution was
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sufficiently viscous, it was decanted. This phase was again extracted with chloroform:isoamyl 
alcohol (24:1) and this was repeated twice. The sample was centrifuged and the aqueous phase 
transferred to a Corex tube and mixed with 2.5vols of absolute ethanol and l/10th volume of 
3M NaAc pH 5.2. The precipitated DNA was spooled out with a glass rod, washed with 70% 
ethanol and dried under a vacuum. It was then dissolved in TE at 4°C overnight.
2.2.3 Estimation of yield and purity of DNA
The amount of DNA isolated was measured using a double beam UV 
spectrophotometer. The number of optical density (OD) units obtained at 260nm was multiplied 
by 50ug (for double strand DNA) or 37ug for single strand DNA or oligonucleotides. Purity was 
based on the ratio of the absorbances at 260/280 nm. A value of 1.8-2.0 for double strand 
templates was an indication of acceptable purity. DNA with a purity below this was re-extracted 
with phenol:chloroform and reprecipitated with ethanol.
2.2.4 Restriction analysis of genomic DNA
The DNA was digested with various restriction endonucleases either singly or in 
combination, at 2-5U/ug of DNA for 2-3hrs in a 37°C water bath. The samples were then 
electrophoresed at 100V in IX TBE on a 0.8% agarose gel containing lug/ml EtBr. The 
integrity of the DNA was checked by running uncut trypanosome genomic DNA in 
parallel with uncut lambda DNA, and Hindlll or Pst - cut lambda size
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markers. After electrophoresis, the DNA fragments were visualised on a UV transluminator. A 
photograph of the gel was taken where necessary.
2.2.5 Southern transfer and hybridization of immobilized DNA
The gel was transferred to a sandwich box and the DNA fragments depurinated 
in 0.25M HC1 for 30mins at room temperature with gentle rocking, to facilitate the transfer of 
large fragments. The acid was subsequently decanted and replaced with 5-10 vols of denaturing 
solution, and then with neutralizing solution for 30mins each time. This was poured off and the 
gel rinsed in several vols of distilled water. Nylon membrane (Hybond-N) was cut to size, 
soaked for 5mins in distilled water and then in 20X SSC. The nylon membrane was placed on 
the vacuum blotter and the gel placed upon the membrane. Blotting was done at 60-80mm Hg 
pressure for 2-6hrs (preferably overnight) and aided by layering 20-50mls 20X SSC on the gel. 
The traditional system of Southern transfer (203) was used on occasion, using a platform to 
support the gel and a wick of four layers of 3MM Whatman paper upon which the gel rests. 
Another set of 3MM paper was placed over the gel and the uncovered areas around the gel were 
covered with cling film to avoid the buffer being soaked up by the blotting tissue. The latter was 
placed about 10cm high on top of which a weight of about 500g was placed. Transfer was 
allowed onto the nylon membrane by upward capillary action in 20X SSC over several hours. 
Following transfer in either method, the set up was dismantled and the membrane rinsed in 2X 
SSC, blotted on 3MM paper, air-dried and baked for 2hrs at 80°C to fix the transferred 
fragments.
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The membrane was prehybridized in 50% deionized formamide/1% SDS/5X 
Denhardts/5X SSC/5mM EDTA pH 7.5/50mM sodium phosphate buffer pH 7.0 and 250ug per 
ml of salmon sperm DNA, at 42°C overnight. Hybridization was carried out in the same buffer 
by adding random primer-labelled rat liver glucose transporter cDNA at the same temperature 
for 16-24 hrs with shaking. The membrane was then washed in steps of increasing stringency 
from 5X SSC/0.5% SDS at room temperature for 15mins (X2); 2X SSC/0.5% SDS at 42°C (2X 
15mins); to IX SSC/0.5% SDS at 55°C for 30mins. It was then rinsed in 2X SSC and blotted 
on 3MM, sealed in cling film and exposed to presensitized film for 24hrs. The film was 
developed and hybridizing fragments identified and sized.
2.2.6 Isolation and purification of specific DNA fragments
The freeze-squeeze technique was routinely used for the isolation and purification 
of DNA fragments following their identification on a Southern blot.
A 1% LMP agarose gel was prepared using Tris-acetate-EDTA (TAE) buffer. 
After electrophoresis and visualization, the band of interest was cut out in a slice of gel using 
a sharp razor blade. The slice was taken in a microfuge tube plugged with glass wool and frozen 
in liquid nitrogen for 2-5mins. The tube was then quickly centrifuged over a 4ml polypropylene 
tube in a microfuge. The eluted DNA was then phenol-chloroformed and ethanol-precipitated 
as previously described. It was further purified by any of the methods for purifying probes as 
described below, though at this stage, it was good enough for restriction or ligations after 
ethanol precipitation.
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2.2.7 Construction of an enriched plasmid library
Following Southern transfer, hybridizing fragments of genomic DNA were located 
with the help of lambda markers. A restriction digest in which the fragments had asymmetrical 
ends was selected and a large volume of this electrophoresed in 0.8% low melting point agarose 
gel and IX TAE buffer. The gel fraction containing those fragments was cut out in a slice of 
agarose. The fragments were purified as in 2.2.6 above.
The plasmid vector, pUC 19 was digested with the same enzymes as those 
yielding the hybridizing fragments (BamHl and EcoRl). The cut vector was purified and ligated 
with the genomic fragments overnight in IX ligase buffer and 16U T4 ligase in a total volume 
of lOOul, at 15°C. The ligation mixture was then centrifuged through a Sepharose CL6B column 
to remove buffer salts, and the eluate collected in a 1.5ml microfuge tube. Hence a trypanosome 
library enriched for fragments hybridizing to the rat glucose transporter cDNA was generated.
2.3 Preparation of probes
2.3.1 Random-primer extension/oligo labelling of cDNA
The rat liver cDNA probe was purified as a 1.5kb fragment (containing 
more than 95% of the reading frame) from the vector pGEM7 by restriction with EcoRl and 
freeze-squeezing as earlier described. This was radiolabeled according to the method of 
Feinberg and Vogelstein (204). Briefly, 100-200ng of the cDNA was heat-denatured, snap-
cooled on ice and labelled with the random-primer DNA labelling kit and 50-100uCi of a-32P
using the Klenow fragment of DNA polymerase 1, and incubated for 
2-3hrs at room temperature, as indicated in the manufacturers protocol. Unincorporated
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radiolabel was removed on a spun mini- column of DE-52.
2.3.2 Design and synthesis of oligodeoxynucelotides
Oligonucleotides were designed from various conserved motifs of the glucose 
transporter superfamily and based on the codon usage of T. brucei genes. Basically, the relevant 
amino acid residues were reverse translated into DNA taking the codon preferences into account 
and allowing for some degree of redundancy, as indicated below.
Synthesis was based on the solid phase B-cyanoethyl phosphoramidite chemistry 
of Caruthers (205) using an Applied Biosystems DNA Synthesizer Model 381 A.
The oligonucleotide was cleaved from the solid support by a l-2hr elution from 
the column with 1ml of concentrated ammonium hydroxide. The DNA solution was then 
incubated overnight at 55°C to remove protecting groups on the exocyclic amines of the bases, 
and then lyophilized prior to dissolving in 1ml of water and precipitating with 1/10 volume of 
3M NaAc pH5.2 and 3vols of absolute ethanol at -20°C for lhr. The DNA was spun down for 
15mins at 12,000 rpm, 4°C and washed with 70% ethanol before drying under vacuum for 
15mins. It was redissolved in 1ml of water. Occasionally, the lyophilization step was omitted 
and the crude DNA was precipitated from the ammonia solution and contaminating deprotection 
products as above, and used without purification.
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Oligonucleotide probes:
Oligo 1 : CCC GA(A/G) AGC CCN CGC T(T/A)(C/T) (C/T)T 
Peptide : P E S P R Y/F L
Oligo 2 : CA(G/A) CA (G/A) (C/T)TN ACN GGN AT(A/C/T) AA(C/T)
Peptide : Q Q L T G I N
Oligo 2 (cont'd): GCN GTN ATG TA(C/T) TA(C/T) GCN C
Peptide •• A V M Y Y A
Oligo 3 : GTN GAA CGC GCN GGN CGC CGC ACN (C/T)T
Peptide : V E R A G R R T L
Oligo 4 : CAA ATA GGT CCA GGT CCA ATA CCA TGG TTT
Peptide : Q I G P G P I P W F
Oligo 5 : GT(A/T) CC(A/T) GAA ACT AAA
Peptide : V P E T K
These oligonucleotides were synthesised from a consensus of the aligned glucose transporters. 
These regions are indicated in Fig. 28. Oligo 4 was initially designed for the Plasmodium GT, 
employing that codon usage. Obviously, this was inappropriate. In addition this was a wrong 
choice of consensus as this region is very poorly conserved in the prokaryote and lower 
eukaryote GTs.
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2.3.3 5’ end-labelling of oligonucleotides
Oligonucleotide (20-100pmol) were labelled with gamma 32-P in the presence of 
T4 polynucleotide kinase and IX kinase buffer in a total reaction volume of 50ul. The reaction 
mix was briefly centrifuged in a microfuge and incubated for 45mins at 37°C. Labelling was 
terminated by adding 0.5M EDTA to ImM final concentration or heating at 65°C for lOmins.
2.3.4 Purification of DNA probes
2.3.4.1 Purification on Quickspin columns
A DEAE-Sephadex 50 mini-column of 0.5ml bed volume was prepared in a 1ml 
syringe. The column was washed twice with distilled water by centrifugation at 2000rpm for 
3mins. The probe was added to the column and recentrifuged. Unincorporated label remained 
on the column and the labelled DNA was collected in a propylene tube.
2.3.4.2 Ethanol precipitation
0.5vol of 5M ammonium acetate was added to the DNA sample and precipitated 
with absolute ethanol on dry ice for 15mins. The probe was collected by spinning at 15000rpm 
for 15mins, 4°C and was washed with 70% ethanol, briefly dried and resuspended in 20ul TE 
pH 8.0.
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2.3.4.3 Denaturing PAGE/"crush and soak11 method
A 20% gel was prepared from a 40% stock of acrylamide:bisacrylamide (39:1) 
and allowed to polymerise over l-2hrs at room temperature. The DNA sample was mixed with 
0.5vol of sample buffer (60% deionised formamide, 0.6% bromophenol blue and 6% TBE) and 
heated for 3mins at 95°C. Samples were then loaded into pre-flushed wells and the gel was 
electrophoresed at 100V until the dye front was 75% down the gel. The latter was removed, 
covered in Saran wrap and exposed to X-ray film for lhr. The film was developed and the 
location of the labelled DNA identified and cut out with a razor blade. The gel slice was crushed 
in a 1.5ml microfuge tube and lvol of elution buffer (TE pH 7.4/50mM NaCl/0.1% SDS) was 
added and left to rock overnight on a table shaker at room temperature. The gel debris was spun 
down and the DNA ethanol-precipitated from the supernatant. The pellet obtained from spinning 
at 15000rpm and 4°C, was washed with 70% ethanol and dried. It was then resuspended in TE.
2.3.4.4 Hydrophobic chromatography on Nensorb columns
Nensorb 20 cartridges were prewashed with 1ml methanol to activate the resin. 
It was again washed with 2ml Reagent A (0.1M Tris-HCl pH 8.0/10mM triethylamine, TEA) 
to equilibrate the resin. The DNA was applied to the column in 1ml TEA, eluted and repassaged 
two more times. The column was then washed with 2ml TEA and again with 2ml water to 
remove the former. 1ml of Reagent B (50% methanol) was then added to the cartridge and the 
DNA was eluted from the column. It was evaporated to dryness and resuspended in an 
appropriate volume of TE.
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2.3.4.5 Estimation of specific activity of probes
Aliquots of the probe (l-2ul) were spotted onto DE-81 paper. One of them was 
washed extensively with several volume changes of 0.5M sodium phosphate buffer pH 7.0. The 
washed filter was then dried and the bound radioactivity on both filters was estimated using a 
Geiger counter (Cerenkov counting) or counted in a scintillation counter using a toluene-based 
scintillant. The percentage incorporation of label was estimated by dividing the counts on the 
washed filter by those of the unwashed filter. The specific activity of the probe was calculated 
as the cpm of the washed filter divided by the number of micrograms of starting template.
2.4 Cloning in bacteriophage lambda
2.4.1 Plaque blotting and hybridization
The libraries were plated out on 24x24cm LB plates at 106-107 plaque forming 
units (pfu) and incubated overnight at 37°C using Q359 as the host E. coli strain. Plaques were 
allowed to grow to confluence, and then blotted onto asymmetrically marked nylon membranes 
(Hybond-N) for lmin and denatured 5min on 3MM paper soaked with denaturing solution. They 
were neutralized on 3MM paper soaked in neutralizing solution for 7mins. The membranes were 
rinsed thoroughly in 2X SSC and any agar sticking to them was gently teased off. They were 
subsequently air-dried, baked for 2hrs at 80°C, and prehybridized and then hybridized using the 
same regime described earlier [see 2.2.5],
Positive clones were identified and carried through two more cycles of 
purification. This was done by orienting the membranes with the agar plates using the 
asymmetrical marks to locate hybridizing plaques. These plaques were picked with the broad end
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of a Pasteur pipette into storage medium (SM) in a universal bottle. The phage were eluted 
overnight by gentle rocking on a table-top shaker at room temperature, and then centrifuged to 
remove cell debris. Dilutions of the phage were made such that isolated plaques would be 
obtained for easy identification. These were then used to reinfect fresh host cells and replated. 
The cycle of plating, plaque blotting, hybridization, and clone isolation were repeated at 
decreasing plaque densities until single positive plaques could be identified.
2.4.2 Preparation of lambda lysates and isolation of lambda DNA
Phage were eluted from positive clones and replated on fresh 10cm diameter LB 
plates. Plate lysates were prepared from these by adding 5ml of SM directly to the plates and 
the phage was eluted. Bacterial cell debris was removed by centrifugation, and the lysate stored 
in a drop of chloroform. This was subsequently used to grow a lytic culture of phage at a 
multiplicity of infection of 109, in 21 flasks. The phage was isolated as before, and precipitated 
in 35%NaCl/40% polyethylene glycol (PEG) at 4°C overnight. The PEG-phage precipitate was 
DNAse-treated (lOOug/ml), extracted with an equal volume of chloroform and centrifuged on 
a CsCl gradient (0.77g/ml lysate) in polyallomer tubes and in a Beckman ultracentrifuge, at 35K 
for 40hrs at room temperature. The phage band was removed with a 18mm gauge needle and 
dialyzed overnight with two changes of dialysis buffer (lOmM MgSO4)/10mM Tris-HCl pH 
7.5). To the dialyzed phage was added a tenth volume of 500mM Tris-HCl/lOOmM 
NaCl/lOOmM EDTA, and 100-200ug/ml of Proteinase K. The mixture was incubated at 37°C 
for lhr. One volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added and mixed 
gently for 5mins and then centrifuged for 5mins at lOOOg at room temperature. To the aqueous
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phase was added one volume of chloroform:isoamyl alcohol and treated as before. To the final 
aqueous phase was added 3M NaAc and three volumes of cold absolute ethanol. The precipitated 
DNA was spooled out, dried under vacuum and allowed to dissolve slowly at 4°C.
2.4.3 Restriction analysis/mapping of lambda clones
Lambda DNA isolated above was digested to completion with various restriction 
enzymes (2-5units/ug DNA) as indicated in the legend on the figure below. The restriction 
digests were electrophoresed on an 0.8% agarose gel containing lug/ml of EtBr (1 mg/ml), at 
50 volts overnight in IX TBE buffer. Fragments were visualized over an ultraviolet 
transilluminator and sized based on the Hindlll restriction profile of lambda DNA.
2.4.4 Southern transfer, identification and isolation of inserts
Southern transfer and hybridizations were essentially as described above. 
Hybridizing fragments were identified with various clones and sized. Hybridizing clones were 
digested in a volume of 500ul with the restriction enzyme whose digest showed a positive 
fragment. About half of this digest was run on a 1 % low melting point agarose gel and the 
fragment of interest was cut out and freeze-squeezed as earlier described.
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2.5 Subcloning strategy
2.5.1 Vectors and vector preparation
0.5 ug of EcoRl-cut and phosphatased pUC or M13 was digested with
Hindlll at 37°C for lhr. The digest was extracted with an equal volume of TE-saturated 
phenol:chloroform:isoamyl alcohol (25:24:1) by vortexing for lmin and spinning in a 
microfuge for another minute. The aqueous phase was transferred to a clean tube and the 
DNA precipitated as before.
2.5.2 Ligation/construction of recombinant plasmids
lOOng of the insert DNA purified in 2.4.4 above, was ligated with 200ng 
of pUC or M13 in a reaction mixture containing 2 units of T4 ligase, IX ligase buffer in 
a total volume of 20ul. Control ligations included vectors without inserts and vice versa. 
Ligation mixes were incubated at 15°C overnight. They were subsequently spin-dialyzed 




L I G A S E
pTGT-4
Scheme for construction of pTGT-4 (subcloning strategy).
I H ' W-d 5
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2.5.3 Preparation of competent cells
An overnight culture of TGI (see Appendix for genotype) cells was grown in 
50ml DYT broth. A 1 in 50 dilution of the culture was made in 100ml fresh broth and cell 
growth was monitored every 20-30mins until the exponential phase of growth i.e the optical 
density reached 0.4-0.6 corresponding to 108 cells/ml. The cells were transferred to sterile 
Falcon tubes and chilled on ice for lOmins. They were centrifuged at 7000rpm for lOmins at 4°C 
in a Sorvall. The supernatant was decanted and traces of media drained by standing tubes 
inverted. Each pellet was resuspended in 50ml of ice-cold 50mM CaCl2 and placed on ice for 
30mins. They were then centrifuged as above, drained and the pellet resuspended in a total 
volume of 5ml of 50mM CaCl2 for each 50ml of original culture. The cells were left on ice in 
the cold room for 24-48hrs to maximise their competence.
2.5.4 Transformation with recombinant constructs
300ul of competent cells was added to the ligation mixes (l-5ul) and kept on ice 
for 40mins. They were then heat shocked at 42°C for 2mins. 1ml of fresh DYT broth was added 
and incubated for lhr at 37°C. This incubation step was omitted in M13 transformations. They 
were centrifuged briefly, the supernatant decanted, and lOul of IPTG (lOOmM), 50ul X-gal (2 %)  
was added. They were spread with a sterile glass rod using a potters wheel, onto agar plates 
containing lOOug/ml ampicillin (sodium salt). The latter was eliminated in transformation into 
M13. For the latter, the transformed competent cells were added to 3mls of DYT broth at 48°C 
and quickly poured onto agar plates. Plates were allowed to dry and then incubated inverted at 
37°C overnight.
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Recombinants (white colonies or clear plaques) were identified and picked for regrowth in 3-5ml 
of fresh broth containing lOOug/ml ampicillin (for pUC recombinants) or without ampicillin (for 
M13 recombinants).
2.5.5 Cloning in plasmid
The enriched plasmid library constructed in 2.2.7 above was transformed into
competent TGI or HB101 cells and plated onto 20cm-diameter agar plates containing ampicillin 
as described above. Colonies were lifted onto nylon membranes as described for plaque lifts. 
After lifting, the plates were re-incubated for lhr to allow the colonies to regrow to ease 
identification after hybridization. The membranes were treated as for plaque lifts and hybridized 
with oligo 2 and the cDNA probes. Hybridizing colonies were picked and processed as below.
2.5.6 Plasmid isolation, purification and restriction mapping
2.5.6.1 Small-scale plasmid isolation (mini-preps)
Recombinant plasmids were grown in 5mls of fresh broth overnight. The cells 
(1.5ml) were pelleted at 5000rpm (12,000g) for 5mins in an Ole Dich refridgerated microfuge 
(Model 154, Camlab). The supernatant was discarded and lOOul of lysis buffer (50mM 
glucose/25mM Tris-HCl pH 8.0/10mM EDTA/2mg per ml fresh lysozyme) added to resuspend 
the pellet. The mixture was incubated on ice for lOmins. 200ul of freshly made 0.2M NaOH/1 % 
SDS was added and incubation continued for a further lOmins. 150ul of 3M KAc pH4.8 was 
added and left on ice for lOmins. The contents were centrifuged at 12,000g for 15mins at 4°C. 
The supernatant was treated with 2.5 vols of cold EtOH and incubated on ice for lOmins. The
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DNA was pelleted by spinning for lOmins at 15,000g in a microfuge and washed with cold 70% 
EtOH. It was briefly dried, redissolved in 50ul of water and purified by spinning through a 
Sepharose CL6B column. An aliquot of each clone was cut with Hindlll for lhr and then with 
EcoRl and electrophoresed in parallel with uncut plasmid and lambda markers on a 1 % agarose 
gel to check and verify the presence and size of the inserts. Plasmids isolated from the plasmid 
library were cut with BamHl and EcoRl as these were the sites at which genomic inserts were 
cloned into the vector.
2.5.6.2 Large-scale plasmid isolation (maxi-preps)
Clones with inserts were grown as 11 cultures in 21 flasks overnight. The cells 
were harvested by spinning in a Mistral 6L centrifuge in 11 bottles at 4000rpm, for 15mins at 
4°C. The supernatant was decanted and the pellet washed with 100ml of STE. The cells were 
respun and resuspended in 10ml of lysis buffer, and left at room temperature for 5mins. 20ml 
of freshly prepared 0.2M NaOH/1% SDS was added and the tube inverted several times and 
then allowed to sit at room temperature for lOmins. 15ml of ice-cold KAc was added, the tube 
capped and its contents mixed and placed on ice for lOmins. It was spun at 4000rpm for 15mins 
at 4°C in a Sorvall. The latter was allowed to stop with the break off. The supernatant was 
filtered through four layers of muslin or gauze. Isopropanol was added to 0.6vol, mixed and 
stood at room temperature for lOmins. The DNA was recovered by centrifuging at 5000rpm for 
15mins at room temperature. The supernatant was decanted and the pellet washed with 70% 
EtOH and evaporated to dryness.
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2.5.6.3 Equilibrium gradient purification of plasmids
The DNA was dissolved in 3ml TE pH 8.0. To each ml of DNA was added lg 
of CsCl and lOOul of EtBr (lOmg/ml). The mixture was centrifuged in a Sorvall at 8000rpm for 
5mins at room temperature to remove the pellicle. The clear purple solution of DNA/CsCl/EtBr 
was transferred by means of a Pasteur pipette into Beckman quickseal polyalloma ultracentrifuge 
vials. The remainder of the vials was filled with lmg/ml CsCl in TE. The vials were sealed and 
centrifuged at 60000rpm in a Ti70 rotor for 24hrs. The plasmid bands were removed as for the 
phage. The EtBr was removed from the plasmid by a series of vortexing, spinning and removal, 
with equal volumes of isoamyl alcohol. This was continued until both aqueous and organic 
phases were clear. The plasmid/CsCl mixture was diluted out with 3vols of water, and 2vols of 
cold EtOH added. The DNA was precipitated at 4°C for 15mins, and spun out at lOOOOrpm for 
15mins at 4°C. The pellet was vacuum dried and resuspended in 1ml TE pH 8.0. The yield of 
DNA was estimated as previously described. Aliquots were digested as for the mini-prep with 
the relevant restriction enzymes to verify the presence and size of insert.
2.5.7 Isolation of single-strand DNA from M13 clones
Clear plaques of M13 recombinants were picked and grown in 2-5ml exponential 
cultures of TGI cells and cultured overnight (6-10hrs) at 37°C with shaking. 1.5 ml of the culture 
was centrifuged in an eppendorf tube for lOmins. The phage-containing supernatant was 
carefully transferred to a clean tube containing l/10vol 20% PEG/2.5M NaCl. The phage was 
precipitated for 15mins on ice and was spun down for lOmins. The supernatant was decanted 
and the tube respun and all traces of PEG carefully removed. The pellet was resuspended in
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200ul of TE and extracted with an equal volume of phenol:chloroform (3:1) by vortexing and 
centrifuging. The DNA in the final aqueous phase was isolated as previously described, dried 
and resuspended in 20ul of TE.
2.5.8 Single-strand plasmid rescue
A fresh plasmid colony was picked into 5ml of DYT containing lOOug/ml of 
ampicillin. The helper phage VCSM13 was added at 107-108 pfu/ml or a multiplicity of infection 
of 10. The culture was grown for 2hrs at 37°C after which kanamycin was added to 70ug/ml 
final concentration, and growth continued overnight. Single-strand DNA was then prepared as 
earlier described.
2.6 DNA sequencing
Sequencing was performed according to Sanger’s dideoxy chain termination 
method (206). All reactions were primer-directed.
, 2 5 5 0 J P _  R
J
Fig. 35 DNA sequencing strategy. Horizontal bar represents double-strand template.
Arrows above and below the template indicate the strand and direction of 
sequencing. Regions of overlapping arrows represent regions for 
primer-initiation of sequencing. Cloning sites are indicated. R= EcoRl and 
H= Hindlll
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2.6.1 Template preparation and sequencing
Double-strand pUC templates (2-5ug per sequencing reaction) were 
denatured in a total volume of 30ul with 0.2M NaOH/2mM EDTA for lOmins. Tliis was 
then spin-dialyzed through a Sepharose CL6B mini-column after repeatedly (2-4 times) 
washing out the resin storage-buffer with distilled water. The denatured template was then 
used immediately. Single-strand M13 templates prepared above were used without this 
step. DNA templates were sequenced using the sequenase kit as instructed in the 
manufacturer’s manual. Sequencing reactions were subsequently electrophoresed on 6-8% 
polyacrylamide gels of 0.2mm-0.35mm thickness, made using the recipe of the supplier 
of Sequagel. Gels were processed as described in the sequenase manual. Sequencing was 
done on both strands (pUC) and oligonucleotide primers complementary to the template 
sequence were synthesised as and when necessary.
2.7 Sequence analysis
2.7.1 Analysis of gene structure
The sequence was analyzed using the programme of Staden (207). As 
sequencing was primer-directed, new sequences were added onto those of the preceding 
segments. This avoided using the contig assembly menu, DBAUTIL as would be the case 
with a shotgun sequencing strategy. Sequence analysis was then performed using the 
ANALYSEQ menu to study the structure (searching for Z-DNA, palindromes, restriction 
enzyme sites etc); for statistical analysis of the sequence with respect to base composition, 
dinucleotide frequencies and codons; to translate the nucleotide sequence into amino
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acids, and to search for open reading frames and possible promoter regions. The translated 
sequence was then analyzed further on the ANALYSEP and Sequence Comparison menus. 
The former enabled the identification of possible hydrophobic segments, and the latter 
was helpful in a direct segmental sequence comparison to identify the binding/ 
hybridization sites of the probes used in cloning.
2.7.2 Multiple sequence alignment and homology search
This was performed according to Barton and Sternberg (208) and the 
HOMED programme of Stockwell (209). Briefly, all the available glucose transporter 
sequences were aligned pair-wise i.e the third sequence was aligned with the best 
alignment of the first two sequences, the fourth with the best of three etc. The 
trypanosome sequence was added to the optimal/consensus template alignment of the 
preceding sequences. Comparisons of the trypanosome sequence were also made with a 
selection of mammalian glucose transporters on one hand, and with prokaiyote and lower 
eukaryote transporters on the other. Gaps were manually included to optimize the 
alignment.
2.73 Secondary structure prediction
This was performed using the Chou-Fasman algorithm (159), to predict 
potential a-helices, b-sheets or regions with a propensity to form turns.
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2.8 Database search
The trypanosome protein sequence was used to search several databases 




3.0 Molecular characterization of the putative glucose transporter clone
3.1.1 Construction of transcription plasmids
The insert from pTGT-4 was isolated from the latter by digesting with EcoRl and 
Apal, and purified after low gelling agarose gel electrophoresis. This was then ligated 
directionally into pBluescript cut with the same restriction enzymes to produce the plasmid 
pBS.TGT-4. Insertion of the fragment into the vector was such as to enable transcription from 
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Scheme for construction of transcription vector.
Enzymes: A= Apal and R= EcoRl. The direction of transcription is 
specified by the orientation of the promoters T3 and T7.
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3.1.2 Cloning and purification of plasmid constructs
The plasmid was subsequently transformed into competent TGI cells as 
previously described. Transformants were picked and grown in 5ml of fresh broth. 
Plasmid DNA was prepared on the small scale as detailed above. The presence of inserts 
was verified by restriction mapping of the plasmids with the above restriction enzymes 
and running on a 1% agarose gel. Plasmids with the expected size of insert were grown 
in 500ml DYT broth and the DNA purified as previously on a CsCl gradient.
3.13 Transcription and capping of transcripts
Sterile procedures were stringently adhered to in this step. RNAse-free 
solutions were prepared in DEPC-treated water (0.1%) and oven-baked or autoclaved 
bottles and tubes. Pipette tips were autoclaved for 70mins on the dry cycle. Pipettes were 
cleaned in DEPC-water and then rinsed with 3% hydrogen peroxide.
The plasmid was linearized downstream of the insert (using EcoRl) and 
downstream of the T7 polymerase promoter to enable transcription of the coding strand. 
Proteinase K was added to the digest to 50ug/ml at 37°C for 30mins. The template was 
then extracted two times with 1:1 phenol/chloroform, and precipitated with ethanol. The 
pellet was vacuum-dried and resuspended at 1 mg/ml in DEPC-treated water.
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Run-off transcripts were prepared according to Melton etal(211) with some modifications 
as follows:
5ul 5X transcription buffer (200mM Tris-HCl
pH8.0/40mM MgCl2/10mM spermidine/25OmM NaCl) 
lul 0.5M DTT
lul RNAguard
4ul lOmM rNTP cocktail
2.5ul 5mM m7G(5')ppp(5')G capping agent
lul DNA template
20U T7 polymerase
Water was added to a final volume of 25ul.
The transcription mix was incubated for lhr at 37°C. After this, 10U of RNAse-free 
DNAse was added and the incubation continued for 15mins. The RNA was then purified 
by phenolxhloroform extraction and precipitated with l/10th volume 3M NaAc pH 5.2, 
and 2.5 volumes of absolute ethanol. The pellet was briefly dried and resuspended in 50ul 
DEPC-treated water. The yield of RNA was estimated by running Sul on a normal/non­
denaturing agarose gel, and the concentration adjusted to lmg/ml.
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3.1.4 In vitro translation
This was performed using rabbit reticulocyte lysate in the following set up:







The mix was made up to 25ul with DEPC-treated water and incubated for lhr at 30°C. A 
positive control was set up to run in parallel using Xenopus laevis oocyte B-globin RNA.
3.1.5 SDS-PAGE
The translation products were separated by electrophoresis on a 10% SDS- 
polyacrylamide gel prepared from a 40% stock. Samples were mixed with 50ul sample buffer 
(6M urea/10%SDS/35% glycerol/0.5 % bromophenol blue supplemented with 10% 
mercaptoethanol), and boiled for 2min. They were then loaded onto the gel and run together 
with molecular weight markers at 100mA constant current in IX electrophoresis buffer. After 
electrophoresis, the gel was stained in Coomassie brilliant blue (30% methanol, 10% glacial 
acetic acid, 0.1 % Coomassie stain) with gentle rocking overnight. It was then destained in 30% 
methanol/10% acetic acid.
3.1.6 Fluorography
The gel was rinsed with distilled water and blotted dry on 3MM paper. En3Hance
was added to the gel and rocked for lhr at room temperature. It was subsequently rinsed 2X for 
lOmins each time, with distilled water, fixed onto 3MM paper and dried on a vacuum slab gel 
dryer. The dried gel was then exposed to X-ray film as before.
3.2 Developmental expression of the glucose transporter-related gene
3.2.1 Isolation of trypanosome RNAs
Bloodstream trypanosomes were purified as above, and culture forms (procyclics) 
were provided by Ms M. Kasraeian, Department of Biochemistry, Bath University. All cells 
were frozen in liquid nitrogen until used. Precautions pertaining to RNA handling were adhered 
to as above.
RNA isolation and purification was carried out essentially by the method of 
Chomczynski and Sacchi (212). Briefly, trypanosomes were resuspended to lOMO8 cells/ml of 
guanidinium thiocyanate (GIT) in a sterile falcon tube whereupon they lysed immediately. In 
sequence, O.lvol of NaAc pH 4.0, 1 vol of water-saturated phenol (Tris-treated) and 0.2vol of 
chloroform:isoamyl alcohol (49:1) were added to the cell lysate and thoroughly mixed after each 
reagent was added. The mixture was briefly vortexed and then chilled on ice for 15mins. It was 
spun for 20min at 10,000g and 4°C. After centrifugation the supernatant containing RNA was 
transferred to a fresh tube and the RNA precipitated with lvol of isopropanol for lhr at -20°C. 
The RNA was spun down as above and redissolved in 0.3vol (original lysate) of GIT in a 1.5ml 
Eppendorf tube. The RNA was reprecipitated and centrifuged for lOmins. The pellet was rinsed
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with 70% ethanol, vacuum-dried and stored in ethanol or as a dry pellet at -70°C until required..
3.2.2 Formaldehyde gel electrophoresis
A 1 % formaldehyde gel was prepared by replacing IX TBE buffer for a normal 
agarose gel, with IX MOPS buffer prepared in DEPC-water. The gel was allowed to cool to 
about 50°C when it was transferred to a fume hood and 37% formaldehyde added to a final 
concentration of 0.66M. The gel was left to cool to about 35°C and then poured in the hood and 
allowed to set. 10-20ug total RNAs (1 mg/ml) were mixed with 2vols of sample buffer (50% 
formamide/2.2M formaldehyde/IX MOPS) and denatured by heating at 65°C for lOmins. They 
were snap-chilled on ice and then mixed with sample loading buffer (0.1% SDS/5% 
glycerol/50ug per ml bromophenol blue). The samples were loaded onto the gel together with 
RNA markers and electrophoresed at a constant voltage of 100V in IX MOPS. After 
electrophoresis, the gel was stained for 30mins in 1 mg/ml EtBr to visualise RNA.
3.2.3 Northern blotting and hybridization
Following visualization, the gel was rinsed in several volumes of 10X SSC to 
remove formaldehyde. All other procedures for Northern blotting were as for those described 
in Southern blotting above. RNA was immobilised onto Hybond-N+ membranes by baking at 
80°C for 2hrs or by UV irradiation for 5mins.
The insert from pTGT-4 was purified as described and radiolabeled by random- 
primer extension as above. The rat liver GT cDNA was similarly purified and treated. Oligo (2) 
was end-labelled as above. All three probes (previously used to isolate the gene) were used to
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hybridize the Northern blots to detect glucose transporter mRNA transcripts and transcripts 
relating to the trypanosome gene, in both bloodstream and procyclic forms. Hybridization and 
subsequent processing were as for Southern blotting.
3.3 Functional expression of the gene
3.3.1 Construction of expression vector
The eukaryotic expression vector pSVL was digested with Smal within the 
polylinker. pTGT-4 was also digested with Hindm and EcoRl, electrophoresed on a 0.8% low 
melting point agarose gel and the insert cut out from the gel. The fragment produced from this 
digest contained all the putative promoter and enhancer elements of the gene. The DNA was 
isolated from the digest by freeze-squeezing and the insert and vector were purified as before. 
The insert was end-filled using Klenow enzyme. Briefly, the fragment was dissolved in 20ul TE, 
5ul of 10X Klenow buffer, lul of 15mM dNTP mix, lul (4U) Klenow, and water to a final 
volume of 50ul. The mixture was incubated for 15mins at room temperature. The reaction was 
stopped by phenol:chloroform extraction and the DNA ethanol-precipitated.
Vector and inserts were ligated in a ratio of 0.5 (vector:insert) in a total volume 






Fig. 37 Construction of eukaryotic expression vector, pSVL/2.5 
Enzymes: H= Hindlll; R= EcoRl; S= Smal;
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3.3.2 Cloning and purification of vector
The expression construct was transformed into competent HB101 cells and 
plated on DYT plates containing lOOug/ml ampicillin. After an overnight incubation at 
37°C, transformants were picked and regrown in 5ml of DYT broth. Plasmid mini-preps 
were prepared and cut with restriction enzymes with recognition sites in the polylinker 
of the cloning vector viz. Xhol and Sacl. (Blunt-end ligations result in the loss of 
original restriction sites, in this case, EcoRl and Hindin. pSVL/2.5. Restriction was 
performed with the knowledge of the restriction maps of both insert and vector). 
Restriction digests were run on a 1% agarose gel and the sizes of the inserts noted with 
respect to the beginning of the coding strand and the regulatory regions of pSVL. 
Plasmids with the expected sizes and native pSVL were grown on a large scale as 
previously described and purified on a CsCl gradient. The maxi preps were again cut with 
the above enzymes (Xhol and Sacl) to confirm the presence of inserts of the expected 
sizes.
3.33 Determination of insert orientation
Even though the orientation was determined by restriction mapping of the 
constructs, an unequivocal result was obtained by cutting out the insert as before and 
subcloning into Xhol and BamHl-cut M13mpl9. Single-strand DNA was prepared and 
sequenced with the universal forward primer. The sequences indicated the orientation of 
the coding strand with respect to the vector promoter and polyadenylation signals.
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3.3.4 Cell culture
COS-7 cells were removed from storage in liquid nitrogen and quickly 
thawed in a water bath at 37°C. Just before the lump completely thawed, the cells were 
diluted with 1ml DMEM supplemented with 10% foetal calf serum (FCS), hereafter 
referred to as "medium" i.e DMEM+FCS. They were then seeded on a 10cm diameter 
petri dish and 9ml of more medium was added. The cells were then incubated at 37°C and 
10% C 02. The medium was changed after every 48-72hrs. At about 90% confluence, the 
cells were washed 2X with PBS equilibrated at 37°C, and the PBS aspirated. They were 
subsequently trypsinized with lml of IX trypsin/EDTA (0.05% trypsin/0.02% EDTA). As 
the cells detached (3-5mins) from the plate, 10ml of medium was added and the cells 
collected in polystyrene bottles with a rubber policeman. They were centrifuged at 1500 
rpm for 3mins and the medium carefully decanted. The cell pellet was resuspended in 
10ml of fresh medium.
3.3.5 Trypan Blue exclusion
To 50ul of the cell suspension was added an equal volume of 0.1% trypan 
blue for 15mins. The number of live cells was counted in a haemocytometer at x40 
magnification. The total harvest of cells per ml was estimated from the number of cells 
counted in the five wells of the haemocytometer, divided by 5 and multiplied by the 
dilution factor of 2 and the volume of the well (104). An appropriate volume of medium 
was added to give a cell count of 104-106cells/ml.
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3.3.6 Transfection of COS-7 cells
3.5cm-diameter dishes were seeded with about 10s cells from the above and 
made up to 3ml with fresh medium. They were then cultured as before.
When cell growth attained about 80-90% confluence, they were transfected 
with expression constructs using lipofectin as instructed by the manufacturer. Briefly, for 
each plate, lOug (lOul) of lipofectin was diluted to 25-S0ul with sterile water. l-10ug of 
DNA containing gene construct or native plasmid (control) was diluted to the same 
volume. All dilutions of lipofectin and DNA templates were done separately in 
polystyrene tubes. TTiey were then gently mixed and left to coprecipitate for 15mins at 
room temperature. In the interval, the cells were washed twice with prewarmed PBS and 
then seeded with 3ml of serum-free DMEM. The lipofectin-DNA complex was added to 
the cells at 50-100ul per plate. The plates were gently swirled to ensure even distribution 
of the complex, and then incubated for 5hrs. After this time the serum-free medium was 
replaced with 3ml of fresh medium containing serum at 10%. Incubation was continued 
for 72hrs. .
3.3.7 Transport assays
Expression of glucose transport activity was measured under zero-trans 
conditions. The cells were washed 2X with Krebs-Ringer-Hepes buffer (KRH) 
equilibrated at 37°C. 0.5ml of this buffer was added after washing and the cells incubated 
for 30mins at 37°C. This was subsequently aspirated and 0.5ml of 100uM/2uCi of 3H-2- 
deoxyglucose (2-DOG, 6.6Ci/mmol) or 1.2 uCi 14C-3-0-methylglucose containing 50-
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lOOuM cold D-glucose was added to each plate. After an appropriate incubation time, 
glucose uptake was terminated by adding 2ml of ice-cold KRH/phloridzin, lOmg/lOOml. 
This was quickly aspirated and the cells washed two more times. For 
background/nonspecific uptake, the stopping solution was added to the cells before adding 
substrate.. All time points were run in duplicate. After the assay, the cells were solubilized 
with 0.5ml 1%  SDS at room temperature for 30mins. Aliquots of lOul of each sample 
were taken for protein determination by the BCA method (213). The remainder of the 
lysates were transferred to scintillation vials and counted in 10ml scintillant as previously.
CHAPTER 4 
RESULTS
4.1 Functional identification and characterization of the trypanosome
glucose transporter
The rate of glycolysis in T. brucei was studied in an attempt to correlate this with 
the rate of glucose transport. Preliminary results from the measurement of glycolysis indicated 
that the rate of this process was approximately twenty-fold that of mammalian systems, at 
86.7nmol O2/min/108 cells. This is consistent with the results of Flynn and Bowman (214).
Functional activity of the glucose transporter was assayed in both whole cells and 
reconstituted vesicles. Results from assays in whole cells were consistent with those reported 
earlier (215) in this laboratory.
An attempt to achieve transport in reconstituted vesicles was replete with several 
difficulties, not least the integrity of the plasma membranes prepared, and the possible 
proteolytic degradation of membranes in storage. The main methods employed to achieve 
physiological reconstitution included cycles of freeze-thawing, sonication and detergent dilution. 
A combination of sonication and detergent dilution achieved functionally reconstituted vesicles 
which transported glucose under trans-stimulation. It must be mentioned that even though this 
was achieved with the expected result of physiological reconstitution, it is not a very 
reproducible technique. This is due to a large number of reasons including the nature of 
detergent, membrane integrity, the sidedness of the vesicles, integrity and homogeneity of size 
of the vesicles, nature and integrity of phospholipid (oxidized phospholipid was no use) etc. The 
amount of incorporation of protein into liposomes varied from 3.8-5% of initial crude membrane
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protein. Even though this level is low, it was not a critical factor for achieving reconstitution 
and transport. The large number of variables therefore makes this technique unavailable for 
routine application.
The biphasic nature of transport in the vesicles in response to trans-stimulation 
intrinsically may hold information regarding the binding, rate of translocation and restitution of 
the transporter molecules. The graph below [Fig. 38] may therefore be the embodiment of the 
phenomenon of facilitated transport, and of substrates which share the same carrier and whose 
uptake and translocation are mutually dependent. There is an initial counterflow/trans-stimulation 
transient as labelled substrate is transported up its concentration gradient. The movement of label 
is simultaneously coupled to the exit of cold intracellular glucose. Uptake peaks within 3secs, 
and tapers at a point where the concentration of label on both sides of the membrane are 
identical. This is the only criterion for delineating glucose transport in the trypanosome from 
speculations of endocytosis or diffusion as the mechanism of substrate uptake. Another point 
from this study was the observation that the stoichiometry of transport was (tentatively) about 
0.8moles of glucose per mole of transporter. This was estimated from the gradient of the graph 
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Fig. 38 Binding and translocation of radiolabeled glucose in the reconstituted 
trypanosome GT. Results are expressed as the amount of radiolabeled glucose 
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Fig. 39 Estimation of the stoichiometry of glucose transport. The gradient of the 
slope represents the number of moles of glucose per mole of transporter.
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4.2 Molecular cloning of the GT-related gene
The trypanosome genomic library was screened with the rat liver glucose 
transporter cDNA. Hybridizing plaques were washed at room temperature with 5X SSC, 
and at 55°C with 2X SSC. In the first round of screening, 17 clones were identified and 
further selected by cross-hybridization with oligo 2 followed by oligo 3. Twenty four 
plaques were picked from the hybridization with oligo 3. These were then cross­
hybridized with oligo 4, and 12 positive plaques were picked. Six of these clones were 
selected on the strength of their hybridization signals, and a large scale preparation of 
lambda DNA was carried out on them. These were cut with various combinations of 
restriction endonucleases to map and identify the inserts by Southern blotting. 
Hybridization with the rat cDNA identified four types of clones: 1-LT2, 1-LT5, and 1- 
LT7; 2-LT3; 3-LT10; 4-LT19. (The number preceding and after each clone denote its 
category and cloning identification number respectively. LT is an abbreviation for each 
trypanosome genomic clone in lambda).
. Of the four categories, 1 and 3 gave hybridizing fragments of about 1200bp 
and 2550bp respectively, when digested with Hindm and EcoRl. Clones 2-LT3 and 4- 
LT19 contained feebly hybridizing inserts. Upon the strengths of their hybridization, the 
inserts of the positive groups represented by 1-LT2 and 3-LT10 were purified and ligated 
into EcoRl and Hindlll-cut pUC. The recombinants were denoted as pTGT-1 and pTGT- 
4, containing the 1200bp and 2550bp respectively.
DNA was isolated from maxi preps of these plasmids and cut with the 
above enzymes to verify the presence and size of the inserts. They were mapped by
125
cutting with other restriction enzymes, and subsequently hybridized with the rat cDNA 
again. pTGT-4 was selected for further study because it contained a more strongly 
hybridizing insert. Also a partial sequence of pTGT-1 showed long tracts of repetitive 
DNA, and a long open reading frame was not revealed. It was also impossible to perceive 
any homology between it and the rat cDNA or any of the oligos which could account for 
the strong signal obtained with this clone.
An enriched genomic library was also prepared from fragments of 
trypanosome genomic DNA hybridizing to the rat cDNA. This library was prepared by 
digesting trypanosome genomic DNA with various restriction enzymes and 
electrophoresis. The restriction fragments of DNA were transferred to nylon membranes 
by Southern blotting. They were subsequently hybridized with the rat cDNA probe. This 
probe hybridized to two fragments on BamHl/EcoRl-cut genomic DNA, one of which 
was about 2800bp and the other about 5000bp. This was possibly due to the presence of 
two copies of the gene or that the two fragments were parts of the same gene. On the 
other hand, either one could bear the gene of interest. There was another fragment from 
a Xhol/EcoRl digest of about 2800bp. Upon screening the library with the cDNA and 
oligo 2, a number of clones were identified one of which, from a partial sequence, was 
identical to pTGT-4.
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Fig. 40 Southern blot and hybridization of trypanosome genomic DNA wiith the rat 
GT cDNA probe. (A) EtBr-stained gel (B) Autoradiograph of (A). M= 
lambda markers; Enzymes :B= BamHl; E= EcoRl; X= Xhol.
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Fig. 41 Southern blot and hybridization of rat GT cDNA to lambda clones isolated
from EMBL4 library. (A) Profile of restriction digests as seen in EtBr- 
staining. (B) Autoradiograph of (A). M= lambda markers; Enzymes: B= 
BamHl; H= Hindlll; R= EcoRl. 2, 3, 5, 7, 10 are clone identification 
numbers. All clones were digested with the same enzyme(s) or 
combinations thereof. Cf the restriction/hybridizing fragments from 








4.2.1 DNA sequencing and sequence analysis
pTGT-4 was sequenced on both strands using the dideoxy chain termination 
method. The 2550bp insert was also cloned and sequenced in M13 in both orientations i.e by 
sequencing the template in M13mpl8 and M13mpl9. Oligonucleotide primers (15-20 bases) 
were synthesized complementary to regions and along the length of the template, to prime all 
sequencing reactions. The sequences of these primers were based on the sequences further into 
the gene to enable sequencing of the entire clone and thus avoiding subcloning smaller 
fragments. Sequencing of both strands in pUC templates and in M13mpl8 and 19 allowed the 
resolution of ambiguities involving GC-rich regions of the sequence.
Fig. 42 Restriction map of pTGT-4. Key cloning sites are indicated. Restriction 
enzyme sites: A= Apal; H= Hindlll; HC= HincII; K = Kpnl; P =  PvuII; R= 
EcoRl; Sl = Sail; S= Sacl; X= Xhol.
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4.2.2 Analysis of gene structure
Fig. 43 Nucleotide and predicted amino acid sequence of the trypanosome gene.
Promoter structures are boxed. The two translational start sites are indicated,and
the stop codon(s) is indicated with a star. Regions of oligo probe hybridization
are underlined. Potential N-linked glycosylation sites are overlined, and potential 
cyclic-AMP dependent protein kinase C phosphorylation sites are indicated by 
broken lines. Two polypyrimidine tracts, which are potential tran-splicing sites 
are underlined with broken bars. Cloning sites are indicated by H (Hindlll) and 
R (EcoRl).
TTCTGGTGCCCCTCCCCCCCCCTcjcACACACACACACACACACACACACACACACACACA
70 80  515 Too n o  120
CAfTTAGGTCTTTTGAAAATAAGGGAACGGCATGTGCGGTTGACCCCTTTGGAGCAGCGGT 
130 140 150 160 170 180
GAATGGAGCAAACGAGCAACCCCACGCCATGCGGAGCAACAAAGAGAGACACGTATCGCC 
190 200 210 220 230 240
TACACATGAAGCGGCTAGCGGGGATGAGGGTTGGAAAACGAATCGGGAGGAAACGGCCTT 
8SQ 260 270 280 290 300
TTTGCCGGCGAAATAAAAATGGTGTCGGCGAGCGAGTAGGTGCGGCAACGCGGGCCTTTA 
310 320 330 340 350 360
AGGCGGACACTTTCTTGATGAAGCGGATCGGCAACTTCCTTTCGGGGATGTAAGGCGTAA 
370 380 390 400 410 420
c g c g g t t g t g c g a a a c c c c g c g g Ig g c c a a t g^ t c a a g c a c c a t t t t t t t t t t t t t t t t t g c
430 440 450 460 « /u  480
AACGACGGTAAACGGGTAGAGAAAGAAAAATAGTAACAGACAGGGCCTCAAGCACTATTT 
490 500 510 520 530 540*
A S L F I  V D G G R N V T V  
TCCCCCCTTTTACATATGGCAAGTCTATTtrATATATfcATGGGGGCCGCAACGTAACCGTG 
550 560 57i3 580 590 600
T T G R N H R E _ A E H P T  A T G A G S C  
ACAACGGGAAGAAATCATCGTGAAGCTGAGCACCCCACTGCAACGGGTGCCGGATCGTGC
610 620 630 640 650 660
_ _  J ______
N E V V K E T F Y G N L N K K K W S A T  
AACGAAGTGGTTAAAGAGACATTTTATGGAAATCTGAACAAAAAAAAGTGGAGCGCCACA 
670 680 690 700 710 720
L L F S D C I L G P L H P A A A G R E ^ S J -  
TTGTTGTTTAGTGATTGCATTTTGGGCCCGCTGCACCCAGCTGCTGCTGGAAGGGAAATG 
730 740 750 760 770 780
G S G H G P S T A Q T A H C L D G K D V  
GGTTCGGGACACGGCCCAAGCACCGCGCAGACAGCTCATTGTTTGGATGGAAAGGATGTT 
790 800 810 820 830 840
F M K E I G V R H W N L R E V V G E R E  
TTCATGAAGGAAATAGGGGTTAGGCACTGGAATTTGAGAGAGGTTGTAGGAGAAAGAGAG 
850 860 870 880 890 900
T G W V K A A I R R G E A V Y L L R R A  
ACTGGTTGGGTGAAAGCGGCTATAAGACGGGGAGAGGCGGTATACTTGTTGAGACGTGCG 
910 920 930 940 950 960
D V E G E K K E G D  I A S G N L C G L R  
GATGTTGAAGGGGAAAAAAAAGAAGGGGATATAGCTTCAGGAAATCTATGTGGTTTACGC 
970 980 990 1000 1010 1020
V S L Y T N V W E M T G V  R M A R R H G  
GTCAGTCTCTACACGAACGTGTGGGAGATGACGGGGGTCCGTATGGCTAGACGCCACGGA 
1030 1040 1050 1060 1070 1090
K G D R P S Q K P K S S S Q K R C R H L  
AAGGGGGACCGACCCTCACAGAAACCGAAATCCAGT AGTC AAAAGCGCTGCCGACATCTG 
1090 1100 1110 1120 1130 1140
S G S J S W K K F K K ' i ' i A P A R T A F E  
AGCGGCAGTAGTTGGAGGGAACCGCGTCGCACAATAGCACCGGCTCGCACCGCATTTGAA 
1150 1160 1170 1180 1190 1200
S T S S P L H S L P M L S R N R G Y V V  
TCCACAAGCTCCCCCCTCCACTCCCTCCCCATGCTTTCCAGGAACCGTGGGT ACGTGGT A 
1210 1220 1230 1240 1250 1260
 2___
I P E K P N R S T A P Y Y E V G P A K A  
ATTCCCGAAAAACCTAATCGGTCAACCGCCCCATATTATGAAGTAGGCCCGGCTAAGGCA 
1270 1280 1290 1300 1310 1320
W G F P M H A Q R Q K V F F S F F M K H  
TGGGGATTCCCCATGCACGCACAGAGGCAGAAGGTTTTTTTTTCCTTTTTTATGAAGCAT 
1330 1340 1350 1360 1370 1380
I R S N S P P S L A A V D M T T L T G A
ATTAGGTCAAACTCTCCACCGTCGCTTGCCGCCGTCGACATGACGACTTTAACAGGTGCA 
1390 1400 1410 1420 1430 1440
V A G D G K N A N L A P I P K F Q K T I  
GTAGCAGGTGACGGCAAAAATGCGAACCTCGCACCTATACCAAAGTTCCAGAAGACGATT 
1450 1460 1470 1480 1490 1500
-  - 1  _ _
K K R K T I C E T L F P D Q H P R Q G P  
AAAAAAAGAAAAACAATATGCGAAACCCTTTTCCCGGATCAACACCCCAAACAGGGACCA 
1510 1520 1530 1540 1550 1560
_ _  J * _______
S A Y I S K R I S N P S L F L E M F L P  
TCCGCCTACATCAGCAAAAGAATAAGTAATCCCTCTCTCTTTTTGGAAATGCGCCTTCCC 
1570 1580 1590 1600 1610 1620
R V S N P V V L P R H L E G V S S T D W  
CGAGTGTCGAACCCTGTGGTGTTGCCGCGTCACTTGGAGGGGGTTTCAAGTACAGACTGG 
1630 1640 1650 1660 1670 1680
F D T S D R N G I I D V V P L S F C E M  
TTCGATACGTCGGATCGCAATGGAATAATAGATGTTGTTCCTCTTAGTTTTTGTGAGATG 
1690 1700 1710 1720 1730 1740
* S
Q C D P Q P N S G I S N G N K T N K T N  
CAATGCGACCCGCAACCCAATAGCGGCATAAGCAATGGAAACAAAACAAATAAAACAAAT 
1750 1760 1770 1780 1790 1800
 fL:_
A N T N K E S S F H N V S R S G K G G S  
GCCAATACTAACAAAGAGTCTTCTTTCCACAATGTTTCACGGAGTGGTAAAGGAGGCTCT 
1810 1820 1830 1840 1850 1860
P P R A D G R W N G R T K G V R S N S P  
CCTCCGCGTGCCGATGGACGATGGAATGGGCGGACAAAGGGTGTAAGAAGTAATAGCCCC 
1870 1880 1890 1900 1910 1920
R M S N Q R P E P L E A H T S A T C S P  
CGTATGTCTAACCAACGCCCTGAACCGTTAGAGGCCCACACTTCTGCAACCTGTTCCCCA 
1930 1940 1950 1960 1970 1980
A F L Q A P A V F V L E M A G I R C T S  
G CCTTTCTTCAGGCGCCTGCCGTGTTCGTACTTGAAATGGCGGGCATTCGGTGTACTTCT 
I § m  2000 2010 2020 2030 2040
P E V K F T A H S T G I S E R K E R L Q  
CCTGAGGTCAAATTCACGGCCCATTCCACGGGAATATCGGAAAGGAAAGAGAGGCTTCAG 
2050 2060 2070 2080 2090 2100
C P N L R Q K T P T T C G K I D A A G V  
TGTCCTAACCTCCGCCAGAAAACGCCAACTACGTGCGGTAAAATCGACGCGGCGGGGGTA 
2110 2120 2130 2140 2150 2160
S R Y P V I T D R R V I H P E T T I  S G  
TCACGGTATCCAGTGATTACGGATCGTCGCGTCATCCATCCAGAGACCACCATATCGGGG 
2170 2180 2190 2200 2210 2220
P E T S K Q V A D Q Q L P F I P S S A A  
CCAGAGACATCCAAACAGGTTGCCGACCAGCAGCTGCCCTTTATTCCTTCGTCTGCTGCT 
2230 2240 2250 2260 2270 2280
G Q *  *
GGCCAGTAGTAGCAGCAGCAAATGAAATCGAGCTCAAGAAGCCAACGCGGACCCTAAAAG 
2290 2300 2310 2320 2330 2340
AAGAAGGGTGAGGTGCCTTAGCGGTTTCCATCCTTCAGGGGCCGCAACAAATACGCAGCC 
2350 2360 2370 2380 2390 2400
TCTTGGCGGAGCTGTTGAACGAAGCAGCGGAGGCGGTGCCCGAAATAGACAAATTGGGAA 
2410 2420 2430 2440 2450 2460
C ACCCGGTGTGTGCAGCCCAAT AAGTGCGTTT ATCGGTGCC AT AGCGGGT ACCTC AGCT A 




4.2.2.1 Structure of the promoter
The sequences upstream of the transcriptional start site in the trypanosome gene 
are consistent with those in a gene that is transcribed by RNA polll. This involves a putative 
promoter core that consists of a classical TATA box which satisfies the consensus 
TATA(T/A)AT (217). Twelve base pairs upstream from this element is what may the first 
translation initiation site, ATG. Further downstream, at about 200bp can be found a second 
possible translation start site. The significance of this arrangement is not clear, although it may 
be said that the first methionine is the more likely candidate for translation to start from.
In addition to this motif, there is a classical CCAAT box (GGCCAAT) at about 
330bp from the start codon. This box is usually found about 80bp from the initiation site in 
eukaryotic genes. The CCAAT and TATA boxes flank two stretches of polypyrimidines. These 
stretches have been underlined with broken lines in Fig. 43. Sequences of that nature have been 
observed in trypanosome genes and have been implicated as the "flag posts" for trans-splicing 
(99).
4.2.2.2 Translational control signals
From an analysis of a number of protozoan genes (see Fig. 15), it has been 
observed that the consensus sequence flanking the initiation codon has the arrangement:
T T  A - - A T G (G/C)
The sequences flanking the translational start site in the trypanosome gene comprise:
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The consensus derived by Kozak comprises the sequence
A/G - -A T G G
as the favoured sequence for eukaryote translation initiation sites. According to this rule, most 
authentic initiator codons are preceded by a purine (usually A, but may also be G) in position - 
3 (47). It may be said that the flanking sequences of the two possible initiation sites observed 
in the trypanosome gene sequence is consistent with that consensus or rule and with the 
consensus derived for protozoan genes.
There is an unusually strong stop signal represented by two (TAGTAG) amber 
codons. The sequence between the start codon and this stop signal constitutes an open reading 
frame of 173 lbp or 577 amino acids. The encoded protein will therefore have a molecular 
weight of about 63,346 daltons.
There is no identifiable polyadenylation signal (AAUAAA). The closest identity 
to that signal is a stretch of nucleotides comprising A A ATG AAA located ~  lObp downstream 
of the stop codon.
Fig. 44 Summary structure of the putative trypanosome gene. The stop codon is 
represented by a star. The putative initiation sites and promoter and enhancer 
elements [4.2.2.3] are indicated, in addition to the polypyrimidine tracts. Cloning 
sites are Hindlll (H) and EcoRl (R).
G G C C A A T





4.2.2.3 The [d(CA).d(GT)] element
There is a run of polypurine/polypyrimidine residues comprising 38bp of 
alternating C and A, approximately lOObp from the Hindlll site. This region adds to the overall 
repetitive nature of the residues 5’ to the coding sequence of the gene.
A G C T
Fig. 45 Autoradiograph of the partial sequence of pTGT-4 showing (CA)19 
stretch. Distance from Hindlll site is indicated.
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4.2.2.4 Codon usage and dinucleotide frequencies
There is little evidence of a biased codon usage in this gene. This may be 
due to a paucity of iso-accepting tRNAs for the various codons. What this implies is that 
it may not have a house-keeping function such as actin or tubulin which are continually 
expressed; genes in that category have a more biased codon choice, and are abundant 
within the cell (41).
However, there is close agreement with previous observations with respect 
to dinucleotide frequencies. According to Nussinov’s definition of dinucleotide patterns 
in eukaryotes, the following hierarchical preference is adhered to: GC > CG, TG > GT, 
CA > AC, AT > TA, CT > TC, and AG > GA (51). In the trypanosome sequence, the 
following pattern has been observed: GC > CG, GT > TG, CA > AC, AT > TA, TC > 
CT, and GA > AG. Hence, there is a significant agreement with that prediction. In 
addition, the sequence agrees with the codon preferences of other trypanosome genes (41); 
it prefers a pyrimidine in the wobble positions of the codons.
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Fig. 46 Codon usage in the trypanosome gene
Amino acid Codons Number of Subtotal Percent of
amino acids___________ total amino acids
Phe TTT 12 2.08
TTC 8 20 1.39 3.47





CTG 4 33 0.69 5.72
Isoleu ATT 7 1.21
ATC 3 0.52
ATA 13 23 2 .25 3 . 98
Methionine ATG 13 13 2.25 2.25
Val GTT 11 1.91
GTC 5 0.87
GTA 9 1.56
GTG 10 35 1.73 6. 06




AGT 12 2 .08
AGC 8 54 1.39 9.36
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Proline CCT 10 1.73
CCC 12 2 . 08
CCA 11 1.91
CCG 11 44 1.91
Threonine ACT 7 1.21
ACC 8 1.39
ACA 13 2.25
ACG 12 40 2.08
Alanine GCT 12 2 . 08
GCC 13 2.25
GCA 10 1.73
GCG 9 44 1.56
Tyrosine TAT 5 0.87
TAC 4 9 0. 69
Histidine CAT 6 1. 04
CAC 11 17 1.91
Glutamine CAA 5 0.87
CAG 13 18 2.25
Asparagine AAT 16 2.77
AAC 12 28 2 . 08
Lysine AAA 24 4.16
AAG 11 35 1.91
Aspartic GAT 12 2.08
acid GAC 7 19 1.21
Glutamic GAA 17 2.95
acid GAG 14 31 2.43











Cysteine TGT 6 1.04
TGC 6 12 1.04 2.08
Tryptophan TGG 8 8 1.39 1.39





AGG 8 47 1.39 8.15
Glycine GGT 9 1.56
GGC 10 1.73
GGA 17 2.95




Total codons 577 100
4.3 Database search
When the entire putative trypanosome GT sequence was used to search the 
databases, a number of protein sequences mainly membrane proteins unrelated to glucose 
transport, were identified.
An alternative approach to searching with the entire sequence was to use a part 
of the sequence which bears a subtle identity to the putative glucose binding site in the GT 
superfamily. Previous attempts at searching with the various conserved motifs of the GTs as
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strings (PESPR, VERAGRRTL, VPETK) had yielded many proteins with no relationship to 
glucose transport whatsoever. Searching with QQLSGINAVFYY, which is implicated in glucose 
binding, however identified glucose transporters exclusively (21 out of a total of 22). Hence this 
is the only diagnostic feature of the GTs. On this premise, QXXSGI from the trypanosome 
sequence was used as the search string. As a result, several of the GTs were identified from the 
database. This is by no means suggestive of its identity.
4.4 Sequence alignment and homology search
The alignments below underscore the low level of homology between the 
trypanosome sequence and the GTs. There is however a better consensus between that sequence 
and the mammalian GTs than with the GTs of other eukaryotes and prokaryotes. A
number of deletions and insertions made alignment difficult. Even though the hybridizing regions 
can be seen, the overall identity is very poor. This low identity may be largely ascribed to the 
evolutionary distance between the trypanosome and other organisms, and to possible selection 
pressures that resulted in replacement substitutions. This is assuming that this sequence is in any 
way related to the GTs. Nonetheless, there are significant pockets of homology corresponding 
to some of the key conserved modules within the superfamily. There is no sequence information 
regarding intrinsic membrane proteins in trypanosomes to enable an objective comparison within 
the context of hydrophobicity profiles, deletions or insertions. This makes it extremely difficult 
to say one way or the other what the nature of the trypanosome sequence is, from which a 
functional inference may be made. At the same time, the spatial or sequential arrangement of 
some motifs (if taken in isolation) is coincident with that in the GTs; this is an arrangement that
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may not occur by chance.
Protein sequence : Q Q L T G I
Oligo probe sequence: CA(G/A) CA(G/A) C(T)TN ACN GGN AT(A/C/T)
Trypanosome sequence: CAA CCC AAT AGC GGC ATA [AGC]
Peptide sequence : Q P N S G I S*
(continued)
Protein sequence : N A V M Y Y A
Oligo probe sequence: AA(C/T) GCN GTN ATG TA(C/T) TA(C/T) GCN 
Trypanosome sequence: AAT GGA AAC AAA ACA AAT AAA
Peptide sequence : N G N K T N K
Fig. 47A (a) Partial sequence alignment and comparison of the gene with Oligo 2.
(*) is a serine insertion.
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Fig. 47A (b) Alignment with rat liver GT cDNA. Colour connotations are as previously
defined.
( 1 - 95) 1 - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - -
RAT2 ( 1- 79): MSEDKITGTLAFTVFTAVLGSFQFGYD IGVINAPQEVIISHYRHVLGV PLDDRRATIN<DINGTDTPLIVTPa HTTPQ*
TGLUTRP ( 1- 71): MGSGHGPSTAQTAH LDGKDVFMKEIGV RHWMLREWGERETGWVKAAIRRGEAVYLLRRADVEGEKKEGD
CONCENSUS ( 1- 13): TA G D IGV RH RR Y D
( 96 - 190) 96---:- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :
RAT2 ( 80-151): WEEETEGSAHIVTMLWSLSVSSFAVGGMVASFFGGWLGDKLGRIKAMLAANSLSLTGALLMG SK FG PAHAl
TGLUTRP ( 72-150): IASGNL GLRVSLYTNVWEMTGVRMARRHGKGDRPSQKPKSSSQKR RHLSGSSWREPRRTIAPARTAFESTSSPLHSL
CONCENSUS ( 1 4 - 2 2 ) :  S G R S G P H I
(191 - 285) 191- - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - -
RAT2 (152-244): IIA GRSVSGLY GLISGLVPMYIGEIAPTTLRGALGTLHQLALVTGILISQIAGLSFILGNQDYWHILLGLSAVPALLQ LLLLF PESPRYL
TGLUTRP (151-241): PM LSR NRGYWIPEKPNRSTAPYY EVGPAKAWGFPM HAQRQKVFFSFFMKHIRSNSPPSLAAVDMTTLT GAVAGDGKMANLAPIPKFQKTI
CONCENSUS ( 23- 35): R P V E P G Q V  L A V  L P
(286 - 380)- - - - - - - 286— :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - ;- - - - - - - - -  :. . . . . . . :. . . . —
RAT2 (245-317): YLNLEEEV RAKKSLKRLRGTEDITKDINEMRKEKEEASTEQKVSVI QLFTDPNYRQ PI W A L  MLHLAQQFSGI
TGLUTRP (242-332): KKRKTI ETLFPDQHPKQGPSAYISKRISNP SL FLE MR LPR VSN PW LPR HLE GV SST DWF DTS DR NGI IDW PL SF EMQ DPQPNSGIS 
CONCENSUS ( 36- 51): KR EMR TO I W  L H Q SGI
(381 - 475) 381- - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - -
RAT2 (318-412): NGIFYYSTSIFQTAGISQPVYATIGVGAINMIFTAVSVLLVEKAGfWTLFLAGMIGMFF AVFMSLGLVLLDKFTWMSYVSMTAIFLFVSFFEIG
TGLUTRP (333-411): NGNKTNKTNAN TNKES SFHMVSRSGKGGSPPRADGRWMGRTKGVRSMSPRMSNQRPEPLEAHTSAT SPAFLQAPAVFV
CONCENSUS ( 52- 64): NG T T S N GR G S A FV
(476 - 570)- - - - - - - 476---:- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :. . . .  :. . . . . . . :..... — :. . . . . — :
RAT2 (413-502): PGPIPWFMVAEFFSQGPRPTALALAAFSNWV NFIIAL FQYIADF LGPYVFFLFA GWL VF TLF TFF KV PETKGKSFDEIAAEFRKKSG
TGLUTRP (412-487): LEM AGIR TSPEVKFTAHSTGISERKERLQ PNLRQKTPTT GKIDAAGVSRYP VITDRRVIHPETTISGPETSKQ
CONCENSUS ( 65- 77): E G R T Q AGV T V  PET
(571 - 665) 571. . . . — :- - - - - - -
RAT2 (503-522): SAPPRKATVQMEFLGSSETV
TGLUTRP (488-503): VADQQLPFIPSSAAGQ
CONCENSUS ( 78- 82): A Q F SS
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Fig. 47B Multiple sequence alignment with mammalian GTs, representing GLUTs 
1-5. Definitions and colour connotations are as earlier indicated in Fig. 28.
GT definitions are as before.







( 1- 52): MEPSSKKLTGRLMLAVGGAVLGS LQFGYNTGVINAPQKVIEEFYNQTW VHR>
( 1- 00): MTEDKVTGTLVFTVITAVLGS FQFGYDIGVINAPQQVIISHYRHVLGVPLDDRKAINNYVINSTDElPTIS‘ShNPKPTP
( 1- 49): MGTQKVTPALIFAITVATIGS FQFGYNTGVINAPEKIIKEFINKTL TDK
( 1- 66): MPSGFQQIGSEDGEPPQQRVTGTLVLAVFSAVLGS LQFGYNIGVINAPQKVIEQSYNETW LGRQGP
( 1- 57): MEQQDQSMKEGRLTLVLALATLIAAFGSSFQYGYNVAAVNSPALLMQQFYNETY YGR
( 1- 63): MGSGHGPSTAQTAH LDGKDVFM KEIGV RHWNLREWGERETGWVKAAIRRGEAVYLLRRADV
CONCENSUS ( 1- 1):
























RFGRRNSMLIVNLLAVTGG FMGL KVAKS 
WLGRKRAMLVNNVLAVLGGSLMGLANAAAS 
KFGRKGALLFNNIFSIVPAILMG SRVATS 
GDIASGNL GLRVSLYTNVWEMTGVRMARRHGKGQRPSQKPKSSSQKR RHLSGSSWREPRRTIAPAR 
G S R  S
(191 - 285) 191
GLUT1 (119-191): FE MLILGRFIIGVY GLTTGFVPMYVGEVSPTAFRGALGTLHQLGIWGILIAQVFGLDSI MGNKD L WPLLLS
GLUT2 (151-223): HI LIIAGRSISGLY GLISGLVPMYIGEIAPTALRGALGTFHQLAIVTGILIS Q IIGLEFI LGNYO L WHILLG
GLUT3 (117-189): VE MLILGRLVIGLF GL TGFVPMYIGEISPTALRGAFGTLNQLGIWGILVAQIFGLEFI LGSEE L WPLLLG
GLUT4 (135-207): YE MLILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNQLAIVIGILIAQVLGLESL LGTAS L WPLLLG
GLUT5 (125-197): FE LI IISRLLVGI AG VSS NW PMY LGE LA PKM LRG AL GWP QLF ITV GI LVA QIF GL RNL LANVD G WPILLG
TGLUTRP (138-229): TAFESTSSPLHSLPMLSRNRGYWIPEKPNRSTAPYY EVGPAKAWGFPM HAQRQKVFFSFFMKHIRSNSPPSLAAVDMTTLTGAVAGDGKNA 
CONCENSUS ( 6 - 1 2 ) :  R P V E P G Q
(286 - 380) 286---:- - - - - - - :---





TGLUTRP (230-317): NLAPIPKF QKTIKKRK’
CONCENSUS ( 13- 17): Q
PESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELF RS P A Y R Q P I L I A W L
PESPRYLYIKLDEEVKAKQSLKRLRGYDDVTKDINEMRKEREEASSEQKVSIIQLF TNSSYRQPILVALML
PESPRFLLINRKEEENAKQILQRLWGTQDVSQDIQEMKDESARMSQEKQVTVLELF RVSSYRQPIIISIVL
PESPRYLYIIQNLEGPARKSLKRLTGWADVSGVLAELKDEKRKLERERPLSLLQLL GS R T H R Q P L I I A W L
FPESPRYLLIQKKDEAAAKKALQTLRGWDSVOREVAEIRQEDEAEKAAGFISVLKLF RMRSLRWQLLSIIVL
I ETLF PDQHPKQGPSAYISKRISNP SLFLEMRLPRVSMPWLPR HLE GV SST DWF DTS DR NGI IDW PL S  

















QQPVYATIGSGIV NT AFT WSL FW ERA GRR TLH LI GLA GMA G AILMTIALALLEQLP 
SKPVYATIGVGAVNMVFTAVSVFLVEKAGRRSLFLIGMSGMFV AIFMSVGLVLLNKFS 
QEPI VAT I G AGW NT IFT WSL FL VER AGR RT LHM IGL GGM AF STLMTVSLLLKONYN 
GQPAYATIGAGWNTVFTLVSVLLVERAGRRTLHLLGLAGM G AILMTVALLLLERVP 
MGG QQLSGV NAIYYYADQIYLSAGVPEEHVQYVTAGTGAVNWMTF AVFWE LL GRR LLL LL GFS I LIA VLTAALALQDTVS 
EMQ DPQPNSGISNGNKTNKTN ANTNKESSFHNVSRSGKGGSPPRADGRWNGRTKGVRSNSPRMSN QRPEPL
Q SG N N GR G
QLS QQLSGI MAVFYYSTSIFEKAGV 
HVA QQFSGI NGIFYYSTSIFQTAGI 




GLUT2 (395-477): WMSYVSMIAIFLFVSFFEIGPGPIPWFMVAEFFSQGPRP*A|AIAAFSNWT NFIVA Q
GLUT3 (361-443): GMSFV IGAILVFVAFFEIGPGPIP^ H*EttSQGPRP V'G S N W S N F L V G  P
GLUT4 (379-461): AMSYVSIVAIFGFVAFFE*GPGPTP E L S Q G P R P  G SN T S N ^ I ’G G Q
GLUT5 (371-453): WMPYISIV VISVV GH GPSP P TE QSSRPS GGS H SN TVG P
TGLUTRP (392-469): EAHTSAT SPAFLQAPAV E* G R TSPE K T HSTGTSERKER q




VAEAMGPYVSLL'AVl l g f f
iQEGIGP’S IV Vi LLTT 
PN RQKTPTT GK DAAG SR P TO 
G
(571 - 665) 571- - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :- - - - - - - :---■
GLUT1 (446-492): IFIUPKVPETKGRT DEIASG RQGGASQSDKTPEE HP G DSQ V
GLUT2 (478-524): LFf* KVPETKGKS EEiAA.E QKKSGSAHRPK^AYE^K GATET V
GLUT3 (444-496): AFT KVPETRGRT EDiTR EGQ HG DRSGKDG yE N S E P A K E T T T N V
GLUT4 (462-509): I T  RVPETRGRT DQISA HRTPS EQEVKPSTELE I.GPDEND
GLUT5 (454-501): I I 'PETKAKT E-NQI TKMNK SEV PEKEEiKELPP TSEQ 
TGLUTRP (470-503): RR HPETT SGPETSKQ DQQl P IPSS VGQ
CONCENSUS ( 30- 32): PET
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Fig. 47C Multiple sequence alignment of select GTs of prokaryotic and eukaryotic 
origins. Colour and transporter definitions from previous figures apply. 
Previous GT definitions apply.




ARAE/H ( 1- 20): MVTINTESALTPRSLRDTRR
XYLE/H ( 1- 8): MNTQfNSS
QAY$NE ( 1- 16): MTLLALKEDRPTPKA.
GAL2$Y ( 1- 66): MAVEENNVPWSQQPQAGEDVISSLSKDSHLSAQSQKYSNDELKAGESGPEGSQSVPIEJPKKPMS
YEAST ( 1- 92): MOPNSNSSSETLRQEKQGFLDKALQRVKGIALRRNNSNKDHTTDOTTGSIRTPTSLQRQNSDRQSNMTSVFTDDIfriDONSILFSEPPQKQ
LACP$K ( 1- 67): MADHSSSSSSLQKKPINTIEHKDTLGMDRDHKEALNSDNDMTSGLKIMGVPIEDAREEVLLPG -SK
CHLORELLA ( 1- 22): M A G G G V A W S G R G L S T G D . RGG
PR01$LEIEN ( 1- 39): MSDRVEVNERRSDSVSEKEPARDDARKDVTDDQEDAPP
TGLUTRP ( - ):
CONCENSUS ( - ):
























1 F VLLISGVAALGGFLFGFOTAV 
: M NMFVSVAAAVAGLLFGLDIGV 
: Y IFSITLVATLGGLLFGYDTAV 
: YNWRVYT AAIASFAS MIGYDSAF 
: EYVTVSLL L VRFGGFMFGWDTST 
: SMMMSI VGVFVAVGGFLFGYDTGL 
: QYYKLYGL FITYL ATMQGYDGAL 










VGVYSTLFGYSTN ASFLQENS TTVPNAQ KWFVSPTGSSY GWPEVT RKEYAYSSPAEMPGALAR 
MGSGHGPSTAQTAH LDGKDVFMKEIGVRHWNLREWGERETGWVKAAIRRGEAVYLLRRADV 
G








CHLORELLA ( 71 
PR01$LEIEN (133 































RF GRRDSLKIAAVL F F ISGVGSAWPE LGFTSINPDNTVPVYLAGY
FLGRRKSLIAFSWFIIGAAIMLAADGQGRGIDPI
M Y GRKKG L S I W S V Y IVG111QIASINKW
SYGRKPTIIFSTIFIFSIGNSLQVGAGGI
WKGRKPAILIG L G W I G A I I S S L T T T K S A
NMGRKVTMGIGGAFFVAGGLVMAFAQDM
EADSR RWSYSDEE QNPSGYSSSESGIFAGSMIAG LIGSVFAGPLASKIGARLSFLLVGLDEFW
EGEKKEGDIASGNL GLRVSLYTNVWEHTGV RMARRHGKGDRPSQKPKSSSQKR RHLSGSSWREPRRTIAPARTA
(286 - 380) 
GLCP$S (110-187): FIFWRVLGGIGVGAASVIAPAYIAEVSPAHLRGRLGSLQQLAIVSGIFIALLSNWFIALMAGGSAQNPWLFGAAAWRW
ARAE/H (113-179): EMLIAARWLGIAVGIASYTAPLYLSEMASEMVRGKMISMYQLMVTLGIVLAFLSDTAFSVS GN WRA
XYLE/H (126-201): VPEFV IYRIIGGIGVGLASMLSPMY IAELAPAHIRGKLVSFMQFAIIFGQLLVY VNYFIARS GDAS WLNTDGWRY
QAY$NE (128-196): IAGRVLAGIGVGGASNHVPIYISELAPPAVRGRLVGIYELGWQIGGLVGFWINYGVNTTMAPTRS QWLI
GAL2$Y (174-243): YQYFIGRIISGLGVGGIAVL PMLISEIAPKHLRGTLVS YQLMITAGIFLGY TNYGTKSYSNSVQ WRV
YEAST (196-265): TLLIVGRVISGIGIGAISAWPLYQAEATHKSLRGAIISTYQWAITWGLLVSSAVSQGTHARNDASS YRI
LACP$K (169-238): LIGGRWFVAFFATIANAAAPTV AEVAPAHLRGKVAGLYNTLWSVGSIVAAFSTYGTNKNFPNSSK AFKI
CHLORELLA (137-204): AMLIVGRVLLGFGVGLGSQWPQYLSEVAPFSHRGMLNIGYQLFVTIGILIAGLVNYAVRDWENG WRL
PR01$LEIEN (200-278): VLIVGRFVIGLFLGVI VA PVYTDQNAHPKWKRTIGVMFQVFTTLGir/Ml MGLALGQSIRFDHDGDQKVMARMQGL
TGLUTRP (140-227): FESTSSPLHSLP MLSRNRGYWIPEKPNRSTAPYY E V G P A K A W G F P ’ ^ a Q R Q K V ' S  KH RSNSPPSLAAVDMTTLTGAVAGOGK
CONCENSUS ( 2- 3): R P



















264): MFWTELIPALLYGV AFLIPESPR 
261): M L G V L A L P A V L L 1 1 L W  PNSPR
284): MFASE; IPAtLFLMLL T. PESPR
285): PFAVQl P G GS PESPR
329): PIGt A S r Ga T PESPR 
359): P G Q V SS I G PESPR 
331): P QMM PG G PESPR 
288): S G AAAPGAI GS PESPN
330): ST1 S U P '  G T R E S R K  DGGEEGRAE NPSE G
308): NaM P PK QKT KKRKT ET PDQHPKQGPS SK
4):
QGQGEK K EGGD PSR EE QATVS DHKPR SD S
EKGRH E EE. R RDTSEK RE E NE RES K KQGG K
SRGKQEQ EG RK MGNT ATQAVQE (CHS DHGR KTGGR 
MGKREE K RN EPTDR QE S DAD ER TRQ GNG KP
E-NKVED-KRS KSNK-SPEDP QAE D *-G E EK G N - S G E  
KDK. DE''KS, S RG-P HDSG EE E1KAT D EAS GSSN ,D 
G GREEE RE K HLNGDRTHP D^E 
EKGKTEKGRE QK RGTSE DAE 
EM PR
R SNPS* ! E^R PRVSNP V L PRH  
E
E.:ES HGTD- SNP Ert. DVR 
D E R P T  RQS S
RRGG
NRN'/RRA L 
G G GVM 
LS KQRKVQ R 
STKTKV Q 
SSKSRPKQT R v TG 




(476 - 570) 4i
GLCP$S (265-350): PIV IG MG S QQ v g : NVI SSVI RS G TE EKS T  rTG INILTTIVAI' DK GRKP GSIGMT'T G S
ARAE/H (262-343): GMu Q- QQ TGM NIIM PR K G TTTEQQ' T G T T T DK GRKP K G S '  GT G
XYLE/H (285-361): SI QQ VG N W L /PEV KT G ST D QT G N T T ' T DK GRKP Q G G G Sl GT
QAY$NE (286-371): i GG QNGSG NA^N SPT- RS G TGTDTG TTG G 1 KM T VD GRRR G GGS IGA
GAL2$Y (330-412): RLLMG .Q1M QQi TGN N G T KS’ G DDS ETSE’ G W N  ST S T VEN GRRK G TNI" A AS
YEAST (360-437): IALQA QQ SG N r GVN NKTG l SNS S TT AVN'1 N PG E GRRK GG T M
LACP$K (332-413): VILMA GQ SGN N' S PT RM G KS S N ' NG SIVT SS G DK GRREG GS SG Al TG S
CHLORELLA (289-370): TS VIQ QQ TG n- : P SS GS N S NT V  G YN GST SDK GRR EGG Q TTG
PR01$LEIEN (331-408): V G T-Q TG Na N -PT GS G P GN N TT S P S T RH GS TS " G
TGLUTRP (309-386): G D *\-P. S EMQ DPQPNSG SNGNKTNKT N NTNKESS HN SRSGKGGSPPR D GR 11GRTKG RS'ISPR SNQ
CONCENSUS ( 5- 8): G N G R
(571 - 665) 571
GLCP$S (351-420): V F G G A T W N G  QP TLT GAAGIIALVTANLYVFSFGFSWGPIVWVLLGEMFNNKIRA A A L S V A A G V Q * I A N  i ISTT PP
ARAE/H (344-417): LMQFD NG TAS SGLSWLSVGMTMM IAGYA MS AAP WWI L SEIQPLK RD FGIT S T T T N v Y S N H I  G^T L T
XYLE/H (362-430): AFYTQ APGIVALLSMLF YVAAFAMSWGPV WVLLSEIFPNAIRG KALAIAVAAQv L^N V S T P 0
QAY$NE (372-450): YIKIADPGSNKAE DAKLTSGGIAAIFFFYLWTAFYTPSWNGTPWVINSEMFDQNTRS LGQASAAANNWFWtf 1!SR TP
GAL2$Y (413-490): VGVTRLYPHGKSQ PSS KGAGN MIVFT FYIF YATTWAPVAWVITAESFPLRVKS K MALASAS NWVWGF L 1A TP
YEAST (438-508): VG SL K TVA AAKVMIAFI LFIAAFSATWGGWWVISAELYPLGVRS K TAI A A A N W L V N F r i L , TP J'l
LACP$K (414-405): TARY E KTKKKSASNGALVFIYLFGGIFSFAFTPMQSMYSTEVSTNLTRS KAQLLMFWSGVAQFVMQl A TP
CHLORELLA (371-447): VLAIEF AKYGTDPLPKAVASGILAVI IFISGFAWSWGPMGWLIPSEIFTLETRP AG TAV AW GNF LFS FV IGQ F
PR01$LEIEN (409-490): PVYPG VSKKLEAKNGVAITGILLFILGFEV VGP YYVLTQDMFPPSFRPRGASFTQVAQFIFNLIINV YP1ATESISGGP
TGLUTRP (307-452): RPEPLEAHTSAT SPAFLQAPAVFVLEMA GIR TSPEVKFTAHSTGISERKERLQ PNLRQKTPTT
CONCENSUS ( 9- 8):











LACP$K (406-570): KAMKNIKYWF YVF YVF F D IFEFIVIYFF FVETKGRS L E E L E W F E A
CHLORELLA (448-533): SML AMEYGVFLFFAGWLVIMVL AIFLLPETKGVPIERVQALYARHW
PR01$LEIEN (491-552): SGNQDKGQAVAFIFFGGLGLI FVIQVFFLHPWDEERDGKKWAP
TGLUTRP (453-503): GKIOAAGVSRYPVITDRRVIHPETTISGPETSKQVAOQQLP
CONCENSUS ( 9 - 9 ) :  E























The overall charge distribution in Tglutrp is inconsistent with that either of the 
GTs or membrane spanning proteins in general. As a result this protein is largely amphipathic. 
Even though charged groups have been found in some membrane spanning domains of 
bacteriorhodopsin (186) and lac permease (144), the preponderance of these groups in Tglutrp 
makes it difficult for its inclusion in that category. However, it may be said that the 
encumbrance of the VSGs and the fact that the overall surface charge of the trypanosome is 
negative (which facilitates their purification from red blood cells on a DEAE-cellulose column), 
may justify the presence of an usually large number of positive charges in this protein. These 
charges would therefore enable it to anchor itself by classical ionic interactions to the VSG coat.
The apparent paucity in hydrophobic segments in the protein should however not 
preclude it from being considered as a membrane protein. It has been noted that several other 
membrane proteins contain charged residues within their presumptive transmembrane segments 
especially the Na+ channel protein of the eel (218). The latter is the strongest case in point with 
about 4-7 arginine residues within the S4 domain, which are presumed to line the walls of the 
channel. The other domains contain several charges as well.
The poor segmental homology observed between Tglutrp and the GTs implies that 
any attempt at delineating hydrophobic segments may meet with only short stretches (8-14) of 
hydrophobic residues. By the dictates of the various algorithms in current use, none of these can 
or should span the membrane. However, there is a possibility that relatively short a-helices may 
be formed by these segments as has been proposed for the eel Na+ channel and depicted and 
discussed in the model below [5.4.2], Hence, by comparison to classical GTs, Tglutrp has a
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relatively diminished hydrophobicity profile with no discernible 12 putatively membrane 
spanning helices. The only discernible hydrophobic and potentially membrane spanning segments 












R e s i d u e  Number
Hydrophobicity profile of the trypanosome sequence oaseu on the Kyte^DoohttU, 
algorithm. The arrow indicates a region with a channel forming potential. 
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Re s i d u e  Number
Fig. 49 Amphipathy profile of the trypanosome sequence based on the Eisenberg algorithm
( 158).
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4.6 Secondary structure prediction
The a-helix content of the entire protein is low although it is fair to say 
that it contains equal numbers of residues with preference for a-helices as it has for b- 
sheets. This means that the contributions of a-helices and b-sheets are about the same, 
which again is not compatible with previous observations on the erythrocyte GT. Only 





Alpha Breaking* trmn f»[MM1 rn r m vm
Fig. 50 Secondary structure prediction for the trypanosome protein.
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4.7 In vitro translation
Run-off RNA transcripts of the gene (cloned in pBluescript) were used for 
translation in a rabbit reticulocyte system. Translation products were run on a 10% SDS- 
PAGE gel under denaturing conditions. The gel was impregnated with a fluor (En3Hance), 
dried and exposed to X-ray film.
A band running at 34-36kD was observed. This is not consistent with the 
molecular weight of ~55kD from the predicted amino acid sequence. This result may be 
due to an incomplete translation product However, the observed molecular weight 
compares well with the sizes of glucose transporters that have been similarly treated. For 
example, the xylose transporter runs at 37-4lkD, the H+/arabinose transporter at about 
36kD. and the H+/galactose transporter (GalP) at about 37kD (219).
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Fig. 44 SDS-PAGE fluorogram of in vitro translation products of pBS.TG-4. [1]
and [2] arc translations with uncapped transcripts from the sense and 
antisense strands respectively. [3] and [4] are capped transcripts of the 
sense and antisense strands respectively. [5] is a translation with water as 
a control. [1], [2], [4] were internal controls. Molecular weight markers are 
indicated by M.
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4.8 Developmental expression of the gene
Northern blot analysis, using this clone as probe on RNA of the 
developmental forms (bloodstream and culture/procyclic) of T. brucei. showed a band that 
ran at about 5.2kb in bloodstream form RNA. This is inconsistent with the size of the 
reading frame observed in the gene. This may be due to the presence of large stretches 
of trailer sequences, or the message is still in the pre-maturation state.
Significantly, when the oligonucleotide probe encompassing the putative 
glucose binding site (Oligo 2) was used to probe the blots, a band of a similar size was 
identified. In addition, the rat cDNA probe seemed to (faintly) identify the same or an 
identical transcript. This band may be one and the same species in all three cases. 
Although the poor signalling from the hybridizations may be attributed to probe 
insensitivity, it is possible that this is due to a low cellular content of the transcript in 
question i.e it is a rare or lowly expressed message. This probably suggests that it may 
be an inducible gene. Constitutive transcripts would normally be present at much higher 
levels than that observed here.
However, the probes did not hybridize to RNA of the culture (procyclic) 
forms of T. brucei. This is probably (preliminary) evidence that the trypanosome gene is 
developmentally regulated at the transcriptional level, as it shuttles between the 
mammalian bloodstream and the insect host. The fact that the identified message is 
recognized by both the gene and the oligonucleotide probe in particular, makes room for 
optimism in further characterizing this gene in terms of glucose transport.
Fig. 52 Northern blot analysis of the RNA of the developmental forms of T. brucei. 
Hybridizations with (A) trypanosome gene; (B) oligo 2; (C) rat GT cDNA. 
M= molecular weight markers; B= bloodstream form; P= procyclics.
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4.9 Functional expression and characterization
An attempt was made at expressing the gene in a mammalian cell line (COS-7) 
after engineering it into the eukaryotic expression vector pSVL.
Transport data were taken by measuring the uptake of radioactive glucose 
analogues (3H 2-deoxyglucose) in COS-7 cells transfected with the gene, and cel s transfected 
with only the vector or salmon sperm DNA. There was no difference in uptake between cells 
with the gene and cells without (controls). A number of explanations may be advanced to 
account for this observation. The gene may not encode glucose transport; if it does, it is not 
expressed because it was probably not transfected into the cell. On the other hand, the intrinsic 




5.1 Relationship between trypanosome glucose transport and metabolism
There are two basic factors that may dictate the course and rate of metabolism in 
the bloodstream trypanosome:
a. there are no energy stores or reserves
b. there are no alternative substrates for producing energy apart from glucose.
These factors compound the already inefficient energy producing step in glycolysis. Both factors 
are equally important and together, may constitute the determinant(s) of the rate of glucose 
uptake.
The bloodstream trypanosome has an extremely high rate of respiration/oxidation, 
and this is justified on the basis of (a) above. In this study, it was found that the rate of 
glycolysis is 86.7nmol O2/min/108 cells or 173.4nmol 0 2/mg of protein. This is consistent with 
previous observations of 60-90nmol O2/min/108 cells or 120-180nmol 0 2/min/mg of protein 
(214). This value is about 20-50X higher than that observed in mammalian cells. This rapid 
oxidation of glucose can only be matched with a consonant rapid flux of glucose into the cell. 
This suggests that the rate of glucose transport may be correspondingly 20-50 fold higher than 
in mammalian cells.
The results of this study identified a saturable carrier consistent with 
Michaelis-Menten kinetics and in line with previous observations (17,124,125). A Km of 
1.13mM for zero trans entry of 2-deoxyglucose was deduced, in tight agreement with 1.54mM 
for 6-deoxyglucose (17) and 1.98mM for D-glucose (125), and satisfying some
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criteria for carrier-mediated transport. These observations are in contrast to others which suggest 
that the glucose transporter in bloodstream forms is coupled to a Na+ gradient (153). It is 
certainly possible to overlook this phenomenon in view of the inclusion of 98mM NaCl in the 
assay buffer used in previous assays, in which case Na+-dependence would have been severely 
masked. An assay system devoid of this ion may be required to confirm or deny either 
observation. Kinetic characterization of the trypanosome GT by Eisenthal et al. indicated that 
the Km for efflux was higher than for influx (17), but this was discounted in view of the 
inherent difficulties in the assay procedure. They therefore suggested that glucose transport 
across the membrane was kinetically symmetric. However, Ter Kuile and Opperdoes 
[1991,(125)] apart from confirming the Km differentials, established an asymmetry factor of 
1.79 in close agreement with 1.8 of Eisenthal et al Hence, it is possible that their previous 
observation was not artifactual afterall, but that the trypanosome GT is indeed kinetically 
asymmetric in disposition, which is a totally plausible concept.
However, the observation of counterflow from this study in the reconstituted 
transporter provides proof of a facilitated carrier although it could be argued that such a trans­
stimulation profile may be observed in the active transport of two substrates sharing a common 
carrier. Incidentally, H+-dependent transport has been observed in the procyclics as well (152). 
The differences in cation specificity has not been explained. Arguably, the observed 
differences/specificities in glucose transport may be attributable to kinetic differences by way 
of affinities of the transporters. Whilst the procyclics have a higher affinity (Km 23uM), the 
corresponding Km for transport in the bloodstream forms is 10X higher at 237uM. This affinity 
is consistent with that in Na+-dependent glucose uptake (220). The observed affinity of the
156
procyclic transporter is similar to that observed in Leishmania donovani promastigotes which 
have a Km of 24uM (149). This is understandable on the basis of the fact that they live in 
similar environments at that stage of their life-cycle in their respective insect vectors. What may 
defy reason is the need for a coupled glucose transporter in the bloodstream forms since they 
are bathed in 5mM glucose.
The sequestration of glycolytic enzymes within the glycosomes may be a 
teleological adaption to maximise energy flux, but at the same time presents a problem for the 
localization of the glucose transporter within the trypanosome. Pulse-labelling with 14-C glucose 
indicated that the glycosomal components were rapidly labelled compared to their cytosolic 
counterparts (26). This suggests that the glycosomal membrane presents a permeation barrier to 
glucose which can only be taken up via a transport protein within the membrane. Unfortunately, 
there is no information on glycosomal glucose transport. As transport has been observed both 
in whole cells and in reconstituted vesicles, there must be a plasma membrane glucose 
transporter. If indeed that is the case as it might, one may be looking at two or three isoforms 
of the glucose transporter differing more in their stage and tissue specificity than in their 
structure.
There are other speculations with respect to the subcellular localization of 
receptor/transport proteins. It has earlier been thought that trypanosomes take up nutrients via 
the flagellar pocket by endocytosis (221). It is possible that transport proteins are within the 
flagellar pocket rather than delocalized or "smeared" over the entire plasma membrane. Such 
an arrangement presupposes that the protein would radiate from this site to expand the repertoire 
of transporter molecules, and would be anchored to the VSG-plasma membrane interface via a
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GPI linker. The VSG coating would also impose some "accessibility constraints" with respect 
to glucose molecules which further amplifies the need for a localised but accessible transporter 
shielded from VSG encumbrance.
Whilst it may be fair to say that the two forms of transporter identified in the 
trypanosome differ kinetically, it is too early to dichotomise them in the absence of more kinetic 
data and molecular evidence based on the sequences of their cognate structural genes. Although 
purely conjectural, one could conceive of two forms within the bloodstream: the facilitated 
transporter being required at the prodromal phase of infection, or probably being glycosomal, 
whereas another transporter (probably Na+-dependent) becomes operative in a chronic infection 
(increased parasitaemia), where increased competition for glucose among the parasites may 
require some form of concentrative mechanism. The latter form of transporter may then be 
modified for use in the late stumpy (infective) forms prior to its deployment in the insect vector. 
Undoubtedly, these proteins will have very high turnover rates. The picture that emerges is a 
glucose transporter(s) under tight molecular controls through and at every stage of the parasite’s 
development. Having said that, one is also looking at a transporter that is potentially structurally 
malleable.
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5.2 Molecular cloning of the putative glucose transporter-related gene
The preferred strategy for cloning genes is to use homologous nucleic acid 
probes derived from the partial amino acid sequence of the encoded protein. Alternatively, 
the peptide may be synthesized and used to raise antibodies with which to screen an 
expression library. In many cases, proteins can be purified easily and in sufficient 
quantities for an N-terminal peptide sequence to be obtained. This is especially possible 
if the purification is of an enzyme which relies on a simple assay system. However, it is 
very difficult to obtain pure intrinsic membrane proteins because their purification often 
relies on using detergents on account of their lipid environment, there is no easy assay 
system to follow, and they are often present in very small amounts within the membrane. 
The only exception is the human red blood cell glucose transporter which constitutes 
about 5% of the total cell protein which eased its purification. Antibodies raised against 
a peptide from a partial sequence of the protein enabled the isolation of the HepG2 
transporter from an expression library (156).
. On the other hand, the binding specificities of the protein may give clues 
as to what tags may be used to identify it to ease purification. Under those circumstances, 
the protein of interest is easily identifiable on an SDS-PAGE gel if some of it can be 
labeled with radioactively-labeled ligands, and electrophoresed in parallel with a cocktail 
of unlabeled proteins from the organism. It has been possible to attach photolabile 
moieties to some sugar analogues to enable a structural-functional dissection of 
mammalian transporters as mentioned above. But this has been possible because of the 
wealth of information regarding the kinetics of those transporters and their presumed
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similarity in structure. This could hardly the case with the trypanosome glucose 
transporter.
In the absence of a protein sequence, the only choice is to employ probes 
based on the sequences of genes within the family of glucose transporters. It was on this 
basis that the rat liver glucose transporter was used, although with hindsight a yeast 
transporter might have been a better candidate in view of the positions of yeasts and 
trypanosomes on the scale of evolution. A multiple sequence alignment of the GTs 
enabled the identification of structural motifs that are presumed conserved in the 
superfamily. These motifs and their translated nucleotide sequences are presented in 
[2 3 .2]. In principle such motifs should exist in the trypanosome transporter as well, 
especially oligo 2, whose sequence is thought to constitute the glucose binding site of the 
superfamily of GTs. As such, probes were synthesised from those regions by reverse 
translation taking into account the codon usage of trypanosome genes and the degeneracy 
of the genetic code.
The cDNA library was screened with the rat liver glucose transporter 
cDNA, and with oligo 1. However, the positives that were picked were not hybridizing 
consistently with these probes or the other oligos. An alternative to screening this library 
was to make primers complementary to the vector lambda g tll  reverse and forward 
sequencing primers, and to use these to prime the amplification of the GT gene using 
pairwise combinations of GT-specific primers and the vector primers in a polymerase 
chain reaction (PCR). This technique was also used on trypanosome genomic DNA. The 
amplified DNA fragments that were obtained from this approach were hybridized with
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the primers to ensure that they were not artifacts and then blunt-end cloned into pGEM-7 
and sequenced. It was found that although the fragments contained the primer binding 
sites, the remainder of the sequences did not code for extensive open reading frames.
The genomic library was then chosen for screening in view of the 
possibility that the gene might be differentially processed and expressed, and therefore 
may not be represented in the cDNA library. This was the only way to ensure that the 
gene was present since such a library would contain all the genes of the trypanosome. In 
addition, the apparent lack of introns in trypanosome genes means that if the glucose 
transporter gene was isolated, there would be no problems relating to that factor.
Due to the relative redundancy of the probes, the genomic library was 
screened at room temperature and 5X SSC to 55°C and 2X SSC. As a result several 
clones were isolated and carried through three more cycles of hybridization with oligo 
probes 2 and 4. Of the 17 primary isolates, 6 were selected on the strength of their 
hybridization to the probes. After Southern blot analysis, only one of these carried a 
strongly hybridizing insert. This insert was therefore selected and subcloned directionally 
into pUC to produce pTGT-4 for sequencing.
The predicted amino acid sequence of pTGT-4 was compared with the GTs 
to identify diagnostic features and to locate oligonucleotide probe binding sites. The poor 
homology between the sequence of pTGT-4 and the GTs masked the identification of any 
sequences that could place it among that family or at least to account for the observed 
hybridization pattern.
As a second approach, a size-selected plasmid library was constructed from
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genomic fragments of trypanosome DNA that hybridized strongly to the rat GT cDNA. 
These fragments were identified from a Southern blot, purified from a BamHl/EcoRl- 
digest that was electrophoresed on low melting point agarose, and ligated into 
BamHl/EcoRl-cut pBluescript. The library was then screened with oligo 2. The 
hybridizing colonies were further selected by probing again with the rat GT cDNA. As 
a result, a number of clones were isolated from this library and sequenced with oligo 2. 
Although the degeneracy of this oligo made sequencing imperfect, the legible portion of 
one of the clones, pUP-1, was identical to pTGT-4. (This was the only plasmid that 
sequenced at all with oligo 2). Although there is a possibility that pUP-1 could be a 
contaminant of the enriched plasmid library, this was unlikely to be the case because the 
two plasmids are of different sizes and they have different cloning ends: pUP-1 has 
EcoRl/BamHl ends whilst pTGT-4 has EcoRl/Hindin ends. This is all the more credible 
because the Southern blot of the lambda clone, 3-LT10 from which pTGT-4 was derived, 
has an identical insert to pUP-1 when restricted with EcoRl/BamHl. In, addition there 
is no BamHl site in pTGT-4. This was evidence that the probes were adequately specific 
and that the techniques of clone isolation were satisfactory. On this basis pTGT-4 was 
characterized further. A partial peptide sequence comparison between the two clones is 
as follows:
pTGT-4 NTNKE S S FHNV S RS GKGGS P PRADGRWNGRTKGV
pUP-1 KESSFHNVSRSGKGGSPPRADGRWNGRTKGV
In the course of screening the plasmid library, a long open reading frame was identified 
which sequenced with oligo 1, but which did not contain the peptide sequence of that 
oligo, and had no structural resemblance to either of the clones above or with the GTs.
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5.3 Gene structure and implications for developmental regulation and
expression
The presence of the canonical regulatory sequences, viz CCAAT and TATA boxes 
in the trypanosome gene is consistent with an RNA polll gene. Classical promoter sequences 
in Kinetoplastid genes have not been easy to identify. This gene may therefore be one of the first 
of such findings in these genes in general.
The TATA box is probably the most prevalent cis-acting element in eukaryotic 
genes, and it is usually located about 25-32bp from the cap or initiation site. However, it has 
been found 109bp and 795bp from the transcription sites in the MAL6S and MAL6T genes 
respectively (223). According to the "TATA box-trap" model, the transcription of a gene is 
enhanced when the TATA box is closely flanked by GC-rich sequences as observed in the 
trypanosome gene (224).
The CCAAT box is normally located about 80bp from the initiation site, but it 
has also been found to occur up to 225bp from that site in the mouse immunoglobulin heavy 
chain gene promoter (225). Although the CCAAT box is not as ubiquitous as the TATA box, 
it is thought to be linked to structural genes whose expression is stringently controlled, as for 
inducible genes, and whose products may be required in large quantities at specific stages of the 
cell’s development. This is especially so for the human a- and b-globin and chicken ovalbumin 
genes (226,227). The promoters of these genes are transcriptionally active at their appropriate 
developmental stages, and all have the CCAAT and TATA boxes which may act in concert in 
the regulation of these genes. In fact, deletion analysis of the b-globin gene showed that its 
transcription was dependent on the TATA box, decreasing about 20-fold, and that the CCAAT
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box played the strongest role in determining the efficiency of the promoter (228). Genes that are 
efficiently transcribed, such as the enzymes of the glycolytic pathway, are known to contain the 
CCAAT box (229). Overall, the modular nature of the trypanosome gene promoter as seen in 
the two boxes, identifies it with class II genes i.e genes that are transcribed by RNA polll. The 
putative trypanosome gene is therefore a likely class two gene.
The other significant feature in the arrangement of this gene is the unusually 
strong stop signal, TAGTAG. Taken together with the CCAAT and TATA boxes, this may be 
indicative of the stringent molecular controls that may regulate its expression.
Structural microheterogeneity in the DNA sequence of the trypanosome gene 
features a run of (CA)19, which has a propensity for Z-DNA formation (230). This middle- 
repetitive element is ubiquitous in nature and has been found to punctuate the genomes of 
eukaryotes through man to yeast (231). It has been found associated with introns and has also 
been mapped to the 5’ flanking regions of actively transcribed genes (232). Such sequences have 
therefore been associated with the regulation of those genes of which they constitute an integral 
part, including the globins (233), prolactin (234) etc. They have also been implicated as 
enhancers of replication, transcription and translation (235), and in viral recombination and 
integration (236). Due to the repetitive nature of these elements, they are potentially structurally 
labile. (Hence there is a dynamic equilibrium between Z-DNA and B-DNA as they interconvert 
between the two forms of DNA). These elements (Z-DNA) have been associated with gene 
conversions and rearrangements as observed in the developmental regulation of the globin 
variants (237). They have therefore been regarded as the "hot-spots" for gene conversions or 
recombinations. The identity of such sequences to the consensus DNA topoisomerase II
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recognition site suggests that cleavage by this enzyme may precede gene rearrangement for 
regulation (238). This consensus is derived as follows:
5' R N Y N C N G Y ^ N G K T N Y N Y  3' 
where R is any purine, Y is pyrimidine, K is G or T and N is any base; cleavage site is denoted
by a caret O .
The presence and significance of this element within the gene under study, is not 
clear at the moment although a plausible conjecture may be made regarding its regulation. If Z- 
DNA stretches of this kind have all the functions detailed above, then this element may represent 
a "cross-over" point between the bloodstream and insect/culture forms of the trypanosome 
regarding the expression of this gene. By appropriately shifting to different expression loci, or 
rearranging itself, expression may be regulated presumably at the level of transcription. One way 
to ascertain this is to perform a deletion mapping coupled with reporter enzyme transfections, 
in order to determine the direction or levels of expression of the gene.
165
a) Tissue specific genes
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Yeast HIS 3 gene
Yeast GAL genes, yeast ADH II gene
Fig. 53 Examples of genes with DNase 1 hypersensitive sites, and with a 
propensity to have Z-DNA. Adapted from (239).
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There is a direct correlation between the relative abundance of a protein and its 
pattern of codon usage. Highly expressed genes have a biased codon usage i.e they contain 
mostly the ’’preferred codons". In contrast, poorly expressed genes do not show this bias, and 
they tend to use many ’Tare" codons. Analysis of the codon preferences of the gene under study, 
shows that it has no particularly strong preferences. This is illustrated below.
Fig. 54 Comparison of Tglutrp codon usage to the codon bias in other trypanosome 
genes as defined in (40).
Amino Codons Genes Amino Codons Genes
acid 1 2 3 4 5 acid 1 2 3 4 5
Phe TTT 12 2 4 3 7 Pro CCT 10 6 0 2 3
TTC 8 6 5 8 3 CCC 12 5 1 1 2
Leu TTA 3 1 0 3 3 CCA 11 3 1 5 1
TTG 10 0 1 6 11 CCG 11 2 0 5 1
CTT 8 4 1 7 8 Thr ACT 7 5 2 6 8
CTC 6 19 5 6 6 ACC 8 10 2 10 6
CTA 2 1 2 16 1 ACA 13 3 1 24 4
CTG 4 9 1 10 4 ACG 12 2 4 12 4
H e ATT 7 4 3 2 6 Ala GCT 12 13 3 5 9
ATC 3 8 6 6 2 GCC 13 12 1 16 5
ATA 13 1 0 9 8 GCA 10 4 0 27 9
Met ATG 13 11 10 9 6 GCG 9 6 4 16 2
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Val GTT 11 11 2 5 7 Tyr TAT 5 2 0 3 6
GTC 5 6 1 7 5 TAC 4 15 1 8 7
GTA 9 1 0 5 11 His CAT 6 2 0 2 3
GTG 10 11 3 5 7 CAC 11 6 1 8 4
Ser TCT 9 5 1 7 6 Gin CAA 5 4 2 14 5
TCC 10 6 4 2 1 CAG 13 10 5 9 1
TCA 7 3 1 7 3 Asn AAT 16 0 1 6 10
TCG 8 4 1 1 2 AAC 12 12 5 12 6
AGT 12 1 0 2 5 Lys AAA 24 7 4 47 14
AGC 8 3 2 14 4 AAG 11 17 5 13 7
Asp GAT 12 5 11 5 12 Gly GGT 9 16 4 2 7
GAC 7 5 6 19 3 GGC 10 15 5 17 1
Glu GAA 17 11 9 26 18 GGA 17 2 2 18 11
GAG 14 17 11 15 13 GGG 11 0 0 6 4
Cys TGT 6 0 0 0 5 Stop TAA 0 1 0 1 1
TGC 6 9 0 14 4 TAG 1 0 1 0 0
Trp TGG 8 5 0 6 5 TGA 0 0 0 0 0
Arg CGT 9 10 2 0 4
CGC 11 12 2 0 0
CGA 4 0 0 3 0
CGG 6 2 1 2 1
AGA 9 0 0 1 3




2. Glycolytic enzyme, aldolase
3. Structural protein, calmodulin
4. Variant surface glycoprotein (VSG MiTat 1.4)
5. Expression site-associated gene (221a ESAG 1 prot.).
From the foregoing, it is clear that there is no strong bias in codon usage in 
Tglutrp. It uses all the 61 possible codons unlike, for example, calmodulin which is highly 
expressed both in terms of mRNA and protein, is highly selective in its choice of codons and 
employs only 45 of the 61 codons (40). Its pattern of codon usage is very similar to those of the 
differentially expressed genes- VSG genes and ESAGs, although even these are slightly more 
biased than Tglutrp. It may therefore be assumed that the cloned gene is lowly or poorly 
expressed in comparison to the housekeeping gene for calmodulin for instance, and therefore will 
be poorly represented in cellular mRNA species. This confirms the finding and the allusions 
made on the possible developmental regulation of this gene, on the basis of the fact that a gene 
that may be rearranged, repressed and derepressed may not have any stringent requirements in 
its codon selection. The speed of assembly of the codons/amino acids may take priority over the 
choice of codons under the circumstances.
An analysis of the nucleotide preference for the third or wobble position of the 
codons showed that a pyrimidine (C or T) is the candidate for this position. This is consistent 
with that previously observed (40). What this implies is that there is a higher frequency of
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purine dinucleotides as suggested in Nussinov’s hierarchy (50,51), which is indicative of strand 
asymmetry i.e there is a purine excess of about 7.33%. This was calculated using the total base 
composition in the coding strand, and based on the equation:
S t r a n d  a s y m m e tr y  =  - A  *  G----------—— C  x
J A + G -t T  + C
Expressed another way, the ratio of the total purine dinucleotides to total pyrimidine 
dinucleotides is 1.4 i.e 168/118. This is in consonance with most eukaryotic genes, even for 
those with unusual nucleotide composition such as the genes of P. falciparum which are 
predominantly A/T rich (240). The significance of this observation of strand asymmetry is that 
the gene sequence under study is a coding sequence, adding to the evidence of differential 
expression observed above.
A number of conclusions can therefore be made on the structure of this gene. The 
poor bias in codon choice implies that it is lowly expressed, i.e it is not constitutive. Its 
expression may be inextricably linked to precursor controls, namely mRNA abundance. The 
turnover rate of the mRNA may be very high. Such a molecular control strategy is peculiar to 
genes with strong promoters. Therefore, the TATA and CCAAT boxes, and the (CA)-enhancer 
element in the trypanosome gene may in concert, constitute the pivot of a highly mobile gene 
or one that may be switched on and off as and when its product is required. Within the context 
of trypanosome survival in the bloodstream of the host, it is envisaged here a gene that may be 
subject to developmental regulation. This may be supported by the finding that the gene is 
differentially expressed in the bloodstream forms only. Although this may be tenuous, it is fair
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to suggest that this gene is vital to its survival under the exigencies of the vector and host 
environments otherwise it would not control its expression. It may well be premature to attempt 
to justify the working assumption that the digenetic life-cycle of the trypanosome requires a 
mobile developmentally regulated GT gene that enables it to shuttle between amino acid and 
glucose dependence. There is kinetic evidence for this possibility (241). If Tglutrp is the de facto 
gene for glucose transport in the trypanosome, then the present molecular information (regarding 
differential expression) lends credence to the kinetic observations, and this would also fall into 
line with the developmental regulation of the enzymes of glycolysis (25).
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5.4 Structural profile: a functional and evolutionary comparison with
"classical" glucose transporters.
5.4.1 Sequence comparison and secondary structure prediction
The secondary structure of a protein may be predicted from a combination of 
algorithms or by relating conserved residues or sequences in a multiple alignment approach. The 
latter is currently the most widely used technique as a result of a burgeoning of sequence 
information from molecular cloning. Since structural homology and hence functional identity 
may be better conserved than sequence homology per se. it is assumed that the conformations 
of conserved residues or groups of residues which may subserve a common function, will remain 
conserved within a family inspite of some form of mutational pressure.
An averaged combinatorial prediction approach involving the use of the Chou- 
Fasman or CHF (159), Gamier-Osguthorpe-Robson or GOR (242) and the Kyte-Doolittle (157) 
methods have been employed to ascribe hydrophobicity, turns or loops, and flexibility to some 
regions of homologous sequences. The larger the number of these sequences, the greater the 
level or accuracy of prediction. However, none of these algorithms or combinations thereof, 
provide tailored solutions to structural predictions. Few predictions have stood the test of an in 
vivo structural dissection, and there are a myriad conflicting views on this point.
A priori predictions have also been used based largely on the knowledge of amino 
acid propensities.
From this study it is difficult to ascribe any secondary structural designation or 
feature to the trypanosome protein with any level of certainty. As already mentioned above, what 
may be said for now is that a large part of the structure is attributed to equal contributions of
172
a-helices and b-sheets. The turn component might also be in a significant proportion.
If Tglutrp is the authentic glucose transporter in the trypanosome, it has a very 
poor homology to the rest of the family. This is more so for its level of hydrophobicity, which 
should be the over-riding criterion for its inclusion among that group. What may be said about 
its low hydrophobicity is that it is probably an amphipathic protein, with a-helices that are 
shorter than usual. These would just about touch the lipid bilayer. In fact, recent evidence from 
experiments with model peptides and phospholipids, suggests that an effective lipid-interacting 
amphipathic a-helix need only be about 8-10 residues in length (243). This has been the model 
suggested by Lodish [1988, (244)] and for the Na+ channel [see fig. 47 (218)], since the 
available algorithms cannot predict or identify short helices.
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Fig. 47 Model of the sodium channel protein of the eel, Electrophorus electricus.
The two short helices are indicated. S1-S8 are the building subunits. 
Charged residues (basic and acidic) are in colour. Amino acid designations 













































TERMINALCYTOPLASMIC DOMAINS A-B (406-564), B-C (792-999), C-D (1268-1320)
(1571-1820)0( 1- 120)
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All the (possible) conserved motifs within the superfamily were used as markers 
to search the trypanosome sequence. There is a diffused motif spanning TM4 and TM5 
represented by:
R G G------P-Y— E----- RG
Within the trypanosome sequence, a very similar run exists in an analogous position of the
sequence except for a two-residue deletion between Y and E. A comparison is made between
the consensus sequence, Tglutrp, and lac permease of K. lactis as follows:
Consensus R-- G G------ P-Y— E----- RG
Tglutrp R-------------- P-Y E----- WG
Klact R-------------- P-Y— E----- RG
Both Tglutrp and Klact lack glycines in the consensus positions.
The sequence has no PESPR motif, but neither does the putative Leishmania or
citrate transporters (56,245). The lac permease of E. coli is probably the most salient example
of a hexose transporter with none of the modules typical of members of that family (144).
The location of the motif QPNSGI(S)NGNKT within Tglutrp would be identical
to that in the GTs except for a serine insertion. Insertions and deletions of 2-10 amino acids are
regular features in trypanosome proteins as has been found in the glycosomal isoenzymes of
glycolysis (27).
Tglutrp QPNSGISNGNKTN
GLUT2 (p robe) QQFSGI-NGIFYY
As already mentioned above, this region is the only diagnostic feature among the GTs. That this
may be the case is borne out by the fact that although the phosphate transporter has all the other
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conserved motifs seen within the GT superfamily, it partly lacks this module, the putative 
glucose binding site (246). It may be surmised that these regions compared above are in fact 
homologous. The substitution of the Y residues in a majority of GTs for T and N in the 
trypanosome sequence is not significant because all these residues are functionally identical i.e 
they are all polar residues. From a structural point of view, T and Y are both ambivalent i.e 
neither of them has any special preference for the interior or exterior of the membrane.
In comparison to the conserved motif VERAGRRT beyond TM8 and VPETK
beyond TM12 in the mammalian GTs, the closest identities are as follows:
Tglutrp AD— GRWN HPETT
Klact IDKIGRRE FVETK
GLUT 2 VEKAGRRT VPETK
Neither of these motifs is present in the putative Leishmania protein. The only 
criteria for its inclusion in this family are its relatively higher hydropathy index, and the 
presence of a motif (LQLTGINAVMNY) that is identical to the putative glucose binding site.
The conserved tryptophan residue (W) in TM11 of the superfamily has been 
implicated in cytochalasin B binding (247). If Tglutrp is the trypanosome GT, the absence of this 
residue in that position of the sequence may account for the failure of cytochalasin B to inhibit 
glucose transport in the trypanosomes (Bayele, unpublished observations).
Generally, trypanosome proteins have a relatively low homology compared to their 
counterparts in other organisms, with identities between 38-57% (40). This is a significant 
pointer to an evolutionarily distant relationship between them and other eukaryotes. The several 
peculiarities alluded to above lend credence to this view, and to the conclusions based on rRNA
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analysis (8), cytochrome c (248) and mitochondrial genes (249), that the trypanosomes diverged 
very early from other eukaryotes. As such, structural comparisons between trypanosome proteins 
or genes and those of other organisms should be done within the context of that tenuous 
relationship.
Fig. 56
Proxim ate h o m olog ies  betw een trypanosom e gene 
sequence and co n serv ed  modules o f  the G lucose  
T ran p orter  S u n erfam ilv : A p r io r i  com p arisons.
T ra n sp o rter  Subdomain
1 2 
H um glutl R F G R R (8 9 ) P M Y V G E V S P T A F R G  (1 4 2 )
R a tg lu t2  R L G R I  (9 2 ) P M Y I  G E . I A P T T L R G  (1 4 4 )
E coaraea R L G R K (8 4 ) P L Y L S  E M A S  E N V R G  (1 3 4 )
E coxy le  R F G R R (8 1 ) P M Y I A E L A P A H I R G  (1 5 1 )
Y e a s tg a l2  M Y G R K  (165) P L Y Q A E A T H K L S R G  (2 1 5 )
C h lo r e l la  N M G R K (110) P Q Y L S E V A P F S H R G  (1 5 5 )
T. b r u c e i  R H A R R  (168) P Y Y  • - E V G P A K A W G  (2 4 5 )
Leishman K I  G A R (179 ) P V Y T D Q N A H P K W K R  (2 1 1 )
E c o c itr  R I  G R R (78) S V Y L S E I A T P G M K G  (1 3 0 )
H um glutl P E S P R F L (210) Q Q L S G I N A V F Y Y (2 8 6 )
R a tg lu t2 P E S P R Y L (213) Q Q F S G I N G I F Y Y (2 8 9 )
E coaraea P N s P R W L (199) Q Q F T G M N I I M Y Y (2 6 0 )
E coxy le P E s P R W L (224) Q Q F V G I N V V L Y Y (3 0 2 )
Y e a s tg a l2 P E s P R Y - (284) Q Q L T G N N Y F F Y Y (3 6 7 )
C h lo r e l la P E s P N F L (221) Q Q F T G I N A I I F Y (2 8 1 )
T. b r u c e i - - E T L F P (321) Q P N S G I S N G N K T N (3 9 9 )
Leishman - - S T L F S (275) L Q L T G I N A V M N Y (3 3 1 )
E c o c itr  Q E T E A F S (202) T T - T T F  Y F I T V Y  (2 4 0 )
» b
Humglutl V E R A G R R (332) V P E T K G R T F D E I (459)
R a tg lu t2 V E K A G R R (335) V P E T K G K S F D E I (461)
Ecoaraea V D K A G R K (310) I P E T K N V T L E H I (438)
E coxy le V D K F G R K (349) V P E T K G K T L E E L (4 7 6 )
Y e a stg a l2 V E N L G R R (414) V P E T K G L S L E E I (5 5 4 )
C h lo r e lla S D K F G R R (330) L P E T K G V P I E R V (461)
T. b r u c e i A D - - G R W (438) H P E T T I S G P E T S (548 )
Leishman V T F M - - R (377) I Q V F F L H P W D E E (508)
E c o c itr  S D R I G R R (390) R L S S G Y Q T W E N K  (418 )
Comparison o f  r e s id u e  numbers and c a lc u la t e d  m o le c u la r  w e ig h ts
Number o f  r e s id u e s C a lc . M.wt
Hum glutl 492 54 ,1 1 7
R a tg lu t2 498 5 5 ,3 3 3
E coaraea 464 5 1 ,5 5 6
E coxy le 491 5 3 ,6 0 7
Y e a stg a l2 574 6 3 ,7 8 9
C h lo r e lla 519 57 ,6 6 7
T. b r u c e i 577 6 3 ,3 4 6
Leishman 567 6 1 ,4 4 9
E c o c itr 431 4 6 ,9 7 9
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5.4.2 Structural motifs: a functional appraisal
A number of motifs may be found in the primary structure of the trypanosome 
sequence. In comparison with the glucose transporters, the N-linked glycosylation site at Asp45 
is not found, but neither is it present in most other GTs of the lower organisms. From the 
consensus N-glycosylation sequence, N-X-S/T (where N is asparagine, X is any amino acid, S 
is serine and T is threonine), six potential N-glycosylation sites as indicated in Fig. 39 above, 
can be identified. It is unlikely however, that all these sites are glycosylated in vivo. S iteJ has 
the same glycosylation sequence to that in the putative Leishmania transport protein. Sites 4 and 
5 (in tandem) are identical both in position and sequence to that predicted for SNF3 at Asp383 
of yeast (168) and almost the same position of the presumed helix. If the GTs are duplications 
of a primordial 6 membrane-spanning transporter as has been suggested (145), this position 
would correspond to the identical position in the second half of the duplicate. It may be surmised 
that the relatively larger number of potential glycosylation sites compared to the GTs, may be 
associated with the heavy glycoprotein environment of the protein involving VSGs. Upon this 
finding it may be said that the trypanosome protein is a (membrane) glycoprotein.
Other features of functional significance include cyclic AMP-dependent protein




where any R (arginine) may be replaced by a lysine (K); S and T are as defined above and X 
is any residue. These may give an indication of the regulatory cascades involved in its operation. 
One of these sites, site is found in an analogous position in GAL2 and the maltose
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transporter. Indeed the lower forms have their phosphorylation sites within their large 
cytoplasmic loops corresponding to that position in Tglutrp. By their structure, all the GTs have 
several potential phosphorylation sites including the R-R-T motif beyond TM8 in the mammalian 
GTs. This position is absent, except the R-R repeat, in the lower GTs. However, the yeast high 
affinity glucose and galactose transporters are known to be kinase-dependent transport systems 
(250). A number of membrane proteins have been reported to act as substrates for protein kinase 
C including the glucose transporter (193). Hence, the regulation of glucose transport may 
involve the coordination of signal transduction mediated by the phosphorylation of the 
transporter by protein kinase C. The location of these potential phosphorylation sites in the 
various GTs sets a dichotomy with respect to their mechanisms of regulation. The presence and 
relevance of such sites in Tglutrp are open to question.
A general feature in all the GTs examined is the location of acidic [glutamic acid 
(E) and aspartic acid (D)], proline (P), serine (S), and threonine (T) residues at their C-termini. 
This region, the so-called "PEST" cluster, is invariably flanked by the basic residues arginine, 
lysine or histidine. These sequences have been thought to have strong implications for protein 
turnover. It has been suggested that proteins with local concentrations of acidic residues have 
very short half-lives and are therefore rapidly turned-over (251). This finding has been 
confirmed with ornithine decarboxylase in mammals, and constitutes the basis for the selective 
toxicity of difluoromethylomithine [DFMO] in trypanosomiasis treatment (252).
The occurrence of these residues at an identical position in Tglutrp puts it in this 
category of PEST-cluster-containing proteins.
Fig. 57 PEST clusters in proteins with high turn-over rates






Abbreviations are as follows :ODC, ornithine decarboxylase; HMG-CoA, 
hydroxymethylglutaryl-CoA; P730, phytochrome 730.
The "PEST" cluster in the trypanosome sequence is as follows:
+ +
HPETTISGPETSK
By comparison to the proteins above, the trypanosome protein would have a PEST score 
that would put it among those proteins that have half-lives of 0.5-1.0hr, on the basis of 
the relative mole percentages of P, E, S, and T residues. Such a high turnover rate 
would imply a rapidly turned-over message/mRNA which would be consistent with an 





B-casein RELEELNVPGEIVESLSSSEESITR ‘ 2-5
P730 HLQYMENMNSIASLVMAVWNENEEDDEAESEQPAQQQK 1.0
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Another structural element observed is an almost perfect repeat of six R 
residues after every 3 and then 4 residues in Tglutrp. This region corresponds to TM9 
in the GTs, and may hold some intrinsic function particularly in channel building. The 
sequence runs as follows:
R R R R R R
< 24 residues >
where (-) is any residue. Within the same run are 3 glycines separated from each other
by three residues (G—G—G). The entire stretch of 24 residues is enough to cross the 
membrane. This repeat unit may act as voltage sensor or a charge relay grid. Similar 
units have been found in the S4 region of K+-channels, the Na4--channel of the eel 
(218,257,258) and the acetylcholine receptor which has 4-6 R (188). In addition, dipole 
shift measurements in the squid Na+ channel indicate that there are about six charges 
that cross the membrane. Where they occur, they have been suggested to form 
amphipathic helices with the Rs lining the walls of the ion channel, and are responsible 
for sensing membrane electrical potential [(218) see Fig. 45]. Changes in membrane 
potential accordingly induces a translocation of the S4 helix with a resulting gating of the 
channel in a helical screw manner (257). This arrangement of positive charges is 
proposed to be stabilized by ionic interactions/salt bridging with proximal (or distal, 
depending on the manner of folding) negatively charged residues. Such a view has been 
noted for the acetylcholine receptor (259,260). It is too early to extrapolate this result to 
the trypanosome sequence, but the identity of the repeat units makes this possible. In the 
context of glucose transport, it may be considered that if Tglutrp is the authentic GT in 
the trypanosome, then it is probably coupled to a cation gradient i.e it is a cotransporter.
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The implication is that a gating mechanism in that region affords a conformational change 
that may facilitate ligand binding. There is no structural equivalent in the GTs that may 
perform this function though it is fair to say that the corresponding transmembrane region 
is only weakly hydrophobic.
From the point of view of the spatial organization of these residues to form 
a channel in the trypanosome, this region may be assumed to span the membrane with 
the R residues located at periodic intervals. If an a-helix is thus assigned, the R residues 
would be distributed along a spiral peptide backbone making one complete turn. They 
may alternatively lie on one side of the helix so that this region would be strongly 
amphipathic. If they are assumed to form a b-sheet structure, they would alternate with 
each other on both sides of the peptide backbone. Negative charges from adjacent or 
distal segments may be proposed to form ion pairs with the R residues of the helix. The 
positioning of glycine residues at periodic intervals among the Rs also signifies a 
tunnel/channel formation. The glycines would confer turns or bumps as they have the 
propensity to create turns and are therefore found in hinge regions of proteins. Proline 
residues (not shown) at both ends of the helix would break the helix at the endoface and 
exoface, inducing sharp turns that connect to the neighbouring segments. Such a model 
would be water-filled in order to traffic the hydrated cation the gradient of which enables 
ligand binding consequent upon an induced conformational change.
This arrangement has been depicted in the models below. Both models (the 
helical wheel and the helical net) confirm the above prediction. One turn of an a-helix 
requires approximately 3.6 residues. Therefore, in any peptide that constitutes an
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amphipathic a-helix, there will be a periodic variation in the hydrophobicity values with 
a periodicity of 3.6 residues per cycle. The helical wheel particularly holds this point well, 
as seen in the clustering of almost all the R residues on one side of the helix, and the 
glycines interspersed with them. This half of the helix is absolutely polar. The other half 
has one potential salt-bridge which would nullify the charge contributions of R and D. 





Fig. 58 Helical wheel of residues with a channel-forming/amphipathic helix
potential. Residues are arranged 100° or 3.6 residues (3607100°) apart. 
Hemisphere [1] is entirely/strongly polar.
184
ROTATION
Fig. 59 Helical net presentation of Fig.48. Rotation along the axis of the helix is 
indicated in degrees. Distance between residues is in angstroms
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Na+ ion binding to the intestinal glucose transporter has been observed 
to produce a conformational change at the glucose binding site which results in an 
increase in affinity for glucose binding (261). By using fluorescence energy transfer, it 
was found that the Na+ and glucose binding sites in the intestinal brush border 
symporter were separated by about 30-35 A (262). This corresponds to about 20-25 
amino acids or one transmembrane segment; this is also a perfect fit to the channel length 
proposed above. Combined with earlier indications that ASA-BMPA binds to TM10, it 
may be said that these observations satisfy the arrangement for a Na+/glucose 
transporter. If this is the case then the finding that the trypanosome transporter is coupled 
to a Na+ gradient is credible (153), depending on whether Tglutrp is the trypanosome 
glucose transporter.
Are there any topogenic or targeting signals 
that might give a clue to the subcellular 
location of the cloned trypanosome protein?
Until recently, there have been speculations as to the nature of the 
targeting signals involved in the post-translational exporting and sorting of microbody 
(peroxisomal, glyoxysomal and glycosomal) proteins (27). Since these proteins lack a 
cleavable signal peptide, their topogenic signals may be internal. In some peroxisomal 
proteins, targeting signal sequences have been identified at the C-terminus with the aid 
of site-directed mutagenesis. These sequences comprise the consensus tripeptide S-K-L
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to within 30 residues of the carboxy terminus. Targeting was abolished with the 
replacement of K with N, probably suggesting a key role for this residue (263,264).
A comparison of the C-terminus of Tglutrp with those of peroxisomal 
proteins identified a very similar and possibly homologous sequence located 19 residues 
from the carboxy terminus. Incidentally, this region of Tglutrp also constitutes the 
putative hot-spot for its turnover. The implications of this coincidence could be very 
strong indeed. An alignment of these sequences is presented as follows:
Protein__________________________ C-terminal sequence____ Ref
Acyl coA oxidase K H L K P L Q S K L  2 65
Bifunctional enzyme S L A G P H G S K L  2 66
Malate synthase I H H P R E L S K L  2 67
Firefly luciferase K A K K G G K S K L  268
Tglutrp T I S G P E T S K Q
Although the identity between these sequences and Tglutrp is significant,
it is not certain whether there is any functional relationship between them in terms of 
targeting. What is certain is that those sequences have been confirmed for the referenced 
proteins. The functional and morphogenetic relationship between the glycosomes of 
trypanosomatids on the one hand, and peroxisomes and glyoxysomes on the other, may 
justify a qualified speculation. If a topogenic function can be ascribed to that region of 
Tglutrp, then the latter is probably a glycosomal membrane protein. The charge 
distribution in Tglutrp, and the presence of insertions and deletions, are consistent with 
those reported for glycosomal proteins (27). IF it is a glucose transporter, then it 
probably is the glycosomal isoform.
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5.5 CONCLUSIONS AND SUGGESTIONS FOR FURTHER STUDY
There are a number of specific differences between the trypanosome and 
mammalian GTs.
a. The trypanosome GT is not inhibitable by phloretin which is routinely employed 
in quenching glucose transport in mammalian systems; the glycone analogue, 
phloridzin, is a more potent inhibitor of transport in the trypanosome. The 
inhibition kinetics of phloridzin in that transporter is identical to those of the 
Na+/glucose cotransporter. Is the trypanosome GT a Na+/glucose cotransporter?
b. Cytochalasin B has no inhibitor effect even though this is the classical tag for 
studying the transporter in mammalian systems.
c. It has a 20*50 fold higher affinity for glucose compared to mammalian GTs.
d. Photolabeling of the transporter with ATB-BMPA is not displaceable by 
phloridzin. This implies that the two ligands probably have different binding sites 
on the transporter (Fry A, unpublished observations).
e. The trypanosome GT is capable of transporting fructose (17) whereas the 
mammalian erythrocyte GT is not. Besides, the furanose form of this sugar is the 
preferred configuration for transport by the former.
These, largely kinetic, differences spell very basic differences in the 
structures of their cognate glucose transporters. The one motif that is unlikely to differ 
is the glucose binding site in both forms of transporter. It may therefore be envisioned 
here that the trypanosome transporter may contain residues proximal or distal to this site, 
that directly or indirectly modulate the kinetics of transport, and to give the observations
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mentioned here.
It may be said that the added specificity requirements of hexokinase, with 
inference from Berlin’s work (138), may place further constraints on the specificity of the 
glucose transporter in the trypanosome. This is especially so since hexokinase is 
ensconced within the glycosome. This may account for a number of positional preferences 
of the transporter for the various carbons or their substituents. It is therefore possible that 
a form of synergistic specificity is imposed stringently on every carbon by both the 
transporter and hexokinase to result in the differences in substrate specificity observed 
between trypanosomes and mammalian systems. Having said that, the question is where 
is the glucose transporter in the trypanosome with respect to hexokinase? Is it glycosomal 
or is it on the plasma membrane?
In this study, a gene has been cloned that bears only segmental homology 
to the glucose transporters. Some key conserved domains or residues are identifiable with 
the cloned sequence. However, its hydrophobicity profile is inconsistent with the GTs or 
with the probe that was used to clone it. This is the one factor that disqualifies it. If it 
were sufficiently hydrophobic, it would pass as a GT. However, if the above differences 
in function or kinetics may be extrapolated to a structural elucidation, it is probably only 
fair to have an open mind in that respect. Therefore, the interpretation of any molecular 
characteristics of the two forms of transporter should be done within the context of those 
observations, i.e the trypanosome GT may be significantly (structurally) different from 
its homologues in other organisms.
However, if it is not a glucose transporter, it is difficult to make any
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functional inferences especially as it shows specific hybridization (from two gene 
libraries) to a well characterized glucose transporter, the rat GT cDNA.
Obviously, the only way to ascribe a function to this gene is to express it 
and measure glucose transport. It would then be possible to raise antibodies to specific 
segments of the protein to assess the transmembrane topology and to provide proof of or 
deny the predictions based on the algorithms used to define its hydrophobicity in this 
study. It may also be possible to create chimaeras with mammalian GTs to characterize 
transport kinetics with the aim of locating regions of "kinetic sensitivity", especially if 
the trypanosome GT may be used as a chemotherapeutic target. The contributions of 
various residues to transport may also be studied by site-directed mutagenesis etc.
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ADDENDUM
At the close of this thesis, two isoforms of a putative hexose transporter 
cDNA (THT) were reportedly cloned using a VSG-specific probe (269). The two are 
highly homologous to the putative Leishmania transporter (LTP). Like the LIP, neither 
isoform has any of the conserved motifs (except the putative glucose binding site) 
discussed in the text, and which have earlier been used as probes to clone the 
trypanosome GT. In terms of motif representation, Tglutrp has a higher score than LTP 
or THT. If the cloned genes are the authentic GTs, the absence of these motifs explains 
the failure to isolate those genes from the gene libraries, using those motifs as probes. 
A number of pertinent questions remain unanswered:
a. Is LTP the Leishmania glucose transporter? No evidence has been advanced within 
the last three years to support the speculation on this issue. The cloned putative 
GTs from the trypanosome will have to satisfy the functional test of glucose 
transport The purely conjectural nature (as to function) of those genes, 
underscores the need for expression studies or at least to demonstrate hybridization 
to a better characterized and de facto glucose transporter. Besides, the homology 
of the citrate transporter (245), the phosphate transporter (246), and the a- 
ketoglutarate transporter (270) to the GT superfamily, makes no room for 
complacency in respect of ascribing glucose transport function to the cloned 
Kinetoplastid genes.
b. If the THTs are true to type, what is the function of a gene that shows specific 
hybridization to a well characterized GT viz. the rat GT cDNA. [Hybridization is
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deemed specific on the basis of having cloned the same gene from two different 
libraries using cDNA and glucose-binding site probes].
c. The homology of THT to LTP suggests a functional identity. There is evidence 
for H+/glucose symport in both Leishmania and T. brucei. with similarities in 
Kms. If the two proteins are GTs, can it be inferred that THT is a coupled 
transporter? What then comes of the evidence of facilitated transport accruing from 
this study and others before?
d. The hydrophobicity profile of THT illustrates a typical 12 membrane-spanner. 
Which membrane does it span? The plasma membrane or the glycosomal 
membrane? [The compartmentation within the trypanosome, teleologically, would 
require a glycosomal GT as well]. Could there be plasma membrane-specific and 
glycosomal membrane-specific isoforms of the trypanosome GT? How structurally 
identical or different are they?
Needless to say, there are many more questions than answers with the new 
information, and unfortunately there will not be answers for some time yet
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Addendum: Comparison of THT with the erythrocyte GT and LTP
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APPENDIX A: REAGENTS 
General Buffers
Krebs Ringer Phosphate, pH8.0 Krebs Ringer Hepes, pH7.6
k h2po4 22mM Hepes lOmM
NaCl 98mM NaCl 140mM
KCl 2 mM KCl 2mM
MgS04 1 mM MgCl2 ImM
k h2po4 2mM
SSC, 2OX CaCl2 ImM
NaCl 3 M
Na2 citrate 0.3M Tris-acetate, TAB,
Tris-acetate 0.8M
SSPE, 2OX pH7 .4 NaAc 1.0M
NaCl 3M EDTA 0.02M
NaH2P04 0.2M
EDTA 20mM Tris-Borate, 20X
Tris base 1M
TE, pH7. 4, 7. ax * 00 • o Boric acid 1M
Tris-HCl lOmM EDTA 20mM
EDTA 1 mM
Tris-glyine, 10X
MOPS, 10X Tris-base 250mM
MOPS 200mM Glycine 2 . 5M
NaAc 50 mM SDS 1%
EDTA 10 mM
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Gel loading buffer for DNA
bromophenol blu§.25%
T4 polynucleotide kinase, 10X
Tris-HCl, pK7 .5 ioo**wi
xylene cyanol FfT&*25% MgCl2 10 OmM
DTT 5 OmM
spermidine ImM
Klenow, 10X One-Phor-All Buffer PLUS,
Tris-HCl, pH7.45 0 OmM Tris-acetate, pttVJ |©©'sKA




T3/T7 RNA polymerase, 10X
T4 DNA Ligase, 10X Tris-HCl, pH8 | o o o * * i a
Tris-HCl, pH7.5500mM MgCl2 8 OmM
MgCl2 10OmM NaCl 50 OmM






Denhardt's solution, 10OX NaOH 0 .4M
Ficoll 2g/100ml NaCl 0. 6M
polyvinylpyrrol)!}/ f o *  wJ. Neutralizing solution
BSA (Fraction NaCl 1.5M
Tris-HCl, pH7 5M
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APPENDIX B APPENDIX C
Nutrient/growth media Recognition sequence
Luria-Bertani (LB) medium enzymes
Bactotryptone 10g/l Enzyme Site
Yeast extract 5g/l Apal GGGCC^C
NaCl 10g/l BamHl G^GATCC
EcoRl G^AATTC
Luria-Bertani (LB) Agar HindiII A^AGCTT
LB medium plus : for Kpnl GGTAC^C
Top agar 7g/l Pstl CTGCA^G
Plate agar 15g/l PvuII CAG^CTG
Sacl GAGCT^C
Lambda storage medium (SM) Sail G^TCGAC
NaCl 5g/l Sau3A AGATC
MgS04.7H20 2g/l Smal CCC^GGG
1M Tris-HCl, pHf* Xhol C^TCGAG.
2% gelatin 5ml/l
(*) Endonuclease cleavage 
2X yeast extract-tryptone site.
(DYT)
Bactotryptone 16g/l 
yeast extract 10g/l 
NaCl 5g/l








Absorbance at A.,^ 
for 1M Solution (E) 
(pH 7.0)
ATP 507.2 259 15,400
CTP 483.2 271 9,000
GTP 523.2 253 13,700
UTP 484.2 262 10,000
dATP 491.2 259 15,200
dCTP 467.2 271 9,300
dGTP 507.2 253 13,700
dTTP 482.2 267 9,600
Conversion formula
(observed absorbance at A.,^) 
absorbance at A.™, for 1M solution = molar concentration of nucleic acid
Reference:
Freifelder, D. (1982) in Physical Biochemistry, W.H. Freeman and 
Company, 494-536.




Lambda DNA 48,502 (circular, dsDNA) 3.0 x 107
pBR322 DNA 4,363 (dsDNA) 2.8 x 106
28S rRNA 4,800 1.6 x10s
23S rRNA 3,700 1.2 x 10s
18S rRNA 1,900 6.1 x 105
16S rRNA 1,700 5.5 x 10s
5S rRNA 120 3.6 x 104
tRNA (E  coli) 75 2.5 x 104
Standards
1. 1kb of double-stranded DNA (sodium salt) = 6.6 x 105 Daltons.
2. 1kb of single-stranded DNA (sodium salt) = 3.3 x 105 Daltons.
3. 1 kb of single-stranded RNA (sodium salt) = 3.4 x 105 Daltons.
4. The average MW of a  deoxynucleotide base = 324.5 Daltons.
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b. Codon Dictionary
1st Position CUA Leu CCA Pro CAA Gin CGA Arq A 3rd Position
2nd Position
u C A G
UUU Phe UCU Ser UAU Tyr UGU Cys U
UUC Phe UCC Ser UAC Tyr UGC Cys C
UUA Leu UCA Ser UAA End UGA End A
UUG Leu UCG Ser UAG End UGG Trp G
CUU Leu CUU Pro CAU His CGU Arg U
CUC Leu CCC Pro CAC His CGC Arg C
g
CUG Leu CCG Pro CAG Gin CGG Arg G
AUU lie ACU Thr AAU Asn AGU Ser U
AUC lie ACC Thr AAC Asn AGC Ser C
AUA lie ACA Thr AAA Lys AGA Arg A
AUG Met ACG Thr AAG Lys AGG Arg G
GUU Val GCU Ala GAU Asp GGU Gly U
GUC Val GCC Ala GAC Asp GGC Gly C
GUA Val GCA Ala GAA Glu GGA Gly A
GUG Val GCG Ala GAG Glu GGG Gly G
The codons read in the 5'-» 3 ' direction. 
Termination codons are in bold.
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c. Single letter annotation and molecular weights o£ 
amino acids
Three-letter One-letter Molecular 
Amino Acid Abbreviation Symbol Weight
Alanine Ala A 89
Arginine Arg R 174
Asparagine Asn N 132
Aspartic acid Asp D 133
Asparagine or aspartic acid Asx B —
Cysteine Cys C 121
Glutamine Gin Q 146
Glutamic Acid Glu E 147
Glutamine or glutamic acid Glx Z —
Glycine Gly G 75
Histidine His H 155
Isoleucine lie 1 131
Leucine Leu L 131
Lysine Lys K 146
Methionine Met M 149
Phenylalanine Phe F 165
Proline Pro P 115
Serine Ser S 105
Threonine Thr T 119
Tryptophan Trp W 204
Tyrosine Tyr V 181
Valine Val V 117
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d. Venn diagram o£ amino acid propensities
tiny
a lipha tic sm all
s-s
positivea ro m a tic
polar
hydrophobic c h a rg e d






supE hsdR <p80r P2
supE hsdh5 thi Mlac-proAB)
F' [traD36 proAB ' l a d q /acZAMl5]
supE44 hsdR 17 recA 1 endAl gyrA46 thi 
re LAI lac
F' [proAB ' lad*  lacZAM15 Tn 10(tetT)]
supE44 hsdS20(rQm^) recA 13 ara-14 
proA2 lacY  1 ga/K2 rpsL20 xyl-5 m*Z-1
supE thi Mlac-proAB)
F' [traD36 proAB * la d q /acZAMl5]
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